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ABSTRACT 
 
Full Name : Muhammad Sajid 
Thesis Title : Screening of endocrine disrupting compounds in biological samples 
and evaluation of their accumulation patterns 
Major Field : Chemistry 
Date of Degree : May 2016 
 
Endocrine disrupting compounds (EDCs) pose serious health risks to human and wild life 
due to their toxicity, very long half-lives and bioaccumulation. EDCs induce a variety of 
carcinogenic and non-carcinogenic disorders in human and they become functional at 
extremely low concentrations. Efficient and cost-effective analytical methods are always 
demanded in order to extract and determine such low concentrations of EDCs in 
environmental and biological samples. In this research work, different analytical methods 
were developed for extraction and determination of different classes of EDCs in biological 
samples. Analytical methods were developed by using four famous classes of EDCs i.e. 
parabens, phthalate esters (PEs), organochlorine pesticides (OCPs) and polychlorinated 
biphenyls (PCBs). EDCs were also screened in biological samples.  
A simple and efficient analytical method was developed for quantification of parabens in 
cancer tissues. This method involved the simultaneous use of microwave-assisted solvent 
extraction (MASE) and micro-solid phase extraction (μ-SPE), in tandem with high 
performance liquid chromatography (HPLC/UV). The parabens studied included methyl, 
ethyl, propyl and butyl parabens. Optimization of the experimental parameters for MASE 
and μ-SPE was performed. RSDs ranged from 0.09 – 2.81%. Coefficients of determination 
(R2) up to 0.9962 were obtained across a concentration range of 5.0- 200 ng g-1. The method 
detection limits for parabens ranged from 0.005 - 0.0244 ng g-1. The procedure was initially 
tested on prawn samples to demonstrate its feasibility on a complex biological matrix. 
Preliminary studies on human ovarian cancer tissues showed presence of parabens. Higher 
levels of parabens were detected in malignant ovarian tumor tissues compared to benign 
tumor tissue samples. 
xix 
 
For the first time, an efficient and cost effective natural material (seed powder of Moringa 
oleifera) was employed as sorbent in µ-SPE. The sorbent was found to be naturally 
enriched with variety of functional groups and having a network of interconnected fibers. 
This method of extraction integrated different steps such as removal of proteins and fatty 
stuff, extraction and pre-concentration of target analytes into a single step. Thirteen 
phthalate esters were selected as target compounds for the development and evaluation of 
method. Some key parameters affecting the extraction efficiency were optimized,  
including selection of membrane, selection and amount of sorbent, extraction time, 
desorption solvent, volume of desorption solvent, desorption time and effect of salt 
addition. Under the optimum conditions, very good linearity was achieved for all the 
analytes with coefficient of determinations (R2) ranging between 0.9768 and 0.9977. The 
limits of detection ranged from 0.01 to 1.2 µg L-1. Proposed method showed satisfactory 
reproducibility with relative standard deviations ranging from 3.6% to 10.2% (n=7). 
Finally, the developed method was applied to tetra pack and bottled milk samples for the 
determination of phthalate esters.  
A novel modification in membrane protected micro-solid phase extraction was introduced 
for screening of PCBs in serum samples. This new configuration of micro-solid phase 
extraction was termed as stir-bar supported micro-solid-phase extraction (SB-µ-SPE). A 
tiny stir-bar was packed inside the porous polypropylene membrane along with sorbent 
material and the edges of membrane sheet were heat sealed to secure the contents. The 
packing of stir-bar inside the µ-SPE device, does not allow the device to stick with the wall 
or any corner or float over the surface of the sample solution. This mode also enhances 
effective surface area of the sorbent exposed to sample solution. Polychlorinated biphenyls 
(PCBs) were selected as model compounds and the method performance was evaluated in 
human serum samples. After extraction, samples were analyzed by gas chromatography 
mass spectrometry (GC-MS).  The factors that affect extraction efficiency of SB-µ-SPE 
were optimized. Under optimum conditions, a good linearity (0.1 – 100 ng mL-1) with 
coefficients of determinations ranging from 0.9868 to 0.9992 were obtained. Limits of 
detections were ranged between 0.003 and 0.047 ng mL-1.  Acceptable values for inter-day 
(3.2 – 9.1%) and intra-day (3.1 – 7.2%) relative standard deviations were obtained. The 
xx 
 
optimized method was successfully applied to determine the concentration of PCB 
congeners in human serum samples.  
In another work, ZnO nanoparticles incorporated porous carbon foam was utilized as 
sorbent for extraction and preconcentration of OCPs in milk samples. This sorbent was 
prepared by a facile single step reaction between the sucrose and zinc nitrate by slight 
modification of a reported procedure. The sorbent was characterized by scanning electron 
microscopy and X-ray diffraction. The sorbent was then packed inside a porous 
polypropylene membrane sheets by heat sealing of membrane to construct µ-SPE devices. 
The factors that affect performance of µ-SPE were optimized. This method provided good 
linearity up to 0.9998 with limit of detections ranging from 0.19 to 1.64 ng/mL. This 
method also provided satisfactory values for intra and inter-day precision with RSDs 
ranged between 2.3 to 10.2%.   
In the last part of the work, OCPs and PCBs were screened in real human cancer tissues 
and plasma samples and accumulation patterns were studied to sort out most frequently 
detected compounds.  
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 CIBARA NI TCARTSBA
 ملخص الرسالة
 
 
 محمد ساجد :الاسم الكامل
 
 اضطراب الغدد الصماء في العينات البيولوجية وتقييم أنماط تراكمهافحص مركبات  :عنوان الرسالة
 
 كيمياء التخصص:
 
 6102مايو  :تاريخ الدرجة العلمية
 
على حياة الإنسان والحياة البرية نظرا ًلسميتها، طول  مخاطر صحية خطيرة اضطراب الغدد الصماء  تشكل مركبات
نصف عمر تفككها وكذلك تراكمها البيولوجي. هذه المركبات تؤدي لمجموعة متنوعة من الاضطرابات المسببة وغير 
 ةالمسببة للسرطان في الإنسان وهي ذات أثر حتى بتراكيز منخفضة للغاية. هناك حاجة لأساليب تحليلية قليلة التكلف
 المركبات في العينات البيئية والبيولوجية. وذات كفاءة عالية لاستخلاص وتحديد مثل هذه التراكيز المنخفضة من
في العينات  في هذا البحث، تم تطوير طرق تحليل مختلفة لاستخلاص وتحديد الأنواع المختلفة من هذه المركبات 
هي البارابينات، استرات الفثالات،  من هذه المركبات ة أنواعالبيولوجية. وقد تم تطوير طرق للتحليل باستخدام أربع
 .مبيدات الكلور العضوية ومركبات ثنائي الفينيل متعدد الكلور، وتم عمل مسح لها في عينات بيولوجية
تم تطوير طريقة تحليلية بسيطة وفعالة لتقدير البارابينات في الأنسجة السرطانية، تضمنت هذه الطريقة الاستخلاص 
المذيب بمساعدة الميكروويف متزامنا ً مع الاستخلاص الدقيق باستخدام مادة صلبة، متبوعين بالتحليل باستخدام ب
الكروماتوغرافيا السائلة عالية الاداء مع كاشف الأشعة فوق البنفسجية. وتضمنت البارابينات تحت الدراسة كل من 
عياري ء عملية تحسين للمتغيرات التجريبية، وتراوح الانحراف المباربين الميثيل، الإيثيل، البروبيل والبوتيل. تم إجرا
في مدى من التراكيز  2699.0بينما وصلت قيمة مربع معامل الإرتباط إلى   % 18.2 – 90.0 النسبي المئوي ما بين
لكل نانوغرام   4420.0 – 500.0نانوغرام لكل جم، وتراوحت الحدود الأدنى الكشف بين  002 – 5.0تراوح بين 
جم. تم إجراء اختبار مبدئىي للطريقة على عينات من الجمبري لإثبات قابليتها للتطبيق على المصفوفات البيولوجية 
المعقدة. أظهرت الدراسات الأولية على أنسجة سرطانية للمبيض في الإنسان وجود هذه البارابينات، كما أظهرت 
 .نات الأنسجة الخبيثة مقارنة بعينات الأنسجة السرطانية الحميدةالتحاليل وجود مستويات أعلى من البارابينات في عي
للمرة الأولى تم استخدام مسحوق بذور البان الزيتوني كمادة مازة طبيعية قليلة التكلفة وفعالة في الاستخلاص الدقيق 
ريقة في عتبر هذه الطبالمادة الصلبة، حيث إنها تحتوي على مجموعات وظيفية مختلفة وشبكة من الألياف المترابطة. ت
الاستخلاص طريقة متكاملة، حيث تشتمل على إزالة البروتينات والمواد الدهنية، واستخراج و تركيز التحاليل المستهدفة 
في خطوة واحدة. وقد تم اختيار ثلاثة عشرة من المركبات المستهدفة من استرات الفثالات لتطوير وتقييم الطريقة. تمت 
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الأساسية التي تؤثر على كفاءة الاستخلاص مثل نوع الغشاء، كمية المادة الماصة زمن دراسة بعض المعايير 
الاستخلاص. كما تمت دراسة نوع وحجم مذيب الإنحلال والزمن اللازم لذلك، وتأثير إضافة الملح. تحت الظروف 
ارتباط تراوحت ما بين  الأمثل تم الحصول على مجال خطي جيد جدا لجميع المواد المحللة تحت الدراسة بمعاملات
ميكروغرام لكل لتر. أظهرت الطريقة  2.1 – 10.0، وتراوحت الحدود الأدنى الكشف بين 7799.0و  8679.0
(عدد مرات التكرار  % 2.01 – 6.3المقترحة نتائج تكرار مرضية مع انحرافات معيارية نسبية مئوية تراوحت بين 
 .ر استرات الفثالات في مجموعة من عينات الحليب المعبأة). أخيرا،ً تم تطبيق هذه الطريقة لتقدي7= 
تم إدخال تعديل جديد في الغشاء للاستخلاص الدقيق بواسطة مادة صلبة للكشف عن مركبات ثنائي الفينيل متعدد الكلور 
لين وبفي هذا التركيب الجديد تم وضع قضيب تحريك مع المادة الماصة داخل غشاء البولي بر  .في عينات مصل الدم
وتم قفله بالحرارة لمنع محتوياته من التسرب للخارج. هذا الترتيب يمنع المادة المازة من الالتصاق بجدار الغشاء كما 
يمنعها من الطفو فوق سطح المحلول مما يزيد من مساحة سطح المادة المازة. بعد استخلاص مركبات ثنائي الفينيل 
تحليلها بواسطة كروماتوغرافيا الغاز المقترنة بمطياف الكتلة. تم تحسين متعدد الكلور من عينات مصل الإنسان، تم 
العوامل التي تؤثر على كفاءة الاستخلاص، وتحت الظروف الأمثل تم الحصول على مجال خطي جيد جدا في مدى من 
، بينما 99.029و  8689.0نانوغرام لكل مل  بمعاملات ارتباط تراوحت ما بين  001 – 1.0التراكيز تراوح بين 
أظهرت الطريقة المقترحة نتائج تكرار مقبولة   نانوغرا لكل مل. 740.0 – 300.0تراوحت الحدود الأدنى الكشف بين 
 خلال اليوم الواحد. % 2.7 – 1.3في أيام مختلفة و  % 1.9 – 2.3مع انحرافات معيارية نسبية مئوية تراوحت بين 
النانوي في رغوة الكربون بغرض تكوين مادة مازة لاستخلاص مبيدات  في عمل آخر، تم دمج أكسيد الزنك ذو الحجم
الكلور العضوية من عينات الحليب. تم تحضير المادة المازة بتفاعل بسيط وفي خطوة واحدة بين السكروز و نترات 
زة داخل دة الماالزنك. وتم تشخيصها بواسطة  المسح الإلكتروني المجهري وحيود الأشعة السينية. تمت تعبئة هذه الما
غشاء البولي بروبلين المسامي والذي تم الصاق جوانبه بالحرارة لعمل أداة للاستخلاص الدقيق بواسطة مادة صلبة. تم 
تحسين العوامل التي تؤثر على كفاءة الاستخلاص، وتحت الظروف الأمثل تم الحصول على مجال خطي جيد جدا 
أظهرت الطريقة نتائج   نانوغرا لكل مل. 46.1 – 91.0الكشف بين ، وتراوحت الحدود الأدنى 8999.0وصلت إلى 
 في أيام مختلفة وخلال اليوم الواحد. % 1.01 – 3.2تكرار مقبولة مع انحرافات معيارية نسبية مئوية تراوحت بين 
ي عينات ف في الجزء الأخير من هذا البحث تم فحص مركبات الكلور العضوية ومركبات ثنائي الفينيل متعدد الكلور 
حقيقية لأنسجة سرطانية وعينات بلازما بشرية وتمت دراسة أنماط التراكم وذلك لفرز هذه المركبات التي أوضح 
 .الكشف عنها عن وجودها في معظم الأحيان
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1 CHAPTER  
INTRODUCTION 
1.1. Analysis of endocrine disrupting compounds in biological samples 
 
Endocrine disrupting compounds (EDCs) are the chemicals that interfere with endocrine 
system in human and wildlife. These chemicals disrupt the endocrine system by interacting 
with hormonal functions [1].  Exposure to EDCs may induce developmental, reproduction, 
neurological and immunological disorders.  EDCs have also been associated with diseases 
like cancer, diabetes and decreased fertility. Most of the EDCs are persistent in nature and 
have ability to accumulate in biological tissues.  
It is the matter of fact that health related issues increasing and more and more abnormalities 
are being associated with the use of EDCs. Some recent reports show that EDCs has 
resulted in increased rates of testicular and thyroid cancers among adult male population 
[2][3].  EDCs have very high impact on insulin signaling, reproductive health, functioning 
of thyroid and bone growth. Some PCBs and pesticide atrazine has been reported to have 
effect over proteomes of the breast cancer cells. EDCs are present in environment as 
mixture and they can have synergistic or additive effects. [4].  
The man-made EDCs include pesticides, polychlorinated biphenyls, personal care 
products, plasticizers, heavy metals and other industrial products. Such EDCs are abundant 
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in the environment. Human exposure to these chemicals may occur through inhalation, 
dermal contact and digestion. Contaminated air, water and food are major sources of EDCs.  
There is the lack of knowledge on the role of EDCs in causing different kind of health 
related issues in Kingdom of Saudi Arabia. This is leading factor which motivates to screen 
biological samples for possible presence of EDCs. Since the country is the largest 
producers of oil based products which might result in the production of toxic by-products 
released into the environment. Studies in other parts of the world have associated presence 
of EDCs in the break down products released from oil combustion and they share similar 
structures to the EDCs [5–8]. Such compounds could enter the system through 
contaminated air, water and food. Till now, no studies were performed to access the effects 
of these toxic compounds in triggering different endocrine related cancers in the Kingdom. 
The study attains more importance considering the drastic increase in the cases of different 
endocrine related cancers in the Kingdom in the recent years which has been mostly 
attributed to changes in life style and over dependence on processed food products which 
might be exposed at some stage to these harmful chemicals [9].    
EDCs become functional at very low concentrations. The presence of EDCs in biological 
samples such as tissues, milk, blood and urine can give an insight to their exposure. Thus, 
accurate measurements of EDCs in biological samples are needed. As biological samples 
represent very complex matrix, sample preparation is an unavoidable step before 
instrumental analysis of EDCs in biological samples. This sample preparation typically 
involves removal of interferences, preconcentration of target compounds and extract clean 
up. Moreover, an ideal sample preparation method for biological samples should utilize 
minimum amount of biological samples.   
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Traditional sample preparation methods such as solid phase extraction (SPE) and liquid-
liquid extraction require large amount of sample. In addition, they utilize extremely high 
volumes of hazardous organic solvents and other chemicals. Thus, the area of sample 
preparation is now shifting toward development of miniaturized extraction techniques. In 
last few years, number of new microextraction techniques have been developed. These 
techniques include solid phase microextraction (SPME), liquid phase microextraction 
(LPME), dispersive solid phase extraction (d-SPE), dispersive liquid-liquid 
microextraction (DLLME) and many of their modified forms. These techniques utilize are 
either solventless or utilize small volume of organic solvents (up to few hundred 
microliters). However, for analysis of complex biological samples, these techniques have 
some limitations such as SPME fiber cannot be directly immersed in biological samples 
because fats can adsorb over it. Similarly, DLLME require pretreatment of the sample, as 
it best suits for clean samples. The major objective of this work is to develop the sample 
preparation methods that can be utilized for screening of EDCs in biological samples. 
1.2. Thesis Summary  
This section provides brief summary of each chapter. Each chapter is written in 
manuscript format.  
1.2.1. Chapter-2 
 
Chapter-2 provides a comprehensive literature survey on advancements and challenges in 
analysis, and health effects of endocrine disrupting and persistent organic pollutants. 
Persistent and endocrine disrupting organic pollutants pose serious health risks to humans 
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and wild life due to their long half-lives, bioaccumulation and toxicity. These compounds 
have negative impact on human health and induce a variety of carcinogenic and non-
carcinogenic disorders. Extremely low concentrations of these compounds can induce 
adverse health effects in human. Efficient analytical methods are always demanded in order 
to extract and determine such low concentrations in environmental and biological samples. 
In the last decade, studies mostly focused on profiling and identification of persistent and 
endocrine disrupting pollutants in tissues and body fluids using various analytical methods. 
However, investigation of trace level pollutants associated with various disorders requires 
complex analytical protocols.  Biological matrix presents serious challenge in extraction of 
these pollutants mainly because of its complexity and inherent limitations of extraction 
procedures. The advantages and pitfalls of recent extraction approaches are highlighted. 
Analysis of these compounds is carried out by using gas and liquid chromatographic 
methods coupled with different detectors. The current status of advancements in area of 
analytical chromatography and accomplishments and weaknesses have been pointed out. 
At the end, some health effects and clinical correlates of persistent and endocrine disrupting 
organic pollutants are encapsulated. 
1.2.2. Chapter 3   
 
This chapter describes an application of microwave assisted micro-solid-phase extraction 
for screening of parabens in human ovarian cancer tissues. Parabens (alkyl esters of p-
hydroxybenzoic acid) are widely used as preservatives in food, cosmetics and 
pharmaceutical products. However, weak estrogenicity of some parabens has been reported 
in several studies, which provided the impetus for this work. Here, a simple and efficient 
analytical method for quantifying parabens in cancer tissues has been developed. This 
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technique involves the simultaneous use of microwave-assisted solvent extraction (MASE) 
and micro-solid phase extraction (μ-SPE), in tandem with high performance liquid 
chromatography (HPLC/UV) analysis for the determination of parabens. The pollutants 
studied included four parabens (methyl, ethyl, propyl and butyl parabens). Optimization of 
the experimental parameters for MASE and μ-SPE was performed. Good relative standard 
deviation (%R.S.D) ranged from 0.09 – 2.81% and high enrichment factors (27 – 314) were 
obtained. Coefficients of determination (r2) up to 0.9962 were obtained across a 
concentration range of 5.0- 200 ng g-1. The method detection limits for parabens ranged 
from 0.005 - 0.0244 ng g-1. The procedure was initially tested on prawn samples to 
demonstrate its feasibility on a complex biological matrix. Preliminary studies on human 
ovarian cancer (OC) tissues showed presence of parabens. Higher levels of parabens were 
detected in malignant ovarian tumor tissues compared to benign tumor tissue samples. 
1.2.3. Chapter 4 
 
This chapter describes method development for screening of phthalate esters in milk 
samples. In the present study, a natural sorbent based micro-solid phase extraction (µ-SPE) 
was developed for determination of phthalate esters in milk samples. For the first time, an 
efficient and cost effective natural material (seed powder of Moringa oleifera) was 
employed as sorbent in µ-SPE. The sorbent was found to be naturally enriched with variety 
of functional groups and having a network of interconnected fibers. This method of 
extraction integrates different steps such as removal of proteins and fatty stuff, extraction 
and pre-concentration of target analytes into a single step. Thirteen phthalate esters were 
selected as target compounds for the development and evaluation of method. Some key 
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parameters affecting the extraction efficiency were optimized,  including selection of 
membrane, selection and amount of sorbent, extraction time, desorption solvent, volume 
of desorption solvent, desorption time and effect of salt addition. Under the optimum 
conditions, very good linearity was achieved for all the analytes with coefficient of 
determinations (R2) ranging between 0.9768 and 0.9977. The limits of detection ranged 
from 0.01 to 1.2 µg L-1. Proposed method showed satisfactory reproducibility with relative 
standard deviations ranging from 3.6% to 10.2% (n=7). Finally, the developed method was 
applied to tetra pack and bottled milk samples for the determination of phthalate esters. 
The performance of natural sorbent based µ-SPE was better or comparable to the methods 
reported in the literature. 
1.2.4. Chapter 5 
This chapter describes a novel modification in membrane protected micro-solid phase 
extraction for screening of polychlorinated biphenyls in serum samples. This new 
configuration of micro-solid phase extraction was termed as stir-bar supported micro-solid-
phase extraction (SB-µ-SPE). A tiny stir-bar was packed inside the porous polypropylene 
membrane along with sorbent material and the edges of membrane sheet were heat sealed 
to secure the contents. The packing of stir-bar inside the µ-SPE device, does not allow the 
device to stick with the wall or any corner of the sample vial during extraction, which is, 
however, a frequent observation in routine µ-SPE. Moreover, it enhances effective surface 
area of the sorbent exposed to sample solution through continuous agitation (motion and 
rotation). It also completely immerses the SB-µ-SPE device in the sample solution even 
for non-polar sorbents. Polychlorinated biphenyls (PCBs) were selected as model 
compounds and the method performance was evaluated in human serum samples. After 
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extraction, samples were analyzed by gas chromatography mass spectrometry (GC-MS).  
The factors that affect extraction efficiency of SB-µ-SPE were optimized. Under optimum 
conditions, a good linearity (0.1 – 100 ng mL-1) with coefficients of determinations ranging 
from 0.9868 to 0.9992 were obtained. Limits of detections were ranged between 0.003 and 
0.047 ng mL -1.  Acceptable values for inter-day (3.2 – 9.1%) and intra-day (3.1 – 7.2%) 
relative standard deviations were obtained. The optimized method was successfully applied 
to determine the concentration of PCB congeners in human serum samples.  
1.2.5. Chapter 6 
 
Organochlorine pesticides belong to famous persistent organic pollutants and are well 
known for their harmful effects on human health and wildlife. The milk stands among 
highly consumed foods and it can get contaminated with OCPs through agricultural food 
that is provided to animals. This demands development of highly efficient and precise 
analytical methods for determination of OCPs in milk samples. In this work, ZnO 
nanoparticles incorporated porous carbon foam was utilized as sorbent for extraction and 
preconcentration of OCPs in milk samples. This sorbent was prepared by a single step and 
fast reaction between the sucrose and zinc nitrate that was accomplished by heating the 
mixture for 10 minutes. The resulting sorbent was characterized by scanning electron 
microscopy and X-ray diffraction. The sorbent was then packed inside a porous 
polypropylene membrane sheets by heat sealing of membrane to construct µ-SPE devices. 
The factors that affect performance of µ-SPE were optimized. This method provided good 
linearity up to 0.9998 with limit of detections ranging from 0.19 to 1.64 ng/mL. This 
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method also provided satisfactory values for intra and inter-day precision with RSDs 
ranged between 2.3 to 10.2%.    
1.2.6. Chapter 7 
 
This chapter describes screening of endocrine disrupting compounds in different types of 
human cancer tissues. Endocrine disrupting compounds are well known for interfering with 
normal hormonal activity in human and thus triggering different kind of carcinogenic and 
non-carcinogenic disorders. Organochlorine pesticides (OCPs) and polychlorinated 
biphenyls (PCBs) have negative impact on the human health. They are persistent in nature 
and accumulate in cells and tissues and induce different type of cancers as a result of 
endocrine disruption. We have evaluated the burdens of OCPs and PCBs in breast, 
colorectal, thyroid and kidney cancer tissues collected from Saudi Arabia. The compounds 
were extracted using ultrasonic assisted solvent extraction and determined by gas 
chromatography mass spectrometry.   ΣOCPs were highest in colorectal (3951.8 ng/g) and 
breast (3921.3 ng/g) tissues while significant concentrations were also found in thyroid and 
kidney tissues. ΣPCBs were highest in thyroid tissues followed by colorectal, breast and 
kidney tissues.  ΣOCPs were several times higher than ΣPCBs in all types of cancer tissues. 
In order to get more deep insight into concentrations and bioaccumulation trends in cancer 
tissues, OCPs were divided into five groups of closely related compounds. Concentrations 
of ΣBHCs were higher than ΣCHLs, ΣDDs, Σdrins and Σendosulfan in all type of tissues 
except the kidney where ΣCHLs were slightly higher than ΣBHCs. These high 
concentrations of OCPs and PCBs in cancer tissues suggest that the environment of Saudi 
Arabia is heavily polluted with these pollutants.  
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1.2.7. Chapter 8 
 
This chapter describes screening of organochlorine pesticides in the plasma samples of the 
patients suffering from different type of cancer. In this study, plasma samples were 
collected from 73 patients suffering from colorectal or breast cancers. Fifteen 
organochlorine pesticides (OCPs) were determined in all samples. The volume of the 
plasma sample that was used for extraction of target compounds was 500 µL. The 
extraction was carried out by adding 1.0 mL of toluene into plasma samples in Eppendorf 
vial and then sonicating for 5 minutes. The vials were placed in refrigerator for 1 hour to 
freeze the plasma and water content inside the vial. Then, 1 µL from the upper layer was 
injected into GC-MS. Out of fifteen OCPs analyzed, only three compounds (heptachlor, 
endrin and endrin ketone) were detected in plasma samples. Data analysis was carried out 
by dividing plasma samples based on malignancy, malignancy type and stage. The data 
analysis indicated that heptachlor and endrin were only present in the plasma samples of 
the patients with malignancies while they were absent in the samples of patient with non-
malignant tumors. This might be an indication that exposure to heptachlor and endrin can 
be a cause of malignancy. However, this needs to be confirmed by the cell line studies. 
Heptachlor and endrin were only found in the plasma samples of colorectal cancer patients 
while they were not detected in any of the samples collected from breast cancer patients. It 
indicates that these two compounds may have a dominant role in triggering colorectal 
cancer tissues. Endrin ketone was detected in the samples of colorectal as well as breast 
cancer patients with high mean concentrations of 154.57 and 83.84 (ng/mL) respectively. 
Moreover, endrin ketone was found in samples of all stages with high mean concentrations 
in stage I and III.  
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1.2.8. Chapter 9 
 
A short summary of conclusions and recommendations is presented in this chapter.  
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2. CHAPTER  
PERSISTENT AND ENDOCRINE DISRUPTING 
ORGANIC POLLUTANTS: ADVANCEMENTS AND 
CHALLAENGES IN ANALYSIS, HEALATH CONCERNS 
AND CLINICAL CORRELATES 
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Abstract 
Persistent and endocrine disrupting organic pollutants pose serious health risks to humans 
and wild life due to their long half-lives, bioaccumulation and toxicity. These compounds 
have negative impact on human health and induce a variety of carcinogenic and non-
carcinogenic disorders. Extremely low concentrations of these compounds can induce 
adverse health effects in human. Efficient analytical methods are always demanded in order 
to extract and determine such low concentrations in environmental and biological samples. 
In the last decade, studies mostly focused on profiling and identification of persistent and 
endocrine disrupting pollutants in tissues and body fluids using various analytical methods. 
However, investigation of trace level pollutants associated with various disorders requires 
complex analytical protocols.  Biological matrix presents serious challenge in extraction of 
these pollutants mainly because of its complexity and inherent limitations of extraction 
procedures. We outline advantages and pitfalls of recent extraction approaches. Analysis 
of these compounds is carried out by using gas and liquid chromatographic methods 
coupled with different detectors. We have reviewed current status of advancements in area 
of analytical chromatography and accomplishments and weaknesses have been pointed out. 
At the end, we encapsulate some health effects and clinical correlates of persistent and 
endocrine disrupting organic pollutants.  
Keywords  
Persistent organic pollutants, endocrine disrupting compounds, micro extraction, 
biological matrix, gas and liquid chromatography, mass spectrometry, health effect 
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2.1. Introduction 
 
Persistent organic pollutants (POPs) represent a toxic class of organic chemicals which 
have potential to travel in lipids, accumulate in tissues and induce variety of health 
complications.  Because of very long half-lives, they manage to sustain in environment for 
years and that is the reason why some POPs can be still found in the environment although 
their use was banned in early 1970s. The causalities caused by these chemicals are blowout 
throughout the history, but the more terrible aspect arises from the fact that this series of 
events have not stopped yet. A more recent story is published about excessive use of 
endosulfan based pesticides in an Indian state, Kerala, where almost 45000 people have 
been reported suffering from different diseases being victim of haphazard usage of such 
chemicals in pesticides [1].  
More chemicals are being added to the famous “dirty dozen” which were confirmed as 
POPs by Stockholm Convention and now this number is preceded to 23. This is a 
significant increase over a period of one decade. Moreover, number of other chemicals 
have been reported to possess persistent nature and ability to accumulate within biological 
matrix and have not been regulated yet.  Stockholm convention categorizes these 23 POPs 
under different annexes like A, B and C. POPs in annex A are banned for production, use 
and applications. POPs belonging to Annex B are also banned for production and use but 
there exist certain exemptions. POPs in annex C are produced as a consequence of some 
unintended processes. It is pretty important to note that these 23 compounds have been 
regulated but there are hundreds of other organic compounds which show similar 
characteristics but have not been paid that much attention with regard of regulations. For 
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examples some organo-metals such as methylmercury and other derivatives are highly 
persistent and tend to bioaccumulate in food chain and human body [2].       
POPs present a global challenge and hundreds of reports are published every year 
describing current status, concentrations in different matrix and health effects. Primary 
sources of POPs, although, have been banned but they had heavily contributed in 
developing secondary sources which include seawater, sediments, aquatic organisms, other 
water bodies, and vegetation soils. These secondary sources are expected to release POPs 
for next hundred years or even more. POPs have been extensively reviewed from different 
aspects in past few years. 
Many organic pollutants including POPs are well-known to interfere  with endocrine 
system by imitating, hindering and prompting normal activity of hormones and thus effect 
the health and reproductive system of humans and wildlife [3].  These compounds are 
named as endocrine disrupting compounds (EDCs). Number of these compounds is 
increasing day by day due to continuous consumption and applications in the industrial 
sector. These compounds are basically of xenobiotic and exogenous origins which are 
considered to have adverse effect on the normal action of endocrine system and disturb all 
the functions i.e. synthesis, secretion, transport, and binding of hormones. 
EDCs are broadly classified into four categories (i) naturally occurring androgens and 
estrogens (ii) artificially synthesized androgens and estrogens (iii) phytoestrogens (iv) 
other industrial compounds [4]. Synthesized or industrial EDCs are members of different 
classes of chemical compounds and they have been identified in all industrial products 
including pesticides, alkyl phenols, personal care products, polychlorinated biphenyls, 
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heavy metals and so on. Synthesized EDCs were basically designed to perform a certain 
kind of action such as plasticizer, solvent or pesticide but later on it was realized that they 
have functional properties which can result in disruption of endocrine systems. 
The studies describing adverse effects of such compounds on human health have been 
increased in recent years [5]. As a result of rapid industrialization throughout the world, 
the production of such chemicals and their introduction into environment has massively 
increased. Prolonged exposure to trace level concentrations of these compounds can induce 
very serious health complications in human body and wild life [6]. Figure 2-1 summarizes 
sources, exposure pathways, health effects and analytical strategies for analysis of POPs 
and EDCs. Table. 2-1 lists some organic pollutants which show different kind of endocrine 
related activities. In the earlier years, it was thought that the EDCs act through nuclear 
hormone receptors (genomically) but now it has been recognized that mechanism of 
interaction of EDCs with body involves many other pathways (non-genomically) as well 
[3]. Endocrine disrupting mechanism of chemicals is described in a recent review article 
[85].  
It is matter of fact that POPs and EDCs occur at trace levels in various environmental and 
biological samples and thus their detection and removal presents a great challenge to 
analytical chemists. It remained a major focus of researchers to extract and detect 
extremely low concentrations of these toxic pollutants. This has been accomplished by 
developing microextraction procedures for sample preparation in combination with 
advances in analytical instrumentation. This review is aimed to probe current status and 
challenges in extraction and detection approaches for analysis of minute concentrations of 
POPs and EDCs in environmental and biological matrices. Chromatographic methods have 
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been considered in detail and accomplishments, weaknesses and challenges in dealing with 
such methods will remain a major focus of this review. We have also listed some studies 
investigating health effects of POPs and EDCs to human and wildlife. A brief detail of 
clinical correlates of EDCs and database resources used to identify perturbations in gene 
and pathways by environmental endocrine disrupters is also included. 
2.2. Specific Classes of Persistent and endocrine disrupting organic 
pollutants  
We describe three major classes of persistent and endocrine disrupting compounds; 
polychlorinated organic compounds represent a very well established class of persistent 
and endocrine disrupting organic pollutants while other two classes mentioned in section 
2.2.2 and 2.2.3 represent some emerging persistent chemicals.  
2.2.1. Polychlorinated organic compounds 
 
This class of compounds mainly includes organochlorine pesticides (OCPs), 
polychlorinated biphenyls (PCBs), polychlorinated dibenzofurans (PCDFs), and 
polychlorinated dibenzo-p-dioxins (PCDDs). Such compounds are defined by aromatic 
structures, low water solubility and high chemical stability. PCDFs and PCDDs are 
obtained as a product of some chemical, photochemical, thermal and enzymatic reactions. 
These compounds are discharged into environment via some incineration plants which 
include clinical, municipal and industrial waste incinerators[7].  
PCBs are persistent synthetic lipophilic compounds, except few of them. In past, PCBs had 
been used in variety of consumer products including plastics, lubricants, capacitors, 
vacuum pumps, paints, transformers, flame retardants, adhesives, gas transition tubes, 
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hydraulic fluids, sealants, and heat transfer fluids  but their manufacturing was stopped in 
late 1970s. Recent reports reveal their measureable levels in the serum [8]. PCB 
concentrations vary from place to place depending on geographical conditions. Higher 
concentrations are found in urban areas relative to rural areas which show substantial 
contribution from the local sources situated in these areas [9]. These compounds have 
ability to bio accumulate in food chain and finally reach to human body.  PCBs have also 
been reported to induce diabetes and also have strong effect on thyroid signaling [10].  Not 
only had the PCBs, all classes of polychlorinated compounds were studied to determine 
their possible character as endocrine disrupters and various correlations were observed. 
Tetrachlorodibenzo-p-dioxin (TCDD) has been reported as an inhibitor of estrogen 
mediated activity but their exact mechanism is not known yet [11]. Another complication 
about PCBs is that they do not show antiestrogenic activity but in reality they are 
estrogenic. 
Classification of pesticides is done based on their action with different substances. They 
are generally classified as insecticides, germicides, fungicides, herbicides, rodenticides, 
avicides, larvicides, and acaricides. They are composed of organic compounds which are 
volatile, semi-volatile or non-volatile in nature. Pesticides have widespread applications in 
the agriculture sector to grow crops and different food stuff. Through food chain, these 
pesticides find their way to human body and wild animals. Volatile pesticides may be 
present in outdoor environment and thus accumulate with various materials. Pesticides are 
added to carpets, paints and building materials, this makes indoor environment suspected 
for their presence and accumulation on stuffs like toys, carpets and any other material [8].  
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Although persistent organic compounds like OCPs were banned to use as pesticides but 
still they can be detected in environmental samples. Stockholm convention has declared so 
for 23 POPs and among them 13 belongs to OCPs. These include aldrin, dieldrin, endrin, 
chlordane, heptachlor, DDT, hexachlorobenzene, toxaphene, mirex, lindane, chlordecone, 
α-hexachlorocyclohexane and  β-hexachlorocyclohexane [12].  
Generalizing health effects of OCPs is a really difficult task because they comprise a 
diversity of chemicals. Pesticides are reported to have very severe neurotoxicity, effects on 
developing reproductive system, ability to induce various forms of cancers. They also 
damage the normal function of thyroid hormones in humans and animals [13]. 
2.2.2. Pharmaceuticals and personal care products 
 
Although pharmaceuticals and personal care products (PPCPs) have not been declared 
POPs but they are thought to be potential endocrine disruptors and there are a lot of 
questions about their persistence in environment. The presence of pharmaceuticals and 
their bioactive metabolites in environment has been studied very extensively in last decade. 
The part of environment which is focused in this regard is water and particularly drinking 
water. Most comprehensive study for emerging organic pharmaceuticals in water resources 
was carried out by U.S Geological Survey. A wide range of pollutants such as  antibiotics, 
prescription and non-prescription pharmaceutical drugs were detected [14].  
 It has been reported by many researchers that many bacterial strain has developed 
resistance against existing antibiotic drugs and there is a need to find new antibacterial 
agents. Keeping in view this aspect of resistance, natural synthetic chemists are searching 
and preparing new drugs to overcome resistance offered by bacterial strains [15]. Their 
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number is increasing and through wastewater or sewage discharges, they absorb into soil 
or sediments and remain persistent. Persistence depends on photo stability, degradation 
capacity and leaching to water. Concentrations higher than estrogenic or proestrogenic end 
point are found in environment samples. Most of veterinary drugs go with manure which 
is spread in agricultural fields and enter into food and water chain. Some reports indicated 
their improper removal from wastewater that leads to contaminate other water resources 
[16]. 
Personal care products (PCPs) are being used by all communities in the world as 
disinfectants, conservation agents, fragrances and sunscreens. Fate of PPCPs in any 
environment is governed by chemical, environmental, retention and transport, and 
accumulation factors [17]. Chemical compounds which are added to sunscreen cosmetics 
to save the consumers from the harm effects of solar UV radiation are known as Organic 
UV filters. But these compounds are not only being added to sunscreen cosmetics but all 
type of cosmetic products. Although they are applied on the outer skin but they have ability 
to absorb through skin and take part in metabolism resulting in bioaccumulation or 
excretion. This absorption may also trigger estrogenic [18] and carcinogenic activity [19]  
. Biotransformation pattern decides about the fate of an exogenous compound in the body 
and it has been evaluated for only few compounds only in serum and plasma and hence 
there is a pressing need to investigate biotransformation patterns of all other compounds in  
variety of tissues (liver, brain, heart, kidney, intestine, skin) [20].  Parabens are also widely 
used in cosmetics, pharmaceutical and preservatives in food. They have been widely 
adopted because of their low toxicity, inertness, broad activity, low cost and long history 
of safe use. However, they have now been reported to show weak estrogenicity which 
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encourages to develop analytical methods for their quantification at low level 
concentrations [21].  
2.2.3. Phthalates and food contact materials  
 
Phthalates have very wide spread applications in cosmetics, plasticizers, insecticide 
carriers, chloride resins, adhesives and cellulose film coatings. The worldwide production 
of these compounds is more than 2.7 million metric tons per year and they are released to 
environment via direct or indirect corridors. Direct emissions take place during the 
production of plastics while indirect emissions take place through leaching and 
volatilization from plastic products and bottles particularly when they are subjected to 
disposal and incineration. Large number of phthalates is included in “priority pollutants”. 
Although these substances have low acute and chronic toxicity but they are  suspected 
EDCs [22]. 
Food contact materials (FCMs) are the chemicals which leach from the packing of food 
and contaminate it. They are underestimated source of chemical but humans are exposed 
to these EDCs on regular basis. Population is exposed to low level concentration of FCMs 
throughout their lives. Exposure of general public to contaminants by FCMs is quantified 
based on amount of food consumed and FCMs leached into food. Food simulants are used 
for this purpose but they don’t predict leaching with desired precision. A famous FCM 
substance, Bisphenol A (BPA), its leaching is always misjudged based on conventional 
methods. Exposures of these compounds are normally analyzed from mutagenicity and 
geno-toxicity. In this approach all other toxicological effects are neglected including 
endocrine disruption, development toxicology and toxicity due to combined effects of 
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several FCM chemicals. Keeping in view these new toxicology parameters, the more 
sensitive population group comprises children, women of children bearing age and women 
with pregnancy. Any innovative method for assessment of toxicology due to FCM should 
incorporate all toxicological parameters and routine analysis of EDCs, with special 
reference to sensitive age groups [23].  
Plastics are the most famous materials used for packaging of food and thus their polymeric 
layers are always in contact with food materials. Plastics, coatings and polymeric layers 
are combination of complex chemical substances. Understanding the nature of all these 
chemicals would be helpful to calculate risk assessment related to FCMs. Chemistry 
involved in formation of polymeric plastics is very complex and some unknown chemicals 
are added to the final products which can migrate into food. It is difficult to identify all the 
substances in the plastics even if starting chemicals and additives are well known 
particularly due to non-intentionally added substances. Monomers and additives are 
considered while assessing the toxicity effects, while rest of the leachate is ignored. It is 
pertinent to mention that in final packaging of food, adhesives, printing inks and labels 
may introduce some supplementary compounds into the food [24]. This department of food 
contamination should be focused more because all the population is unceasingly exposed 
to these products.  
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Figure 2- 1: Summary of sources, health effects, and routes of exposure to human and 
analysis of persistent and endocrine disrupting organic pollutants 
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Table 2- 1: List of Some common organic compounds which show endocrine disrupting 
properties 
Class of 
compounds 
Chemicals Uses Problems 
induced in 
human 
Activity Ref. 
Pesticides  DDT, 
Chlordane, 
Methoxychlor 
Insecticides, 
fungicides 
etc. 
Neurotoxicit
y, Disorders 
in 
reproductive 
systems, 
cancers 
including 
breast cancer 
Estrogenic
, anti-
estrogenic
, anti-
androgeni
c  
[86,87
] 
[8] 
Polybrominate
d compounds  
Polybrominated 
diphenyl ethers 
(PBDEs) 
Flame 
Retardants 
Harm to 
developing 
brain and 
reproductive 
organs 
Effect on 
thyroid 
hormones 
[88] 
Plolychlorinate
d compounds 
Polychlorinated 
biphenyls 
(PCBs), 
Dioxins 
Electrical 
equipment, 
by product 
of 
incineration   
 
Endometriosi
s 
 
Anti-
estrogenic 
[3] 
 
 
 
 
Phthalates Dibutyl 
phthalate, 
Benzylbutyl 
phthalate 
Plasticizers, 
detergents, 
resins  
Infertility, 
effects on 
developing 
male 
reproductive 
tract 
Estrogenic [89] 
Alkylphenols Octylphenol, 
nonylphenol 
surfactants Reproductive 
disorders in 
Estrogenic  [90] 
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human, 
carcinogenic  
Parabens Para-substituted 
hydroxybenzoat
e  
Preservative
s and anti-
microbial 
agents 
Decreased 
sperm 
number and 
motile 
activity  
 
Estrogenic [91] 
Natural and 
synthetic 
hormones  
Estradiol, 17β-
Estradiol, 
Estrone, Estriol 
Ethinylestradiol 
 Reproductive 
disorders 
Estrogenic [45] 
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2.3. Methods for analysis of POPs and EDCs and problems associated 
with them 
2.3.1. Extraction procedures  
 
Efficient extraction and sample preparation methods are required to extract extremely low 
level concentrations of POPs and other potential emerging pollutants present in complex 
environmental and biological matrices. Classical extraction techniques are time consuming 
and labor extensive because several clean-up cycles are needed after extraction which may 
take several hours to few days [25].  
Solid phase extraction (SPE) and liquid-liquid extraction (LLE) are among most commonly 
employed extraction procedures for POPs in complex environmental and biological 
samples. SPE uses a solid sorbent which captures a particular analyte through adsorption 
when liquid or gas sample is passed through it. A washing solution is used to remove any 
unwanted constituents captured with target analyte and finally target analyte is eluted by 
using a suitable organic solvent or mixture of organic solvents. Selection of suitable 
combination of sorbent material and solvents for extraction of particular class of target 
compounds is critical. The sorbent is normally packed into small tubes or cartridges that 
are available in different shapes and prepared by many companies with specific housing 
for suction or pressure generation to make the elution through the column a faster process.  
Conventional SPE and LLE require large volume of organic solvents and thought to be 
environment unfriendly. Moreover, requirement of large volumes of samples, huge time 
consumption and multiple clean-up procedures make them rather difficult extraction 
techniques. In current years, there remained a trend in development of miniaturized 
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extraction procedures which can be easily automated and configured according to analysis 
requirement and more importantly they are environment friendly. The main idea behind 
miniaturized extraction techniques is development of methods which can easily extract 
target compounds at trace level concentration in different matrices by employing minimum 
amount of sorbents, samples and solvents. But still they are accurate, precise, and 
reproducible. 
Solid phase microextraction (SPME) uses fibers coated with different organic materials 
and these fibers are either dipped in the aqueous samples or placed in headspace in case of 
complex matrix. Target compounds are adsorbed or absorbed on the fiber which is then 
injected to GC column where analytes are desorbed by providing high temperature for a 
certain period of time. Very high enrichment factors are achieved by using SPME. SPME 
can be fully automated with GC systems. SPME was used for extraction of polybrominated 
diphenyl ethers (PBDEs) in sediments [26].  Another recent publication describes use of 
headspace SPME (HS-SPME) for extraction of POPs in serum samples followed by GC-
MS analysis. As this HS-SPME was coupled with instrument, so the steps like sample 
handling, removal and transfer of solvents, separate extraction steps and sample 
transferring to instrument station were reduced. High enrichment factors are obtainable 
because analyte transfers from relatively large volume of liquid sample to solid fiber. 
SPME has some limitations which include expensive and fragile fibers, lesser affinity and 
selectivity of commercial fibers towards target compounds [27].  
Liquid phase microextraction (LPME) has been attempted in various ways. Earlier in 1997, 
static and dynamic LPME was developed using a single drop of organic liquid at the tip of 
conventional micro syringe. In static mode, tip of syringe is immersed in aqueous sample 
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and then a drop of organic liquid is formed at the tip and exposed for certain time to the 
sample and retract back into syringe and injected to the instrument for analysis. In dynamic 
mode, organic solvent is taken in a micro syringe and syringe is immersed in the sample 
solution. Few microliters of samples are withdrawn into syringe and then re-injected into 
sample vial. Procedure is repeated for several times and finally organic drop from the 
syringe is injected into instrument [28].  Single drop LPME (SD-LPME) has also been tried 
as headspace technique, but the stability of the drop is main drawback because most of the 
organic solvents have high vapor pressures and they are easily evaporated. So in such case, 
selection of suitable solvent is crucial. Another modification in LPME procedure was done 
by putting a hollow fiber at the tip of the syringe. Fiber is filled with organic solvent which 
activates the pores of the fiber. Then this is exposed to liquid samples. Small pore size of 
the fiber does not allow large sized molecules and hence this can be an ideal method for 
extraction of organic pollutants from complex biological matrix because it can easily reject 
any unwanted fatty stuff [29]. Hollow fiber protected LPME (HF-LPME) can easily be 
used for headspace because it provides a support for the organic solvent to be held for 
longer time [30].  
Dispersive liquid-liquid microextraction was developed in 2006 for extraction of PAHs in 
water samples. This involves a rapid injection of proper mixture of extraction and disperser 
solvent in water samples which changes to cloudy and extraction solvent is dispersed 
throughout the sample and is recollected by centrifugation. Method has been extremely 
used for extraction of organic pollutants from aqueous samples [31]. More recently, 
DLLME was used for extraction of organochlorine pesticides (OCPs) in honey [32]. The 
major advantages of DLLME lie in less extraction time, simple operation, lesser volumes 
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of organic solvents and high recoveries and enrichment factors [31]. DLLME has been 
applied for extraction of variety of organic pollutants in variety of matrices [33].  Area of 
LPME has gone through a rapid progression and new advancements have been included in 
the procedure, these review articles can be helpful in understanding advancement in LPME 
with time [34–36] .    
Micro solid phase extraction (µ-SPE) uses small amount of sorbent compared to SPE. It 
works in two ways (1) Solid is directly immersed in liquid samples to extract target 
compounds and then separated by centrifugation and desorbed in small volume of organic 
solvent (2) solid is packed inside a porous membrane and thrown into liquid sample and 
then this membrane packed solid is taken out and desorbed with small amount of organic 
solvent. Nature of sorbent is critical in such extractions and choice is dictated by nature of 
target compounds. Main advantages are requirement of lesser amount of sorbents and 
organic solvents, higher enrichment factors and freedom in choice of sorbents. µ-SPE was 
used for extraction of persistent organic pollutants from biological tissue samples [37] . As 
sorbent is effectively secured inside the porous membrane in µ-SPE, it does not allow 
extraneous matter or fats to be adsorbed over the sorbent. Advantages and disadvantages 
of commonly used extraction techniques for POPs and EDCs from environmental and 
biological samples have been described in Table 2. 
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Table 2- 2: Advantages and pitfalls of extraction techniques 
Extraction  Advantages  Pitfalls 
Solid phase extraction · Selective sorbents have high 
affinity towards target POPs 
· Molecularly imprinted polymers 
are sorbents which can be 
designed according to the 
structure of target analytes. 
· Method is suitable for large 
volume of samples. 
 
· Consumption of large 
volumes of organic 
solvents.  
· Huge time 
consumption  
· Multi clean-up 
procedures 
 
Liquid-liquid extraction · Simplicity of operation 
· Rapid analysis 
· Reasonable selectivity  
 
· Large volumes of 
organic solvents are 
needed. 
· Environment 
unfriendly 
· Formation of 
emulsions which 
prevents proper 
separation of two 
phases. 
· Co-extraction of some 
interferences  
  
Solid phase 
microextraction 
· Solvent less technique 
· Works on adsorption equilibrium 
between SPME fiber and sample 
containing analytes.   
· It can be easily automated with 
GC and HPLC systems. 
· SPME can be performed in 
normal as well as headspace 
mode for more complex samples. 
· Due to small size of device, 
equally suitable for in field 
applications.  
· Rapid, simple and sensitive 
method for variety of target 
compounds. 
· Fibers are highly 
expensive and fragile. 
· Carry over effects 
even after longer 
period of thermal 
desorption. 
· Low recommended 
operating temperature 
ranges. 
· Fibers are highly 
sensitive to organic 
solvents and easily 
deshaped on contact. 
 
Micro solid phase 
extraction 
· Sorbent required is in range of 
milligrams 
· Small volume of organic solvents 
are needed for desorption. 
· In case of porous 
membranes packed µ-
SPE, pores may get 
blocked by the 
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· It has variety of formats like 
immersing a solid directly into 
sample solution or packing the 
solid in a membrane. 
· Same sorbent can be used for 
various cycles of extraction. 
· Extraction can be assisted by high 
temperature or microwave 
radiation.  
contents of real 
samples. 
· Selection of sorbent is 
critical in order to 
increase the 
performance of 
extraction process.   
Liquid phase 
microextraction  
· Few µL of organic solvents are 
needed. 
· Huge reduction in acceptor to 
donor phase ratios. 
· It has lot of operational 
flexibility.  
· Number of well-known LPME 
techniques has been developed by 
variation in extraction procedure.  
· Some examples are single drop 
liquid micro extraction, hollow 
fiber liquid microextraction, 
dispersive liquid-liquid 
microextraction and many more. 
 
· Like SPME, no 
preconditioning is 
needed. 
· In case of single drop 
LPME, solvent with 
low vapor pressure are 
employed. 
· Difficult to maintain a 
single drop. 
· SD LPME, not 
suitable for complex 
samples. 
· In case of hollow fiber 
membranes, extraction 
time is enhanced 
because membrane 
acts as a barrier 
between donor and 
acceptor phase.  
·  Fiber pores can be 
blocked in case of 
fatty or dirty samples. 
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2.3.2. Detection procedures 
 
POPs and EDCs are very diverse classes of chemical compounds and hence large numbers 
of instrumental methods are employed to analyze these compounds. Gas chromatography 
and liquid chromatography with MS and tandem MS detectors are among few best 
instrumental techniques because of their inherent ability to analyze certain classes of 
analytes present within very complex matrices providing high sensitivity and selectivity 
[38].  Main problem concerned with chromatographic methods is their limitation of 
separating single class of compounds in one run under specified set of operating conditions. 
Developing a method which would be capable of detecting multi classes of POPs will be a 
great achievement.  
 Because of their tendency to induce serious health problems in humans and wild life at 
very low concentration and inherently low concentrations in environmental and biological 
samples, researchers intend to improve sensitivity of analytical methods for detection of 
POPs that can go down to parts per billion (ppb) or even low.   
Gas chromatography coupled with electron capture detector (GC-ECD) is most commonly 
employed when compounds of interest are halogenated such as OCPs and PCBs. This is so 
for least expensive instrumental approach for chlorinated organic pollutants. GC-MS has 
now arrived in variety of MS detectors which perform a specific job. Problem of co-elution 
of similar compounds which is experienced in GC-ECD is resolved by application of MS 
detectors. Low resolution MS is now a days most commonly employed detector with GC 
systems and it can go up to pg levels detection of PCBs and OCPs when operated under 
selective ion monitoring (SIM) mode under electron impact ionization. High resolution MS 
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can give more specificity for closely related chlorinated compounds and it can go up to 
ultra-trace levels [12].  
High pressure liquid chromatography (HPLC) is also another chromatographic method 
used for analysis of EDCs. Hyphenated liquid chromatography with mass spectrometry has 
resulted in increased sensitivity and has become a unique method for analysis of organic 
pollutants in environmental and biological samples. Analytical methods are judged based 
on their ability of performing high-throughput analysis and time required to complete the 
analysis. Three approaches have been adopted to achieve these goals in HPLC without 
affecting resolution and separation efficiency. These approaches involve use of monolith-
sorbent bases columns [39], performing separation at higher temperatures [40] and use of 
ultra-high pressures [41]. Mainly for bioanalysis, monolith columns are promising and they 
allow very high flow rates of solvent nearly 10 mL/min without producing significant back 
pressures and compromising characteristic performance of HPLC. High temperature liquid 
chromatography is the one where high temperatures are used to perform the separation 
process in normal length columns. High temperature reduces viscosity of mobile phase 
which makes analysis faster and minimizes total run time. But the main problem with high 
temperature liquid chromatography is availability of column materials which would be 
stable under high temperature conditions. Also, any thermally sensitive compounds may 
degrade at high temperatures. Ultra-high pressure liquid chromatography (UHPLC) is the 
one in which very short columns with narrow diameters are employed. This allows using 
very high pressures which results in very well peak separation and reduces analysis time 
significantly [42].    
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Recent advancements in chromatographic systems have led to highly efficient separations. 
This is mainly attributed to fast GC and LC methods by using narrow bored, short columns, 
high mobile phase flow rates with the help of ultra-high pressures. With these advanced 
systems, total run time for analysis has greatly reduced from tens of minutes to few 
minutes. Shortening of analysis time is very promising step towards high throughput 
analysis which is generally required by research and analysis laboratories [43]. These 
highly efficient separation systems must be accompanied by suitable sample preparation 
and after all a good detection system for ultra-trace level analysis of EDCs. 
Advancement in detection area is coupling of GC or LC with Mass spectrometry (MS) 
detector. This detector can determine molecular structure with high sensitivity and 
selectivity. Compounds are separated by chromatographic methods and then identified 
qualitatively and quantitatively by the MS. Use of selective ionization mode, coupling of 
quadruple with time of flight (TOF) enables the method to analyze and quantify target 
compounds from very complex matrices [44].   
Whole organism assay is also used for monitoring of EDC in some aquatic organisms and 
it gives indication of total estrogenic activity. But these assays suffer from lack of 
specificity of organism response towards certain classes of EDCs. Cellular based assays 
are another attractive alternative to mass based analytical techniques but the results are not 
consistent and repeatable. Non-cellular assays which don’t require whole cells make the 
analysis simple and more quantitative with much better detection limits [45].  
Among non-cellular assays, enzyme linked imuunosorbent assay (ELISA) is most famous 
method but it has several disadvantages including longer analysis time, washing and 
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addition of reagents, multi-step procedures, and requirement for experienced personnel. 
Another Immunochromatographic assay combines unique detection capabilities of 
molecular recognition probes like antibodies, aptamers with separation advantages 
chromatography. Strips based on Immunochromatographic principle are known as lateral 
flow test strips (LFTS). These strips are being used in detection of EDCs such as pesticides 
[46]. But the major problem related with these strips is their selectivity for only one or two 
compounds at a time and cannot detect number of EDCs at a time. Also they suffer from 
the problems in the selection of molecular recognition probes, conjugation with label 
molecules and less sensitivity. From this detail, it can be concluded that gas and liquid 
chromatography coupled with mass spectrometric detector are best techniques to analyze 
number of EDCs in single sample in a single run.   
2.4. Challenges in Analysis of POPs and EDCs in biological samples 
 
Despite of all advancements in analytical instrumentation, pretreatment of sample to 
remove complex matrix effects is considered as the bottleneck in all analytical methods. In 
this way, sample pretreatment plays a vital role in enhancing the sample amount and 
removing interferences due to matrix. 
Biological samples present various challenges prior to their analysis by using 
chromatographic methods. These challenges arise because of the complex nature of 
biological samples which sometimes contain huge protein content. This protein content can 
adsorb on the column in an irreversible way and thus reduce column efficiency and produce 
significant backpressure. This complex biological matrix when combined with trace level 
concentrations of EDCs emphasis to treat the sample before analysis by any instrumental 
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technique. This pretreatment helps in enriching the analyte and removing interferences 
from biological matrices. But these sample pretreatment methods are most time consuming 
parts of analytical process. In multiresidue analysis, the biggest challenge is optimization 
of experimental conditions. Some compromises are to be done in this step.  
Biological samples include urine, tissues, plasma or serum, breast milk, faeces, and semen 
.One recent study reveals that organic UV filters which are used in cosmetics (which are 
potential EDCs) have been mostly studied in urine (57%) and then plasma or serum (23%) 
and rest of matrices have not been focused much [20].  
For the extraction of organic pollutants from urine samples different extraction 
methodologies are applied such as solid phase extraction (SPE), liquid-liquid extraction 
(LLE), membrane assisted liquid-liquid extraction (MALLE). But the big disadvantage 
with these extraction methods is that they consume too much organic. These organic 
solvents are not only toxic and expensive but they are also considered as environmental 
pollutants. In order to overcome this problem some other extraction techniques such as 
solid phase micro extraction (SPME) [47], liquid phase micro extraction (LPME), hollow 
fiber liquid phase micro extraction (HF-LPME) [48],  stir bar sportive extraction 
(SBSE)[49] were employed and these methods consume organic solvents in microliters.  
In case of blood, it is treated to get plasma or serum. Plasma is obtained by removing 
cellular components of the blood and retaining proteins that are responsible for the 
coagulation by centrifuging the blood sample in heparinized tubes while serum is obtained 
by removing both cellular components and proteins and this is attained by doing 
centrifugation in non-heparinized tubes [50]. Once the serum or plasma sample is obtained, 
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hydrolysis is carried out to determined bonded or conjugated target analyte. When anlayte 
is attached to proteins, acidic hydrolysis helps to determine it. On the other hand, proteins 
are the materials which are thought to be biggest hurdle in analytical detection of organic 
compounds as they represent a very complex class of matrix. These proteins are 
precipitated and then removed from the samples by the use of organic solvents to avoid 
interferences. Further purification could be achieved by LLE or SPE.   
In case of semen, breast milk and tissues hydrolysis as well as removal of proteins is a 
mandatory step before detection of target analye in the sample through any instrumental 
techniques. Selection of suitable solvent is crucial. Tissues are normally homogenized with 
water or acetonitrile and LLE is done to remove any protein content. Soxhlet extraction or 
LLE is used for pretreatment of faeces [50,51].      
Data summarized in Table 2 shows some of the recent studies which were carried out in 
different parts of the world for detection of EDCs in environmental and biological samples. 
It can be noted that EDCs pose serious environmental and health challenges to the human 
all around the globe and all the components of the environment (air, water, soil and biota) 
are being contaminated with EDCs. 
2.5. Health Effects of POPs and EDCs 
 
EDCs are associated with changed endocrine functions both in animals and humans. They 
create long lasting adverse effects on the metabolism, neurological function, reproduction, 
and other physiologically important processes. Health concerns are being raised with every 
passing day and more and more abnormalities are being associated with the use of these 
toxic compounds. Some recent reports show that EDCs has resulted in high incidences of 
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thyroid and  testicular cancers in males [52,53].  EDCs disturb hormonal signaling. Those 
which block or interrupt the function of sex hormones have been paid much attention but 
it is recognized fact that EDCs have very high impact on insulin signaling, functioning of 
thyroid and bone growth. Some PCBs and pesticide atrazine has been reported to have 
effect over proteomes of the breast cancer cells. Literature reveals that there is a great 
debate on the classification and effects of EDCs on humans. EDCs are present in 
environment as mixture and they can have synergistic or additive effects. So determining 
the effects from individual EDCs will be really difficult without considering all other 
affecting parameters [54].  
Human exposure to EDCs have gained  too plentiful consideration in recent years due to 
experimental results indicating endocrine-related effects on reproduction, development, 
cancer, and metabolism, and observations for increasing tendencies (as well as geographic 
trends) in endocrine-related ailments among populations [55]. There are thousands of 
persistent organic pollutants  for which toxicity information either does not exist or 
insufficient[56]. The main targets of EDC effects are homeostasis of sex steroids and the 
thyroid ; hence, reproductive health, is also concerned with endocrine disruption [57]. 
However, studies carried out to find the impact of environmental EDCs in relation to 
endocrine associated cancers and outcomes in human are limited in number. 
A significant increase in breast cancers in last 50 years has developed a perception that 
hormonally active industrial chemicals which are result of industrial revolution could be 
possible reason for these cancers. Same half century witnessed an increased incidence of 
testicular cancers and disorders in quantity and quality of human sperm [58,59]. EDCs are 
involved in disruption of reproductive system in human and other animals. They are 
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thought to be responsible for incidences of cancers and transgenerational effects [60,61]. 
Glyphosate which is used in pesticides was thought to be safe but a new study states that it 
has endocrine disrupting properties and  promotes breast cancer on human cells through 
estrogen receptors at very low concentrations of 10-12 to 10-16 M [62]. When human 
peripheral blood cells were exposed to micro molar concentrations of EDCs, it resulted in 
change of their gene expressions. This change in gene expression was independent of 
gender [63]. Luteinizing hormone receptor  (Lhcgr) of zebrafish follicle cells showed very 
high response to estrogenic EDCs [64]. Human MCF-7 cells were exposed to PCB-153 
and atrazine concentrations for a period of 36 hours and proteins isolated from cytosol and 
membrane were tested for presence of biomarker as a result of this exposure. It resulted in 
an altered protein expression which is an indication that these compounds can have 
potential impacts on human health [65] A study was carried out to see the effects of mixture 
of five pesticides when exposed to rats, developmental changes in gestation length and 
increased number of nipples and genital  disfigurements were observed in male offsprings 
[66]. It is an indication that how these compounds can effect on sexual developments in 
human and other animals.  A comprehensive review was done which included 91 studies 
dealing with BPA and human health and it showed that BPA exposure has adverse effects 
on human of all age groups and also early exposure in children leads to asthma and changed 
behavior [67].  A study which was designed to determine endocrine disrupting activity of 
some compounds in bottled flavored and mineral drinking water showed hormonal activity 
in 78 % of samples [68]. EDCs have great impact on reproductive system particularly 
disorders in female fertility [69].  Estrogenic activity of fruits and vegetables was 
40 
 
determined and it showed positive results. This activity was attributed to presence of 
pesticide residues in fruits and vegetables [70]. 
Studies suggest a link between exposure to low doses of POPs and incidence of type 2 
diabetes. This risk is boosted when exposed to POP mixtures instead of few individual 
POPs. But results are somehow inconsistent in this regard because of unequal distribution 
of POPs in environment [71]. High levels of POPs concentrations were found in biological 
and environmental matrices around the globe. A recent report indicates frequent presence 
of POPs in the serum of  most of Tunisian women [72].  POPs and EDCs are linked with 
malfunctions in ovarian function and the women exposed to such compounds are more 
likely to get menopausal at earlier ages than non- exposed women [73]. Similarly, an 
association between concentrations of POPs in breast milk of mothers and faeces of infants 
was found [74].  Subject of health effects of POPs and EDCs is highly diversified and it 
covers wide range of ailments in human and wildlife and reports covering this aspect are 
increasing by every coming day. Covering every single report which describes negative 
impact of POPs is beyond the scope of this review.  Some review articles covering health 
effects of POPs and EDCs can be studied to get more comprehensive overview of the 
subject [75–79].  
2.6. Conclusive Remarks  
 
It needs to develop systematic criteria in order to assess toxicity and risk assessment related 
to new organic pollutants being added into environment. Most scarce aspect of risk 
assessment studies is that researchers focus on particular aspect of their interest. Compiling 
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such reports is very difficult and it cannot lead to straightforward conclusions about a 
compound or group of compounds.  
Consumable foods in different localities need to be explored for presence of POPs and 
EDCs levels. Studies in this regard are highly scattered. For example, a review article was 
conducted to compile the studies carried out in Spain to find the relationship between 
human diet and its effect on POP concentrations in humans. Results reveal that only few 
compounds were consistently studied in fish and human serum but most of the foods such 
as cereals, vegetables and fruits have not been evaluated for POP concentrations [80]. All 
food stuff has to be studied in systematic pattern at all geographical locations in order to 
reach some conclusive outcomes. 
There exists sufficient evidence that POPs have considerable concentrations in fats and 
other body compartments of the people in all around the globe which have been linked with 
serious health implications [81–84]. These POPs come from environment and 
contaminated food and thus accumulate in fatty tissues. There should be some minimum 
allowable limits of POPs in serum, adipose tissues and other body compartments, so that 
above levels can be treated as health risk. POPs concentrations in body fluids can be used 
as a biomarkers for near or far future health implications. Although hundreds of reports 
have been published describing toxicity and health effects of POPs but standard procedures 
and limits to be regularized in clinical applications to determine and establish a relationship 
between POP levels and disease stages.     
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2.7. Conclusion  
 
In this review article we have comprehensively looked into the diverse types of POPs and 
EDCs prevalent in human environment. We have also described the various methods that 
could be used to enrich these compounds from tissues, body fluids and environmental 
samples, which could enable their detections using advanced mass spectrometry based 
chromatographic techniques. We have very clearly highlighted the advantages and 
disadvantages of more commonly used extraction methods. Advancements in analytical 
instrumentation has made the analysis of low levels of organic pollutants a doable job 
within a time span of few minutes but still there exists some challenges while dealing with 
complex biological samples. Accomplishments, weaknesses and future challenges in area 
of analytical chromatography are critically discussed. Gene-protein-metabolite 
relationships play a key role in the incidence of diseases associated with exposure to toxic 
chemicals in the environment. We have summarized those reports associated with role of 
POPs and EDCs in triggering health related problems. Studies in this regard could be 
extended to the development of novel sensors and biosensors that could be used to monitor 
the range of toxicity associated with newly identified toxic chemicals.  
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Abstract 
 
Parabens (alkyl esters of p-hydroxybenzoic acid) are widely used as preservatives in food, 
cosmetics and pharmaceutical products. However, weak estrogenicity of some parabens 
has been reported in several studies, which provided the impetus for this work. Here, a 
simple and efficient analytical method for quantifying parabens in cancer tissues has been 
developed. This technique involves the simultaneous use of microwave-assisted solvent 
extraction (MASE) and micro-solid phase extraction (μ-SPE), in tandem with high 
performance liquid chromatography (HPLC/UV) analysis for the determination of 
parabens. The pollutants studied included four parabens (methyl, ethyl, propyl and butyl 
parabens). Optimization of the experimental parameters for MASE and μ-SPE was 
performed. Good relative standard deviation (%R.S.D) ranged from 0.09 – 2.81% and high 
enrichment factors (27 – 314) were obtained. Coefficients of determination (r2) up to 
0.9962 were obtained across a concentration range of 5.0- 200 ng g-1. The method detection 
limits for parabens ranged from 0.005 - 0.0244 ng g-1. The procedure was initially tested 
on prawn samples to demonstrate its feasibility on a complex biological matrix. 
Preliminary studies on human ovarian cancer (OC) tissues showed presence of parabens. 
Higher levels of parabens were detected in malignant ovarian tumor tissues compared to 
benign tumor tissue samples. 
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3.1. Introduction  
 
Chemical compounds which possess endocrine disrupting properties represent a wide and 
ever growing class of chemicals. Endocrine disrupting compounds (EDCs) interfere with 
normal hormonal function in humans and wildlife by interacting with estrogen receptors 
and induce adverse effects in developmental [1,2], reproductive [3,4] and neurological 
systems [5]. EDCs have been associated with increasing susceptibility to different kind of 
cancers [6–8] . They become functional at very low concentrations [9]. Alkyl esters of 4-
hydroxybenzoic acid (methyl paraben, ethyl paraben, n-propyl paraben, and n-butyl 
paraben) are also found to exhibit estrogenic activity [10,11]. 
 The properties which dictate widespread applications and worldwide regulatory 
acceptance of parabens include broad activity, a long history of safe applications, low cost, 
wide working pH range, reasonable solubility in water, no significant odor or taste and 
inertness [12]. Because of their high antimicrobial potential, parabens are used as 
preservatives in food, cosmetics and pharmaceuticals and personal care products [13]. 
However, current studies report  parabens as endocrine disruptors because of their 
estrogenic activity [14], the magnitude of which is reliant on their structure [15,16]; though, 
much lower than that of estradiol [17]. In recent years, more research focused on finding 
out role of parabens in inducing infertility [18] and different cancers in human. 
Measureable concentrations of parabens have been found in human breast cancer tissues 
and linked as one possible cause for the disease [19,20]. Presence of parabens in urine can 
serve as a biomarker to assess human exposure [21]. Concentrations of parabens in urine 
may have effect on ovarian age and reproductive health [22] .   
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Several analytical methods have been reported for the sample clean-up of parabens in 
different complex matrices. Specifically, parabens have been pre-concentrated by using 
molecularly imprinted polymer solid phase extraction in milk samples[23], liquid-liquid 
extraction (LLE) in human placental tissue samples [24],  solid-phase extraction (SPE) in 
human urine [25] and breast cancer tissues [26], and solid phase microextraction (SPME) 
in pharmaceutical formulations [27] and cosmetics [28].   
Since parabens are relatively lipid soluble compounds, they would tend to bioaccumulate 
in the lipid fraction of the biological tissues. Hence, it is necessary to perform sample clean-
up to extract parabens from fatty contents which otherwise can interfere with the 
experimental results. When it comes to extract organic pollutants from real biological 
samples, above mentioned techniques suffer from some inherent limitations such as SPME 
fibers have been reported to absorb fatty contents and exhibit carryover effects due to 
incomplete desorption by gas chromatography [29]. Similarly, SPE and LLE require large 
volumes of solvents which are by itself a drawback.   
The key advantages of microwave assisted solvent extraction (MASE) lie in reduced 
solvent usage and less time consumption. Furthermore, multi-vessel systems can be used 
for simultaneous MASE.  Moreover, lesser amounts of samples are required which 
significantly reduce waste generation. Temperature can also be effectively controlled and 
the entire process is not labor intensive. MASE is carried out by high frequency microwave 
energy  which lies  in between RF and the IR regions of electromagnetic spectrum [30–
32].
 
In contrast to the conventional heating such as in normal solvent extraction heat is 
provided from outside and it gradually transfers to middle parts of solid sample, but 
microwave energy starts from core of sample and spreads from inside to outside. We have 
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already developed MASE for analysis of persistent organic pollutants in marine sediments 
[33].   Due to increased extraction efficiency, less interferences from complex matrices, no 
need for additional clean ups,  membrane protected μ-SPE has been used for extraction of 
halo acetic acids in swimming pool waters [34], acidic drugs and organophosphorus 
pesticides in wastewater [35,36],  persistent organic pollutants in tissue samples [37].  
Combination of MASE and μ-SPE provides a single step extraction and clean up procedure 
for analysis of target analytes present in complex matrices [38].  Extraction of analytes can 
be performed by throwing number of μ-SPE devices in a microwave vessel which contains 
sample in NaOH solution. Extraction of analytes from tissues to NaOH solution and then 
adsorption on μ-SPE devices take place simultaneously.  The porous membrane of the μ-
SPE device allows the diffusion of parabens onto the sorbents packed within the μ-SPE 
device, while eliminates the entrance of fatty contents. μ-SPE does not require many 
experimental steps, as the device can be easily made and is readily available for usage by 
simply conditioning it via ultrasonication in methanol. Another advantage of μ-SPE is that 
it requires as little as 200 μL of organic solvent for desorption of parabens. This volume of 
solvent consumption is significantly much lower compared to the volume of organic 
solvent required by SPE, which is in the range of tens of milliliters. Thus, this makes it an 
environmental-friendly technique. Furthermore, the length of desorption time required is 
short, which means that considerable amounts of time are reduced when dealing with 
multiple samples. Hence, the new μ-SPE technique can be a better alternative to SPE.  
To our knowledge, this is the first study to report the concentrations of individual parabens 
in human ovarian cancer tissues using single step extraction and clean up procedure 
involving MASE and μ-SPE.  This method could be used for rapid, precise, and cost-
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effective analyses of large numbers of samples in epidemiologic studies to assess human 
exposure to parabens. Structures of target anayltes are given in Table3-1.  
3.2. Experimental  
3.2.1. Chemicals 
 
HPLC-grade methanol, acetone, hexane and acetonitrile were bought from Tedia 
Company, Inc. (Fairfield, OH, USA). Sodium hydroxide (NaOH) of analytical grade was 
obtained from J.T. Baker (Philipsburg, NJ, USA). Nanopure water obtained from a 
Nanopure water purification system (Barnstead, USA) was used.  The four parabens 
studied were methyl paraben (purity 99%), ethyl paraben (purity 99%), propyl paraben 
(purity 99%) and butyl paraben (purity 98%). They were purchased from Alfa Aesar (A 
Johnson Mattey Company). Stock solutions containing 1mg ml-1 of each parabens were 
prepared in methanol and diluted with methanol to obtain working solutions at various 
concentrations. All solutions were filtered and stored at 4oC. C2, C8, C18, HayeSepA
 
and 
HayeSepB were obtained from Alltech (Deerfield, IL, USA). Q3/2 Accurel 2E HF (R/P) 
polypropylene sheet (157 µm thickness, 0.2 µm pore size) were purchased from Membrana 
(Wuppertal, Germany). 0.6 mL microcentrifuge tubes used for chemical desorption by 
ultrasonication and pipet tips from Axygen Scientific (California, USA) were used. 0.45 
μm syringe filters from Titan (New York) were also used. A MARS (CEM, Matthews, NC, 
USA) microwave extraction system (maximum power: 1200W) was used for parabens 
extraction from tissues. Uncontaminated grey prawns were bought from a supermarket. 
Ovarian tumor (malignant and benign) samples were obtained from Department of 
Obsterics and Gynaecology, Yong Loo Lin School of Medicine, National University of 
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Singapore with approval from the Domain Specific Review Board (DSRB). Safety 
considerations were put in place in the handling of tissues. All tissues and solvents used in 
this project were discarded according to the safety procedures. The apparatus used were 
decontaminated in a proper manner.  
3.2.2. Preparation of μ-SPE device 
 
The μ-SPE device was made by packing the sorbent in a polypropylene envelope.  The 
procedure for making μ-SPE device was described earlier [35]. Briefly, the envelope was 
fabricated by folding the equal lengths of membrane over each other and open ends were 
heat sealed except the one end which was left for packing of the sorbent. 25 mg of sorbent 
was packed via the remaining open end, which was then heat-sealed to produce the 
extraction device (2.0 cm x 0.5 cm). The dimensions of the μ-SPE device ensured that it 
could fit into a 600 μl plastic vial during the desorption process. Each device was first 
conditioned by ultrasonication in nanopure water for 5 minutes followed by 10 minutes 
ultrasonication in methanol. The μ-SPE device was then stored in methanol until use. C2 
(Si-C2H5), C8 (Si-C8H17), C18 (Si-C18H37), HayeSepA
 (divenylbenzene-
ethyleneglycoldimethylacrylate) and HayeSepB (divinylbenzene-polyethyleneimine) were 
the sorbent materials that were used in the making of μ-SPE device. Both HayeSepA and 
HayeSepB are polar polymer based sorbents. The former is of intermediate polarity while 
the latter is of high polarity. 
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Table 3- 1: Structures of analytes 
Analyte                    Structure        Elution order 
Methyl paraben  
 
 
 
 
1 
Ethyl paraben  
 
 
 
 
2 
Propyl paraben  
 
 
 
 
3 
Butyl paraben  
 
 
 
 
4 
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3.2.3. MASE-μ-SPE 
 
5 g of prawn tissues were accurately weighed and taken in a microwave vessel. These 
tissues were spiked with known concentrations of parabens and vessel was covered and 
kept overnight so that analytes can be properly entrapped within the matrix. The sample 
was then subjected to microwave heating after addition of 10 mL of 5 mol L-1 NaOH 
solution in same microwave vessel (600W, 90ºC, 20 minutes). Two μ-SPE devices were 
introduced into the microwave vessel prior to microwave heating and allowed to tumble 
freely in the stirred sample during extraction (Figure 3-1). After the completion of MASE, 
the μ-SPE devices were removed with a pair of tweezers. The analytes were desorbed by 
ultrasonication in 200 μl of acetonitrile for 20 minutes. No further clean-up was required. 
Lastly, 80 μL of extracts were injected into the HPLC system for analysis.  
3.2.4. MASE-SPE 
 
SPE was performed using a 12-cartridge vacuum extraction manifold (Supelco) with 
commercially available SPE cartridge with 200 mg (6 cc) WATERS Oasis HLB sorbent. 
The cartridge used was first conditioned with 1 mL of ultrapure water, followed by 1 mL 
of methanol. Upon MASE digestion (10 mL of NaOH and 10 mL of hexane, 600W, 90ºC, 
20 minutes), the digested spiked prawn tissue was first filtered using SPE filtering cartridge 
(Waters Oasis HLB Vac RC 60 mg Extraction cartridge) and washed with 10 mL of hexane. 
The filtered sample solution was collected and SPE was then carried out at a flow rate of 
approximately 5 mL min-1. The cartridge was then washed with 15 mL of a mixture of 
acetone and n-hexane 1: 1 volume ratio. The extracts were subsequently evaporated to near 
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dryness by rotatory evaporator and then reconstituted in 1 mL of acetonitrile, followed by 
HPLC/UV analysis. 
 
3.2.5. HPLC conditions  
 
Analysis of samples was performed using a Waters Analytical liquid chromatography 
system made up of Waters 600E quaternary pump, Waters 486 UV detector with a 100 μl 
loop and EMPOWER software. In this study, a Shimpack C18 VP-ODS column (250 mm 
x 4.6 mm column, 5 μm particle size) from Shimadzu was used. The detector wavelength 
was set at 254 nm. The mobile phase ratio was acetonitrile – water (65: 35) at a flow rate 
of 0.5 mL min-1. 
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Figure 3- 1: (a) MASE - μ-SPE setup (b) μ-SPE system (c) enlarge image of extraction 
device (not    drawn to scale 
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3.3. Results and discussion  
3.3.1. Optimization of MASE-μ-SPE procedure 
 
Optimization was carried out by considering triplicate uncontaminated grey prawn sample 
analysis spiked with known mass fractions of parabens. The parameters investigated 
include: MASE duration and temperature, membrane selection, suitable sorbent materials, 
multiple μ-SPE devices, desorption solvent and desorption time.  
The minimum amount of solvent recommended by the manufacturer of the microwave 
extraction system was 10 mL. This volume of NaOH solution was sufficient for the 
complete immersion and digestion of tissue samples. Hence, 10 mL of NaOH was used for 
digestion of all tissues because higher volumes would lead to dilution of analytes. 
Here it is important to describe that method development and optimization cannot be 
performed on real samples particularly when you are dealing with very expensive and rare 
human cancer tissues. Following are the major reasons that we adopted prawn tissues for 
method development and optimization  
(1) Among other tissues (fish, chicken etc.), prawn tissues represent very complex 
matrix because they contain lot of fatty stuff. 
(2)  Number of values are needed to be optimized for every parameter. For example, 
for optimization of type of sorbent, five different sorbents were tried. Each sorbent 
type was tested for n=3. In this way 15 samples are needed only for the optimization 
of sorbent type. Similarly, each affecting parameter will require at least 15 samples. 
For optimization of all factors this number may reach to100.  
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(3) This much number of cancer tissues is difficult to obtain and that is why methods 
are developed on closely related matrices and then their applicability is further 
confirmed by recovery experiments. Good recovery values are supportive to apply 
the method for tested matrix. 
3.3.1.1. MASE duration and temperature 
 
The time required for MASE was short compared to conventional Soxhlet extraction. 
Digestion time was evaluated between 10 and 30 minutes at 5-minute intervals. It required 
15 minutes for the complete digestion of prawn tissues into solution and 20 minutes was 
found to be optimal. A longer digestion time would result in the bursting of μ-SPE devices. 
Therefore, 20 minutes was selected as MASE time for further optimization of the method.  
 
The effect of temperature was investigated over a range of 50ºC to 90ºC. The optimum 
extraction efficiency was found to be at 90ºC. This could be attributed to the fact that an 
increase in temperature weaken the interactions between parabens and tissue, thereby 
increase the desorption rate of parabens from tissue to solution phase. The temperature was 
sufficient to digest the tissues and release the analytes into solution. The vials were cooled 
to room temperature at rate of 5°C minute-1 before collection of µ-SPE devices for 
desorption. 
3.3.1.2. Membrane selection  
 
There were many different types of commercially available membranes, which could be 
used to contain sorbent materials. Porous polypropylene membrane was chosen as the most 
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suitable membrane in the making of μ–SPE device. This was based on the earlier 
experimental results obtained from our research group. The high temperature resistance 
nature and wide chemical compatibility of polypropylene membrane makes it an 
appropriate material for μ–SPE device. In addition, membranes such as polycarbonate, 
cellulose acetate and PTFE were deemed unsuitable. Polycarbonate membrane was flimsy 
whereby vigorous stirring during extraction would tear the device even before the 
completion of extraction. Cellulose acetate membrane was brittle and could snap upon 
folding during the preparation of μ –SPE device. PTFE membrane was not heat sealable.  
3.3.1.3. Suitable sorbent materials and number of μ –SPE devices  
 
The selection of suitable sorbent materials is crucial as the target analytes (parabens) have 
different affinities for the functional groups of the different sorbent materials. Different 
sorbent materials were tested in the extraction of parabens. Five different sorbents materials 
(C2, C8, C18, HayeSepA and HayeSepB) were investigated. It was found that HayeSepA, 
which is of intermediate polarity,
 
showed higher extraction efficiency towards parabens 
(Figure 3-2). This is probably because parabens are relatively polar and thus higher 
electrostatic interaction occurs between the polar paraben and polar porous polymer base 
sorbents. 
 
The number of μ –SPE devices added into the microwave vessels for extraction was 
investigated as well. Experiments were performed by adding in one or two μ–SPE devices. 
For the studied parabens, the addition of two μ–SPE devices gave greater peak areas 
compared to just adding in one μ–SPE device. This could be due to the increase in surface 
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areas, which facilitate the adsorption of parabens onto the sorbent materials packed within 
the polypropylene membrane.  
3.3.1.4. Desorption solvent and desorption time  
 
The analytes were desorbed in a suitable organic solvent after extraction. Since parabens 
are generally polar compounds, they tend to be more favorably desorbed into a polar 
solvent during the desorption process. Thus, various polar organic solvents such as 
methanol, water, acetone and acetonitrile were tested. Acetonitrile was chosen as the 
suitable desorption solvent as it gave the greatest peak area. 
The effect of desorption time is investigated over a range of 5 to 30 minutes. Parabens were 
completely desorbed within 20 minutes of ultrasonication. Desorption was incomplete 
when shorter periods of time were used. Above 20 minutes, no considerable increase in 
desorption efficiency was observed (Figure 3-3).  
After the first desorption round, the μ-SPE device was re-desorbed in methanol for the 
second time to investigate for carryover effects. No analytes were detected in the second 
desorption round. However, protein from the prawn sample tends to clog the pore of the μ-
SPE device and compromise its extraction efficiency. Thus, we decide not to re-use the μ-
SPE device. 
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Figure 3- 2: Effect of various sorbents on the extraction efficiency of MASE-µ-SPE of 
parabens in spiked prawn samples. Prawn samples were spiked with 25 ng g-1 of parabens. 
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Figure 3- 3: Effect of desorption time on the extraction efficiency of MASE-µ-SPE of 
parabens in spiked prawn sample. Prawn samples were spiked with 25 ng g-1 of parabens 
 
 
 
 
 
 
 
0.00E+00
1.00E+06
2.00E+06
3.00E+06
4.00E+06
5.00E+06
6.00E+06
7.00E+06
methyl parabenethyl paraben propyl paraben butyl paraben
p
e
ak
 a
re
as
5 min
10 min
15 min
20 min
25 min
30 min
68 
 
3.3.1.5. μ-SPE after digestion 
 
The effects of conducting μ-SPE only after MASE were also investigated. This was based 
on the assumption that microwave heating of the sample in absence of μ-SPE devices can 
desorb the analytes more favorably from the biological tissues. Thus, conducting μ-SPE 
separately might give better analysis. After conducting MASE, the microwave vessels were 
allowed to cool down to room temperature before adding two μ-SPE devices for extraction. 
Different extraction times were investigated from 10 to 25 minutes at 5- minute interval. 
The digested samples were stirred at 1000 rpm using a magnetic stirrer. After μ-SPE 
extraction, the subsequent steps and conditions were kept constant as mentioned earlier. It 
was found that 20 minutes of extraction time gave the optimized results for this sequential 
approach. After 20 minutes, there was no significant increase in the adsorption efficiency. 
Experimental results of simultaneous MASE-μ-SPE were compared with MASE followed 
by μ-SPE, no significant differences in peak areas of analytes were observed. Hence, 
simultaneous mode which was less time consuming was selected as an optimum mode.  
3.3.2. Method validation  
 
To access the practical applicability of the proposed MASE-μ-SPE method, the optimized 
conditions for MASE and μ-SPE were adopted in the evaluation of the method’s linearity, 
reproducibility, limits of detection (LODs) and enrichment factor (Table 3-2). Calibration 
plots were obtained by plotting the HPLC peak area of the analytes against their 
corresponding concentrations in the uncontaminated grey prawn samples spiked with 
known mass fractions of parabens ranging from 5-200 ng g-1 (seven calibration levels). The 
linearity of the calibration plot was evaluated using the least-squares linear regression 
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analysis. All the parabens exhibited good linearity with coefficients of determinations (r2) 
up to 0.9962. The relative standard deviations (RSDs) corresponding to peak areas were 
calculated from analysis of five replicates of uncontaminated grey prawn samples spiked 
at  5 ng g-1 which were subjected to same extraction procedure and good values  ranging 
from 0.09 – 2.8% were obtained. LODs were determined by progressively decreasing the 
mass fractions of parabens spiked in the uncontaminated grey prawn tissues until distinct 
responses were still clearly observed at a signal to noise (S/N) ratio of 3. The LODs for 
parabens were found to be between 0.005 – 0.0244 ng g-1. Enrichment factor (EF) was 
calculated as the ratio of extracted analyte concentration to its initial concentration in the 
prawn tissues. EFs were calculated by using three replicates of uncontaminated grey prawn 
samples spiked at 25 ng g-1 and their values ranged from 27 to 314.  
In order to study the applicability of the proposed method for the determination of parabens 
in real cancer tissues, ovarian cancer tissues (with predetermined mass fractions of 
parabens) were spiked with 25 ng g-1 of each compound and recoveries were calculated 
after subjecting to the proposed procedure. Recoveries were calculated as the percentage 
ratio of mass fraction of the analyte found to mass fraction of the analyte added.  
Table 3-3. Compares current method with some methods reported in literature for 
extraction of parabens in different biological matrix.  
 
3.3.3. Comparison of μ-SPE with SPE  
 
The extraction efficiency of μ-SPE was compared with the commercial SPE using Waters 
Oasis HLB SPE-sorbent. Real ovarian cancer tissues were spiked with 25 ng g-1of parabens 
and standard addition method was used for calculation of percentage recoveries. The 
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recoveries of the parabens using MASE-SPE and MASE-μ-SPE methods were reported in 
Table 3-4. Theoretically, recoveries of SPE are expected to be higher than any micro-
extraction technique because it is an exhaustive extraction technique.  Micro extraction 
techniques are non-exhaustive and extraction is based on concentration equilibrium 
between extraction phase and sample solution, in turn, their recoveries are expected to be 
lower relative to SPE. However, from Table 3, we observed that the recoveries for MASE- 
μ–SPE are slightly higher than MASE-SPE. 
One possible explanation could be that the type of packing sorbents used in the μ-SPE 
device was more suitable for extracting the targeted parabens. The packing sorbents used 
in the μ-SPE device was HayeSepA, which was of intermediate polarity. The SPE 
cartridges utilized in this experiment were non-polar silica-based C18 as the packing 
sorbent. The targeted parabens were relatively polar thus; HayesepA provided better 
affinity for the parabens. Very good recoveries (82-100%) were obtained for all of the 
parabens using MASE-µ-SPE. 
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Table 3- 2: Analytical features of MASE-μ-SPE method 
 
a Coefficients of determination for linear range of 5-200 ng g-1 
 b Relative standard deviation evaluated at 5 ng g-1  
 c Limit of detection evaluated at 5 ng g-1 
 
 
 
 
 
 
 
Analytes Coefficients of 
determination a 
RSDs b  
(%, n = 5) 
LOD c  
(ng g-1) 
Enrichment 
Factors 
Methyl paraben 0.9939 0.0919 0.022 222 
Ethyl paraben 0.9905 0.7733 0.005 314 
Propyl paraben 0.9963 0.2054 0.024 70 
Butyl paraben 0.9923 2.813 0.015 27 
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Table 3- 3: Comparison of analytical performance data of the proposed method with 
reported methods for determination of parabens in different biological samples 
 
 
 
 
 
 
 
 
METHOD Matrix LODs 
 
RSDs 
(%) 
REF. 
 SM-SLLME-UHPLC-
MS/MS  
Human 
breast 
milk 
0.1-0.2 ng mL-1 <8 [40] 
LLE-SPE-GCMS Human 
breast 
cancerou
s tissues 
1.05-3.75 ng g-1 
 
4.6-13 [26] 
SPE-LC-ESI-MS/MS Human 
urine 
1-3 pg mL-1 1.2-4.5 [25] 
SPE-HPLC-MS/MS Human 
Urine 
0.2 ng mL-1 5.3-10.6 [41] 
MSPD-UHPLC-MS/MS Human 
placental 
tissues 
0.1  ng g-1 5.4-12.8 [42] 
MASE-μ-SPE-UPLC-UV Human 
Ovarian 
cancerou
s tissues  
0.005 - 0.0244  ng g-
1 
0.09 -
2.81 
Curren
t  
work 
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Table 3- 4: Comparison of paraben recoveries from ovarian cancer tissue achieved by 
MASE-SPE and MASE-µ-SPE (n=3) 
Analytes Recovery* (%) for 
MASE-SPE 
RSD (%) Recovery* (%) for 
MASE-μ-SPE 
RSD 
(%) 
Methyl paraben 81 2.6 82 1.2 
Ethyl paraben  83 4.2 85 2.7 
Propyl paraben  102 3.5 92 1.0 
Butyl paraben 76 5.6 100 2.1 
 
*evaluated at 25 ng g-1 
 
 
Figure 3- 4: HPLC/UV chromatogram of parabens standards peaks: (1) methyl paraben, 
(2) ethyl paraben, (3) propyl paraben & (4) butyl paraben 
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3.3.4. Studies of human ovarian tissues  
 
We applied MASE–μ–SPE method to determine the concentrations of the four parabens 
that might be present in 30 human ovarian tissues (15 ovarian cancer tissues and 15 benign 
tissues). These ovarian tissues were not spiked with parabens. The mass fractions of 
parabens present in human ovarian tissues were then calculated as shown in Table 3-5 and 
3-6. The tissue mass fractions of methyl paraben and propyl parabens were the highest 
among the four parabens examined. This finding is in agreement with another work which 
reports higher concentrations of methyl paraben in human breast tumors compared to 
concentrations of other parabens [19]. In addition, the higher tissue mass fractions of 
methyl and propyl parabens could be due to the fact that these two parabens are the most 
widely used [39]. From our studies, the tissue mass fractions of four parabens in all the 
ovarian cancer tissues are at least twice as much as those present in the benign tissues. The 
HPLC/UV chromatograms of the OC and benign tissues studied were shown in Figure 3-
5.   
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Table 3- 5: Mass fractions of parabens found in human ovarian benign tissues from 15 
patients 
 
 
Table 3- 6: Mass fractions of parabens found in human ovarian cancer tissues from 15 
patients 
Analytes                               Mass fractions of parabens in (ng g-1)   
Ovarian cancer 
tissues 
T10 T16 T35 T39 T40 1086 1060 1072 1080 1101 1161 1089 1022 1092 1131 
Methyl paraben 6.26 10.86 14.91 17.06 6.03 12.13 5.65 2.38 2.23 4.45 2.78 1.77 2.66 2.81 5.85 
Ethyl paraben 1.2 0.23 0.14 0.24 1.1 0.61 1.01 1.56 1.03 1.57 1.85 0.61 0.86 0.59 1 
Propyl paraben 1.09 3.35 1.64 3.08 1.53 1.22 0.63 3.13 0.67 0.82 0.71 0.71 0.85 0.63 0.79 
Butyl paraben 0.08 4.12 3.24 3.75 2.45 0.84 0.17 1.67 0.24 0.23 0.36 0.02 0.02 0.3 0.54 
 
 
 
 
 
Analytes                               Mass fractions of parabens (ng g-1) 
Benign tissues T11 T12 T15 T19 T20 1099 1055 1045 1124 1003 1169 1138 1164 1144 1120 
Methyl paraben 2.4 2.38 2.76 3.58 3.3 1.15 3.33 2.86 1.15 3.08 0.1 1.77 5.94 5.98 0.17 
Ethyl paraben 0.16 0.11 0.3 0.29 0.5 1.65 0.35 0.52 0.06 0.31 0.43 0.61 2.02 0.74 0.35 
Propyl paraben 1.44 1.18 1.13 1.67 0.7 1.28 0.54 1.04 0.18 0.64 0.51 0.71 0.18 0.99 1.29 
Butyl paraben 0.16 0.55 0.04 0.1 0.1 0.19 0.02 2.16 0.01 0.02 0.11 0.02 n.d 0.37 0.8 
76 
 
 
 
 
Figure 3- 5: HPLC/UV chromatogram of parabens extracted from (a) ovarian cancer tissues 
and (b) ovarian benign tissues.  Peaks: (1) methyl   paraben (2) ethyl paraben (3) propyl 
paraben and (4) butyl paraben. 
 
 
 
 
(a) 
(b) 
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3.4. Conclusion  
 
The optimized MASE μ-SPE technique used in tandem with HPLC/ UV as a novel and 
efficient method in identifying and quantifying parabens present in biological tissues was 
reported. The porous polypropylene membrane of the μ-SPE device, which eliminates the 
entrance of fatty contents and interferences, removes the necessity of conducting additional 
sample-cleanup. Reduced solvent consumption and time usage are major advantages of μ-
SPE compared to SPE. Furthermore, μ-SPE device is inexpensive and can be prepared 
easily. Our research suggests that human ovarian cancer tissue contains significant mass 
fractions of parabens, although a direct causative effect cannot yet be attributed to these 
compounds.  This work is continuing in our laboratory. 
 
 
 
 
 
 
 
 
 
78 
 
3.5. References  
[1] T. Colborn, F.S. vom Saal, A.M. Soto, Environ. Health Perspect. 101 (1993) 378. 
[2] M. Axelstad, S. Christiansen, J. Boberg, M. Scholze, P.R. Jacobsen, L.K. Isling, A. 
Kortenkamp, U. Hass, Reproduction 147 (2014) 489. 
[3] D. Balabanič, M. Rupnik, A.K. Klemenčič, Reprod. Fertil. Dev. 23 (2011) 403. 
[4] P.A. Fowler, M. Bellingham, K.D. Sinclair, N.P. Evans, P. Pocar, B. Fischer, K. 
Schaedlich, J.-S. Schmidt, M.R. Amezaga, S. Bhattacharya, S.M. Rhind, P.J. 
O’Shaughnessy, Mol. Cell. Endocrinol. 355 (2012) 231. 
[5] M.M.L. Dingemans, M. van den Berg, R.H.S. Westerink, Environ. Health 
Perspect. 119 (2011) 900. 
[6] D.A. Gibson, P.T.K. Saunders, Endocr. Relat. Cancer 21 (2014) T13. 
[7] K.C. Knower, S.Q. To, Y.-K. Leung, S.-M. Ho, C.D. Clyne, Endocr. Relat. Cancer 
21 (2014) T33. 
[8] H.-R. Lee, K.-A. Hwang, K.-H. Nam, H.-C. Kim, K.-C. Choi, Chem. Res. Toxicol. 
27 (2014) 834. 
[9] L.N. Vandenberg, T. Colborn, T.B. Hayes, J.J. Heindel, D.R. Jacobs, D.-H. Lee, T. 
Shioda, A.M. Soto, F.S. vom Saal, W. V Welshons, R.T. Zoeller, J.P. Myers, 
Endocr. Rev. 33 (2012) 378. 
[10] E.J. Routledge, J. Parker, J. Odum, J. Ashby, J.P. Sumpter, Toxicol. Appl. 
Pharmacol. 153 (1998) 12. 
[11] S. Esteban, M. Gorga, M. Petrovic, S. González-Alonso, D. Barceló, Y. Valcárcel, 
Sci. Total Environ. 466-467 (2014) 939. 
[12] M.G. Soni, I.G. Carabin, G.A. Burdock, Food Chem. Toxicol. 43 (2005) 985. 
[13] P.D. Darbre, P.W. Harvey, J. Appl. Toxicol. 34 (2014) 925. 
[14] T.T.B. Vo, E.-B. Jeung, Toxicol. Sci. 112 (2009) 68. 
[15] Int. J. Toxicol. 27 Suppl 4 (2008) 1. 
[16] Y. Guan, Q. Chu, L. Fu, J. Ye, J. Chromatogr. A 1074 (2005) 201. 
[17] R. Golden, J. Gandy, G. Vollmer, Crit. Rev. Toxicol. 35 (2005) 435. 
79 
 
[18] R.S. Tavares, F.C. Martins, P.J. Oliveira, J. Ramalho-Santos, F.P. Peixoto, Reprod. 
Toxicol. 27 (2009) 1. 
[19] P.D. Darbre, A. Aljarrah, W.R. Miller, N.G. Coldham, M.J. Sauer, G.S. Pope, J. 
Appl. Toxicol. 24 (2004) 5. 
[20] L. Barr, G. Metaxas, C.A.J. Harbach, L.A. Savoy, P.D. Darbre, J. Appl. Toxicol. 
32 (2012) 219. 
[21] X. Ye, A.M. Bishop, J.A. Reidy, L.L. Needham, A.M. Calafat, Environ. Health 
Perspect. 114 (2006) 1843. 
[22] K.W. Smith, I. Souter, I. Dimitriadis, S. Ehrlich, P.L. Williams, A.M. Calafat, R. 
Hauser, Environ. Health Perspect. 121 (2013) 1299. 
[23] L.P. Melo, M.E.C. Queiroz, Anal. Methods 5 (2013) 3538. 
[24] I. Jiménez-Díaz, F. Vela-Soria, A. Zafra-Gómez, A. Navalón, O. Ballesteros, N. 
Navea, M.F. Fernández, N. Olea, J.L. Vílchez, Talanta 84 (2011) 702. 
[25] S. Lu, S. Gong, S. Ma, X. Zeng, Z. Yu, G. Sheng, J. Fu, Anal. Methods 6 (2014) 
5566. 
[26] G. Shanmugam, B.R. Ramaswamy, V. Radhakrishnan, H. Tao, Microchem. J. 96 
(2010) 391. 
[27] J.K. Lokhnauth, N.H. Snow, Anal. Chem. 77 (2005) 5938. 
[28] T. Fei, H. Li, M. Ding, M. Ito, J.-M. Lin, J. Sep. Sci. 34 (2011) 1599. 
[29] Y. Yang, D.J. Miller, S.B. Hawthorne, J. Chromatogr. A 800 (1998) 257. 
[30] V. Camel, TrAC Trends Anal. Chem. 19 (2000) 229. 
[31] C.S. Eskilsson, E. Björklund, J. Chromatogr. A 902 (2000) 227. 
[32] L. Sanchez-Prado, C. Garcia-Jares, M. Llompart, J. Chromatogr. A 1217 (2010) 
2390. 
[33] C. Basheer, J.P. Obbard, H.K. Lee, J. Chromatogr. A 1068 (2005) 221. 
[34] H. Nsubuga, C. Basheer, J. Chromatogr. A 1315 (2013) 47. 
[35] C. Basheer, H.G. Chong, T.M. Hii, H.K. Lee, Anal. Chem. 79 (2007) 6845. 
80 
 
[36] C. Basheer, A.A. Alnedhary, B.S.M. Rao, S. Valliyaveettil, H.K. Lee, Anal. Chem. 
78 (2006) 2853. 
[37] C. Basheer, K. Narasimhan, M. Yin, C. Zhao, M. Choolani, H.K. Lee, J. 
Chromatogr. A 1186 (2008) 358. 
[38] L. Xu, H.K. Lee, J. Chromatogr. A 1192 (2008) 203. 
[39] E.M. Jackson, Cutan. Ocul. Toxicol. 11 (1992) 173. 
[40] R. Rodríguez-Gómez, M. Roldán-Pijuán, R. Lucena, S. Cárdenas, A. Zafra-
Gómez, O. Ballesteros, A. Navalón, M. Valcárcel, J. Chromatogr. A 1354 (2014) 
26. 
[41] X. Ye, Z. Kuklenyik, A.M. Bishop, L.L. Needham, A.M. Calafat, J. Chromatogr. 
B. Analyt. Technol. Biomed. Life Sci. 844 (2006) 53. 
[42] F. Vela-Soria, I. Rodríguez, O. Ballesteros, A. Zafra-Gómez, L. Ballesteros, R. 
Cela, A. Navalón, J. Chromatogr. A 1371 (2014) 39.  
 
 
 
 
81 
 
4. CHAPTER  
DEVELOPMENT OF NATURAL SORBENT BASED 
MICRO-SOLID-PHASE EXTRACTION FOR 
DETERMINATION OF PHTHALATE ESTERS IN MILK 
SAMPLES 
 
 
This chapter has been published in “Analytica Chimica Acta”. 
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Abstract  
In the present study, a natural sorbent based micro-solid phase extraction (µ-SPE) was 
developed for determination of phthalate esters in milk samples. For the first time, an 
efficient and cost effective natural material (seed powder of Moringa oleifera) was 
employed as sorbent in µ-SPE. The sorbent was found to be naturally enriched with variety 
of functional groups and having a network of interconnected fibers. This method of 
extraction integrates different steps such as removal of proteins and fatty stuff, extraction 
and pre-concentration of target analytes into a single step. Thirteen phthalate esters were 
selected as target compounds for the development and evaluation of method. Some key 
parameters affecting the extraction efficiency were optimized,  including selection of 
membrane, selection and amount of sorbent, extraction time, desorption solvent, volume 
of desorption solvent, desorption time and effect of salt addition. Under the optimum 
conditions, very good linearity was achieved for all the analytes with coefficient of 
determinations (R2) ranging between 0.9768 and 0.9977. The limits of detection ranged 
from 0.01 to 1.2 µg L-1. Proposed method showed satisfactory reproducibility with relative 
standard deviations ranging from 3.6% to 10.2% (n=7). Finally, the developed method was 
applied to tetra pack and bottled milk samples for the determination of phthalate esters. 
The performance of natural sorbent based µ-SPE was better or comparable to the methods 
reported in the literature.  
Key words: Natural sorbent, food analysis, microextraction, gas chromatography/mass 
spectrometry 
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4.1. Introduction  
 
Phthalate esters (PEs) are famous class of polymer additives, which are used to introduce 
plasticity and durability to polyvinyl chloride (PVC) and other plastic materials. Since, 
they are not chemically bound to the structure of the polymer chains in plastics, they can 
migrate from plastics to the substances they are in contact with. The considerable 
environmental concern arises from their migration to food materials and water [1].  
PEs have been specially considered from the perspective of their health implications on the 
human and wildlife. They are reported to induce reproductive, developmental and 
neurological disorders and thus considered as endocrine disrupters (EDCs) [2–4]. Due to 
their potential risks to human health and environment, PEs have been placed in priority 
pollutant list issued by United States Environmental Protection Agency (USEPA). 
Ingestion of contaminated food is major route of human exposure to PEs. Therefore, it is 
highly desired to develop sensitive analytical methods for trace level monitoring of PEs in 
food. 
Due to its nutritional value and immunological benefits to infants and aged people, milk 
stands among imperious and highly consumed foods. Thus, monitoring of potential 
pollutants such as PEs in milk samples has great significance from human health 
perspective [5]. Milk can get contaminated with PEs through different sources including 
environmental diffusion, direct uptake by the animals through air or food, and processing 
by contact with different plastics, pipes, containers etc. [6]. In dairy forms and milk 
processing units, bulk transfer of milk between tankers and storage tanks is carried out 
through plastic pipes which can introduce PEs into milk [7]. Machine milking, where milk 
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comes in contact with rubber parts of the machine, was also reported to enhance PE 
contents in milk [8].  
Since milk represents a very complex matrix which is enriched with fats, lipids, 
carbohydrates, vitamins and minerals. Extraction of target compounds from milk samples 
is a rather challenging task. Conventional extraction methods such as liquid-liquid 
extraction and solid phase extraction require large amounts of solvents, samples and 
adsorbent materials. Furthermore, they are labor and time extensive and materials have 
lesser possibility to be reused. Thus, sample  preparation scientists are nowadays dedicated 
to develop efficient, green, inexpensive and miniaturized  extraction procedures in order to 
extract and pre-concentrate the analytes of interest prior to instrumental analysis [5]. 
Hence, over a period of time, number of microextraction methods have been developed for 
extraction of PEs in milk samples. In this regard,  most commonly used methods are 
dispersive liquid-liquid extraction (DLLME) [5,9] and headspace solid phase 
microextraction (HS-SPME) [10]. For DLLME, clean samples are preferred for proper 
phase separation. Additionally, complex samples like milk cannot be used directly without 
pre-treatment.  In order to remove proteins and fatty stuff from the samples, DLLME 
involves some additional steps such as use of number of organic solvents, which are not 
desired when analyzing PEs because PE residues can be found even in organic solvents 
and they are abundant in laboratory environment [11]. Moreover, pretreatment of proteins 
and fatty stuff using organic solvents such as methanol and acetonitrile may lead to loss or 
dilution of the target analytes. HS-SPME also has several limitations when dealing with 
PEs, particularly most of PEs show low volatility and reasonably high temperatures are 
required to vaporize PEs. In addition, SPME fibers are expensive and highly fragile [12]. 
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In the current study, we applied porous membrane protected micro-solid phase extraction 
(µ-SPE) for extraction of PEs in milk samples. This technique was first introduced in 2006 
[13] and is increasingly popular sample preparation method for different classes of organic 
compounds [14–16] present in food [17–19], environmental [20,21], and biological [22,23] 
matrices.  Technique continued to evolve over the period of time and it was assisted by 
vortex [21], microwave [24], and by combining with other extraction approaches [17,25].  
In most of the previous studies, synthetic sorbents were used in µ-SPE. Although these 
sorbents offer unique advantages such as high affinity and selectivity toward target 
compounds but their preparation is labor and time extensive due to extended synthesis 
procedures. Any small variations in synthesis conditions may affect the activity of sorbent 
to a large extent.  Likewise, the consumption of large amount of chemicals for synthesis of 
selective sorbents is hazardous both for workers and environment and contradicts basic 
rules of green chemistry approaches. Hence, there is a pressing need to explore green and 
readily available sorbent materials for extraction applications. Thus, low cost, easily 
assessable and disposable natural sorbents derived from plants can be an alternative.  
We tested different natural sorbents for extraction of PEs in milk samples. Inspired from 
its better extraction efficiency and highly fibrous, heterogeneous and naturally 
functionalized surface, seed powder of Moringa oleifera (M. oleifera) was selected as 
sorbent. M. oleifera belongs Moringaceae family and it grows in many countries. It is an 
environment friendly, non-toxic and biodegradable sorbent [26]. A recent review article 
describes potential of M. oleifera for treatment of water and wastewater [27]. In addition, 
it has been widely used for removal of metals [28,29] and dyes [30] in aqueous solutions. 
However, in few studies, it has been employed for analytical extractions [31]. To best of 
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our knowledge, this is the first report where seed powder of M. oleifera is used as sorbent 
for extraction of PEs.  
4.2. Experimental  
4.2.1. Chemicals and materials 
 
The mixture of PE standards was purchased from Restek (Bellefonte, PA, USA). Following 
13 compounds were considered for analysis from the mixture: dimethylphthalate (DMP), 
diethylphthalate (DEP), phthalic acid diisobutyl ester (DIBP), di-n-butylphthalate (DNBP),  
bis(2-methoxyethyl)phthalate (BMEP), bis(4-methyl-2-pentyl)phthalate (BMPP), bis(2-
ethoxyethyl)phthalate (BEEP), dipentylphthalate (DPP), di-n-hexyl phthalate (DNHP), 
benzyl butyl phthalate (BBP), bis(2-n-butoxyethyl)phthalate (BBEP), phthalic acid 
dicyclohexyl ester (DCHP), bis(2-ethylhexyl)phthalate (BEHP). HPLC-grade toluene, 
acetone, acetonitrile, carbon tetrachloride and n-hexane were purchased from Tedia 
Company (Fairfield, OH, USA). Ultrapure water was produced on a Siemens Ultra Clear 
water purification system. Q3/2 Accurel 2E HF (R/P) polypropylene (PP) membrane sheet 
(157 μm thickness, 0.2 μm pore size) was purchased from Membrana (Wuppertal, 
Germany) and used for fabricating envelopes for the μ-SPE device. Cellulose acetate (0.2 
μm pore size, 47 mm diameter), polytetrafluoroethylene (PTFE) (0.2 μm pore size, 47 mm 
diameter) and polycarbonate (0.2 μm pore size, 47 mm diameter) were purchased from 
Advantec (Toyo Roshi Kaisha, Japan). C18 was obtained from Alltech (Deerfield, USA). 
Dried M. oleifera seeds were purchased from local market (Alkhobar, Saudi Arabia) and 
ground to powder before using as sorbent. Banana peels were properly dried and powdered 
to use as sorbent and rice husk was obtained by a rice mill in India.   
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4.2.2. GC-MS 
 
Analysis was carried out using Shimadzu QP2010 GC–MS system equipped with a 
Shimadzu AOC-20i autosampler and  Rxi -5 Sil MS (Restek) fused silica capillary column 
(30 mm × 0.25 mm internal diameter, 0.25 μm film thickness). High purity helium 
(99.9999%) was used as carrier gas at a flow rate of 1.01 mL/min. Samples were injected 
in splitless mode. The injector temperature was set at 250 °C and the interface temperature 
maintained at 220 °C. The GC oven was initiated from  40 °C, and was then increased  to 
200 °C at 8 °C/min, and held for 1 min, after that it was increased to 220°C at 5 °C/min, 
and held for 1 min, and finally it was increased to 250 °C at 3 °C/min . First, a standard 
solution containing high concentrations of all analytes was run in scan mode for qualitative 
analysis and analyte peaks were detected and confirmed using MS library. The analytes 
were analyzed in selective ion monitoring mode for quantitative determination. The 
monitored ions were selected based on good selectivity and high sensitivity, selected m/z 
values are listed in Table 4-1.  
4.2.3. Preparation of natural sorbent and its characterization  
 
Natural sorbent was obtained by grinding the seeds of M. oleifera to fine powder. This 
powder was then passed through 75 µm sieve and washed with deionized water for several 
times to remove any exterior contamination. After washing, sorbent was dried in oven at 
60°C for 8 hours.  Field emission-scanning electron microscopy (FE-SEM), Fourier-
transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), thermogravimetric 
analysis (TGA) and differential scanning calorimetry (DSC) were used to characterize the 
sorbent.  
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Table 4- 1: List of target compounds, their CAS numbers and chromatographic parameters 
Analyte CAS Number  Retention 
time  
Target ions 
m/z for SIM 
mode 
Elution order 
DMP 131-11-3 15.875 163, 77 1 
DEP 84-66-2 18.050 149, 177 2 
DIBP 84-69-5 22.145 149,57,223 
 
3 
DNBP 84-74-2 23.735 149,104 4 
BMEP 117-82-8 24.340 59,149,207 5 
BMPP 146-50-9 25.575 149,85, 167 6 
BEEP 605-54-9 26.385 45, 72, 149, 
104 
7 
DPP 131-18-0 27.185 149,237 8 
DNHP 84-75-3 31.260 149,251 9 
BBP 85-68-7 31.440 149, 91, 206 10 
BBEP 117-83-9 34.120 57, 149, 193 11 
DCHP 84-61-7 35.140 149, 167 12 
BEHP 117-81-7 35.645 149, 167, 279 13 
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4.2.4. Sample preparation 
 
A stock solution (1000 µg L-1) was prepared by diluting the standards mixture of PEs with 
n-hexane, and was stored in the refrigerator at 4 °C. Working standard solutions (50 µg L-
1) were freshly prepared by diluting the stock solution appropriately. Milk samples used 
for studying the extraction performance were prepared by spiking PEs free milk at known 
concentrations. Different brands of bottled and tetra-pack milk were purchased from the 
local market and stored at 4 °C till the analysis. 
4.2.5. μ-SPE 
 
The μ-SPE device was constructed by packing natural sorbent in a PP envelope.  
Fabrication of PP envelope to serve as μ-SPE device was based on very simple procedure. 
Briefly, the envelope was fabricated by folding the equal lengths of membrane over each 
other and open ends were heat sealed except the one end which was left for packing of the 
sorbent. 30 mg of natural sorbent was packed via the remaining open end, which was then 
heat-sealed to produce the extraction device (2.0 cm × 0.7 cm). The dimensions of the μ-
SPE device ensured that it could fit into a 600 μL glass vial during the desorption process. 
Fabrication of a single μ-SPE device took 3 to 4 mins and about 15 to 20 devices could be 
fabricated within one hour. Each device was first conditioned and cleaned by dipping in 
acetone and ultrasonicating for 10 mins.  After conditioning μ-SPE devices were air dried.  
For extraction, the μ-SPE device and magnetic stirrer were placed in a 5 mL sample 
solution and vortexed for 10 mins. After extraction, using a pair of tweezers, the μ-SPE 
device was removed, dried with lint free tissue, and then fitted into a glass vial for 
desorption. Analytes were desorbed by adding 100 μL of acetonitrile into glass vial. 
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Desorption was assisted by ultra-sonication for 5 mins. After that, μ-SPE device was taken 
out of the glass vial and 1 μL of extracted liquid was injected into GC-MS. The schematic 
of extraction procedure is shown in Figure 4-1. 
4.2.6. Optimization of extraction conditions, calibration plots and analysis of 
real samples 
 
Factors that affect extraction efficiency of μ-SPE were optimized. These factors included 
membrane selection, selection of sorbent and its amount, desorption solvent and its volume, 
extraction and desorption times, effect of salt addition. Carryover effects and reusability of 
the μ-SPE device were also tested. All the optimization experiments were performed using 
5 mL sample solution containing 50 µg L-1 of PEs. 
6-point calibration plots were drawn under optimum extraction conditions by using PEs 
free milk spiked at 1, 5, 10, 25, 50 and 100 µg L-1. Finally, the method was adopted for 
extraction and quantitation of PEs in three different brands of milk samples.     
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Figure 4- 1: Schematic of extraction method using µ-SPE. For clarity, schematic not drawn to scale. 
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4.3. Results and discussion 
4.3.1. Characterization of natural sorbent 
 
Surface morphology is critical in determination of the sorption properties of the sorbents. 
FE-SEM images were used to inspect surface morphology. Highly porous framework of 
interconnected fibers was observed by SEM images which reveals the potential of material 
as sorbent (Figure 4-2). Presence of various functional moieties was confirmed by FTIR 
spectra of the sorbent (Figure 4-3). A peak of O—H stretching found at 3429 cm-
1corresponds to proteins, fatty acids, carbohydrates and lignin units. Because of high 
protein content, same region is also attributed to N—H stretching of amides. Peaks at 2924 
and 2853 cm-1 correspond respectively to asymmetric and symmetric stretching of   C—H 
in CH2 group. Peaks at 1710 and 1653 cm
-1 are related to C=O stretching, which is present 
in proteins and fatty acid structures. Hence, the functional groups enriched bio-sorbent is 
supposed to interact with target compounds through above said functional moieties.    
The XRD patterns of the sorbent showed a single and poorly resolved broad peak indicating 
the amorphous nature of the material (figure not shown). TGA) and DSC were performed 
using SDT Q600 analyzer (TA instruments, USA) to characterize the stages of 
decomposition and the thermal stability of the sorbent. Both techniques present the mass 
loss curve of the bio-sorbent material. TGA curve (Figure 4-4a) indicates that the sorbent 
consist of a mixture of several components confirming the heterogeneous nature. The three 
main stages in the mass loss curve are: (I) from 30-128oC, 8% of mass loss related to water 
desorption, (II) from 128-268oC, 32% of mass loss occurs due to decomposition of organic 
matter and protein components; (III) from 268-541oC the greater decomposition part of the 
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seed constituents was observed, most probably including fatty acids such as oleic acid. At 
950oC, decomposition occurred due to the presence of some inorganic oxides and ash. 
These facts were also supported by DSC curve (Figure 4-4b). 
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Figure 4- 2: SEM images of natural sorbent (Seed powder of M. oleifera) at different magnifications 
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Figure 4- 3: FTIR spectrum of seed powder of M. oleifera 
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Figure 4- 4: TGA (a) and DSC (b) of seed powder of M. oleifera 
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4.3.2. Optimization: Factors affecting extraction efficiency  
 
The most frequent problem that has been reported to encounter while analysis of PEs is 
contamination of PEs from the glassware, reagents and plastic materials in the lab. There 
is a probability of contamination during any step of analysis. Hence, in order to avoid the 
contamination of PEs, glassware was washed with ultrapure water, acetone and methanol 
and then dried at 120°C overnight. This glassware was then stored in a thermally treated 
aluminum foil. The ultrapure water was extracted by proposed method and then desorbed 
by toluene. The resulting chromatogram showed some PE peaks. In order to find the source 
of these peaks, blank toluene was also injected into GC-MS. The concentrations of PEs in 
toluene was same as found in ultrapure water. Hence, the source was toluene.    
Other solvents employed during this extraction were also tested for contamination and PE 
traces were also found in carbon tetrachloride. No traces of PEs were found in acetonitrile 
and n-hexane.  The solvents toluene and carbon tetrachloride were also investigated during 
solvent optimization step, however, the initial contamination was taken into account while 
quantitation of PEs. The best extraction performance was obtained with acetonitrile. As 
initial screening showed that it was free of PE traces, hence, no additional calculations were 
needed for all upcoming optimization procedures. 
Optimization was carried out by analysis of triplicate uncontaminated milk samples spiked 
with 50 µg L-1 of PEs.  
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4.3.2.1. Membrane selection  
 
We tested different types of commercially available porous membranes (PP, 
polycarbonate, cellulose acetate and PTFE in order to contain sorbent materials for μ–SPE. 
Porous polypropylene membrane was chosen as the most suitable membrane for making 
μ–SPE devices. The wide chemical compatibility of PP membrane makes it an appropriate 
membrane for μ–SPE device. Other membranes such as polycarbonate, cellulose acetate 
and PTFE were deemed unsuitable. The polycarbonate membrane was flimsy whereby 
vigorous stirring during extraction would tear the device even before the completion of 
extraction. Cellulose acetate membrane was brittle and could snap upon folding during the 
preparation of μ –SPE device. PTFE membrane was not heat sealable. 
4.3.2.2. Sorbent selection and amount 
 
The selection of the sorbent is of vital importance for µ-SPE because it determines 
selectivity towards analytes. Extraction efficiency of seed powder of M. oleifera was 
compared with C18, banana peel and rice husk. C18 is commonly used conventional sorbent 
in µ-SPE for extraction of organic analytes [32] while banana peel and rice husk are among 
other commonly used bio-sorbents. The constant mass of each sorbent (50 mg) was used 
for selection of optimum sorbent. Seed powder of M. oleifera was found to be most 
effective sorbent and gave highest peak areas compared to other sorbents (Figure 4-5). M. 
oleifera seeds are reported to contain significant fiber, protein and ash content [33]. All 
these properties are advantageous for adsorption of target compounds. Hence, better 
extraction performance of M. oleifera may be attributed to  
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(i) Its fibrous structure which comprise a highly porous network of interconnected 
fibers. In general, fibrous structures have good adsorption capabilities. 
(ii) Presence of proteins and other naturally functionalized moieties that may 
interact with target compounds. Larger the amount of proteins in a bio-sorbent 
corresponds to abundance of functional groups. The overall protein content of 
M. oleifera seeds is reported up to 38% [34] and it is much higher than the 
protein content of banana peel (0.90%) [35] and rice husk (2.5%) [36].   
(iii) Electrostatic interactions between carbon content of ash and target compounds.   
Hence, M. oleifera was selected as sorbent for further experiments.  
Different amounts (20, 30, 60, 90, 120 mg) of natural sorbent were packed into 
polypropylene membrane and 30 mg was found as an optimum sorbent amount. Peak areas 
increased up to 30 mg and then became constant.   This amount can easily fit into a 
desorption vial and desorption can be done using smaller volume of the organic solvent. 
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Figure 4- 5: Influence of sorbent type on extraction of PEs. Conditions: PEs concentration: 
50 µg L-1; extraction time: 10 mins; desorption solvent: toluene; desorption volume: 
250µL; desorption time: 5 mins; amount of salt: 0%. 
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4.3.2.3. Desorption solvent and its volume   
 
After extraction, the µ-SPE device was transferred into a glass vial. After that, desorption 
solvent was added to the glass insert and desorption was carried out with aid of 
ultrasonication. Desorption solvents with varying polarity index were investigated to get 
the maximum desorption of the analyte from sorbent to desorbing solvent.  The solvents 
toluene, acetonitrile, n-hexane and carbon tetrachloride were tested. Figure 4-6 shows that 
highest peak areas were obtained by using acetonitrile and it was selected as an optimum 
desorption solvent for further experiments.  
A series of experiments was performed to find out the optimum volume of the desorption 
solvent (acetonitrile). Different volumes of acetonitrile ranging from 100 to 400 µL were 
investigated. The highest peak areas were obtained with 100 µL of desorption solvent. This 
can be attributed to the high enrichment of analytes in lower volumes. The volumes below 
100 µL were not considered in order to have sufficient volume for immersion of µ-SPE 
device and complete desorption thereafter. Hence, 100 µL acetonitrile was adopted as an 
optimum value of desorption solvent (Figure 4-7).  
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Figure 4- 6: Influence of desorption solvent on extraction of PEs. Conditions: PEs 
concentration: 50 µg L-1; extraction time: 10 mins; desorption volume: 200µL; desorption 
time: 5 mins; amount of salt: 0%. 
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Figure 4- 7: Influence of volume of desorption solvent on extraction of PEs. Conditions: 
PEs concentration: 50 µg L-1; extraction time: 10 minutes; desorption solvent: acetonitrile; 
desorption time: 5 minutes; amount of salt: 0%. 
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4.3.2.4. Extraction and desorption times 
 
The extraction efficiency of µ-SPE device depends on the rate of mass transfer of analytes 
from the donor phase (sample solution) to the sorbent phase. Sample agitation improves 
extraction efficiency by enhancing contact between the analytes and sorbent phase. Hence, 
extraction (agitation) time is an important parameter to consider. The extraction time was 
evaluated in range of 5–20 mins. Figure 4-8 shows that peak areas of analytes increased 
with extraction up to 10 mins with no significant increase thereafter. After 10 mins, peak 
areas reached to a steady state. As in µ-SPE, the analytes are dynamically distributed 
between the sorbent and solution phase. Establishing a steady state after 10 mins is 
indicative to mass transfer equilibrium between sorbent and solution phase. Hence, 
extraction time of 10 mins was selected as an optimum time for next experiments. 
The effect of desorption time was investigated over a range of 5 to 20 mins. Maximum 
extraction efficiency was observed at desorption time of 5 mins. After 5 mins, extraction 
efficiency was gradually decreased which can be attributed to increased temperature as a 
result of longer periods of ultra-sonication. PEs may evaporate at increased temperatures 
(Figure 4-9).  
4.3.2.5. Effect of salt addition 
 
In most of the microextraction studies, experiments are performed to evaluate the effect of 
salt addition on extraction efficiency. Upon salt addition, solubility of the target analytes 
decreases in the aqueous phase and it leads to their migration to extractant phase. Salting-
out effect was studied by adding various amounts of NaCl to milk samples (ranging from 
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0 to 20%, w/v). The highest peak areas were obtained at 0% (without salt addition) (Figure 
4-10).   
Upon addition of 5% salt, we observed that peak areas of some analytes were significantly 
decreased while for other compounds they remained constant. Further addition of salt up 
to 20% did not affect peak areas. This  decrease in extraction efficiency upon salt addition 
can be due to enhanced viscosity of the sample solution  which hinders movement of target 
analytes from donor to acceptor phase [37]. Moreover, salt addition will precipitate 
proteins which may hinder adsorption of target compounds into µ-SPE device.  
4.3.2.6. Carry over effects and reusability of µ-SPE device 
 
After the first desorption round, the μ-SPE device was re-desorbed in acetonitrile to 
investigate carryover effects. No analyte peaks were detected which meant that device can 
be re-used. Hence, we investigated the repeated use of μ-SPE device and results confirmed 
that it could be used for 20 to 25 times.  RSD values for reusability data ranged between 
3.8 to 9.2 %. The reusability of μ-SPE device is, however, highly dependent on the 
durability of membrane material itself.   
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Figure 4- 8: Influence of extraction time on extraction of PEs. Conditions: PEs 
concentration: 50 µg L-1; desorption solvent: acetonitrile; desorption volume: 100µL; 
desorption time: 5 mins; amount of salt: 0%.  
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Figure 4- 9: Influence of desorption time on extraction of PEs. Conditions: PEs concentration: 50 µg 
L-1; desorption solvent: acetonitrile; desorption volume: 100µL; extraction time: 10 minutes; amount 
of salt: 0%. 
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Figure 4- 10: Influence of salt addition on extraction of PEs. Conditions: PEs 
concentration: 50 µg L-1; desorption solvent: acetonitrile; desorption volume: 100µL; 
extraction time: 10 minutes; desorption time: 5 minutes. 
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4.3.3. Method validation  
 
To evaluate analytical performance of the proposed natural sorbent based µ-SPE-GC-MS 
method, parameters like linearity, repeatability, limits of detection and enrichment factors 
were investigated under optimum experimental conditions. The results are summarized in 
Table 4-2.  
Calibration curves were plotted under most favorable extraction conditions using milk 
samples that were originally free from PEs and spiked with different concentrations of PEs 
(1,  5, 10, 25, 50, 100 µg L-1) . Each point of the calibration curve corresponded to the 
average value obtained from seven measurements. Good linearity was observed over a 
concentration range of 1-100 µg L-1 with coefficient of determination (R2) ranging from 
0.9768 to 0.9977. LODs calculated based on signal-to-noise (S/N) ratio of 3, were in the 
range of 0.01 to 1.2 µg L-1. Precision of any developed method is determined by 
reproducibility data.  Intra-day and inter-day reproducibility was accessed by extracting 
the spiked milk samples (n=7 for each) under the same extraction conditions and the values 
of relative standard deviations (RSDs) were in between 3.6% and 10.2%. This reflects an 
acceptable precision. Similarly, repeatability of extraction was studied with different µ-
SPE devices and satisfactory RSD values ranging between 2.5% to 7.2% were obtained.  
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Table 4- 2: Analytical features of the proposed method 
 
aDynamic linear range; bLimit of detection: calculated as three time of the baseline noise ; 
cLimit of quantitation: 3×LOD; dreproducibility. 
 
 
 
Compound  DLRa 
(µg L-1) 
Coefficient of 
determination 
(r2) 
LODb 
(µg L-1) 
LOQc 
(µg L-1) 
RSDd(%)  
(n=7) 
 
Intra-day Inter-day 
DMP 1-100 0.9977 0.07 0.22  
5.4 
6.7 
DEP 1-100 0.9966 0.06 0.18  
4.1 
4.5 
DIBP 1-100 0.9973 0.04 0.12  
8.7 
9.1 
DNBP 1-100 0.9928 0.01 0.4  
6.0 
5.7 
BMEP 5-100 0.9908 1.2 3.7  
7.6 
8.3 
BMPP 1-100 0.9943 0.07 0.21  
3.6 
5.8 
BEEP 1-100 0.99 0.09 0.27  
5.9 
7.2 
DPP 1-100 0.9914 0.03 0.10  
7.0 
6.7 
DNHP 1-100 0.9768 0.06 0.18  
4.6 
4.3 
BBP 1-100 0.9949 0.06 0.19  
4.7 
5.9 
BBEP 1-100 0.9898 0.11 0.34  
8.4 
7.8 
DCHP 1-100 0.9926 0.08 0.24  
6.2 
4.7 
BEHP 1-100 0.9843 0.07 0.21  
9.4 
10.2 
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4.3.4. Real Samples 
 
The proposed method was applied for determination of PEs in the milk samples. For this 
purpose, three different brands of milk samples (2 bottled and 1 tetra pack) each with fat 
content of 3% were obtained.  In order to access the matrix effect, the relative recoveries 
of the method were calculated by extracting the spiked milk samples and comparing with 
extraction of the same concentrations spiked in water samples. The mean recoveries for all 
analytes in three different brands of milk samples are listed in Table 4-3. Some differences 
in the recoveries were observed such as long alkyl chain containing PEs e.g.   BBEP and 
BEHP showed relatively low recoveries. It can be explained by two ways 
(i) As the sorbent is naturally functionalized with polar moieties, it will interact 
strongly with relatively polar PEs. As the length of alkyl chain increases in PEs, 
their polarity will decreases, which in turn leads to their relatively poor 
extraction by the sorbent.  
(ii) Secondly, it is probably an indication that matrix effect is less effective in case 
of relatively polar PEs but as the length of alkyl chain in PE molecules 
increases, the interactions between PEs and proteins in the milk become more 
prominent. Similar findings have also been reported in another study [5]. 
Only seven compounds DMP, DNBP, BMEP, DPP, BBP, DCHP and BEHP were detected 
in some of the real milk samples (Table 4-4). Maximum contamination levels (MCLs) of 
PEs in milk have not been regulated yet, but the MCLs for DEHP in water is 6 µg L-1 [38]. 
The concentrations found in milk samples were higher than this level. 
The performance of the proposed method was compared with those reported in the 
literature (Table 4-5).  The natural sorbent based µ-SPE-GC-MS method has several 
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advantages on the methods reported in literature. It requires small volume of sample (5 
mL). In addition, it utilizes very small amount of the natural sorbent (30 mg) compared to 
conventional SPE. The proteins and fats from the milk samples cannot deposit over the 
sorbent as it is protected inside the membrane by heat sealing. No additional steps are 
needed for removal of proteins from the milk prior to extraction, which is usually time 
extensive. Moreover, very small volume (100 µL) of the organic solvent is required for 
desorption of the target analytes from the sorbent, which is a unique advantage in terms of 
green methods. A single µ-SPE device can be reused for 20-25 times before any signs of 
wear and tear appears on it. Similarly, very good values of LODs and linear range make 
this method comparable or superior than the reported methods. All this discussion shows 
that proposed method is rapid, and efficient for determination of PEs in the milk samples.   
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Table 4- 3: Study of matrix effect on extraction of PEs from different brands of milk 
samples 
Mean relative recovery ± standard deviation (n=3) 
Analyte Spiked at 25µg L-1 Spiked at 50 µg L-1 
Brand 1 Brand 2 Brand 3 Brand 1 Brand 2 Brand 3 
DMP 102±3 99±4 101±4 101±5 99±2 100±1 
DEP 98±2 100±3 99±6 102±2 98±5 99±4 
DIBP 98±3 99±6 94±4 100±2 99±3 96±3 
DNBP 97±2 98±5 100±4 99±2 96±6 101±1 
BMEP 99±5 102±4 100±3 97±1 103±4 101±2 
BMPP 96±5 96±7 93±5 98±4 97±6 98±5 
BEEP 89±8 92±7 95±4 90±9 92±6 97±5 
DPP 91±7 88±8 94±3 93±9 91±8 96±4 
DNHP 86±11 89±9 85±4 88±5 92±5 88±3 
BBP 89±9 98±3 82±8 91±8 101±2 83±4 
BBEP 78±5 79±4 82±5 79±6 81±4 85±7 
DCHP 81±6 79±5 85±2 82±7 78±4 83±5 
BEHP 79±5 77±9 83±6 80±4 78±5 81±2 
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Table 4- 4: Concentrations of PEs in real milk samples 
Analyte  Concentrations of PEs (µg L-1) in real milk samples 
Brand 1 Brand 2 Brand 3  
DMP ND 25.1 ND 
DEP ND ND ND 
DIBP ND ND ND 
DNBP 32.3 6.3 19.2 
BMEP ND ND 12.5 
BMPP ND ND ND 
BEEP ND ND ND 
DPP ND 15.2 ND 
DNHP ND ND ND 
BBP 15.8 ND ND 
BBEP ND ND ND 
DCHP 18.8 ND ND 
BEHP 8.9 10.2 ND 
 
ND= not detected  
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Table 4- 5: Comparison of the proposed method with others reported in the literature. 
 
 
 
 
 
 
Method  Number 
of PEs 
studied 
LODs 
(µg L-1) 
Linear 
range 
(µg L-1) 
Extraction 
Time  
(min) 
Sample 
volume 
(mL) 
Reference  
SPE-GC-
MS 
5 0.06-
0.12 
----- -------- ---- [6] 
DLLME-
GC-FID 
5 0.5-3 50-800 15 5 [5] 
LE-SPE-
LC-
MS/MS 
6 0.01-0.5 ----- 100 3 [39] 
LLE-SPE-
LC-
MS/MS 
5 5-9  LLE and SPE 
needs 
extraction, 
drying, 
reconstitution 
and clean up. 
Huge time 
consumption 
Large 
volumes 
of 
organic 
solvents 
utilized.  
[40] 
µ-SPE-
GC-MS 
13 0.01-
0.20 
1-100 15 5 Present 
work 
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Figure 4- 11: GC-MS trace of a spiked real milk sample extracted under most favorable µ-SPE 
conditions. (1) DMP, (2) DEP,  (3) DIBP, (4) DNBP, (5) BMEP, (6) BMPP, (7) BEEP, (8) DPP, 
(9) DNHP, (10) BBP, (11) BBEP, (12) DCHP, (13) BEHP. 
117 
 
 
 
 
 
 
 
 
 
 
 
Figure 4- 12: GC-MS trace of a real milk sample extracted under most favorable µ-SPE conditions. 
Detected compounds are: (4) DNBP, (10) BBP, (12) DCHP, (13) BEHP. 
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4.4. Conclusion  
In the present study, a natural sorbent based µ-SPE was utilized for the extraction of PEs 
in the milk samples. Efficient extraction of PEs was originated from the unique properties 
of the natural sorbent such as porous and fibrous structure and natural enrichment with 
functional moieties. M. oleifera as sorbent is easy to use, reuse and dispose of.  It is green, 
low cost and readily available sorbent.  The proposed natural sorbent based µ-SPE method 
gave reasonable reproducibility and good linearity with LODs lower or comparable to the 
methods reported in the literature. 
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STIR-BAR SUPPORTED MICRO-SOLID-PHASE 
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POLYCHLORINATED BIPHENYLS IN SERUM 
SAMPLES   
 
 
This chapter has been submitted to “Journal of Chromatography A”. 
 
 
 
 
 
 
 
124 
 
Abstract  
In present work, a new configuration of micro-solid phase extraction was introduced and 
termed as stir-bar supported micro-solid-phase extraction (SB-µ-SPE). A tiny stir-bar was 
packed inside the porous polypropylene membrane along with sorbent material and the 
edges of membrane sheet were heat sealed to secure the contents. The packing of stir-bar 
inside the µ-SPE device, does not allow the device to stick with the wall or any corner of 
the sample vial during extraction, which is, however, a frequent observation in routine µ-
SPE. Moreover, it enhances effective surface area of the sorbent exposed to sample solution 
through continuous agitation (motion and rotation). It also completely immerses the SB-µ-
SPE device in the sample solution even for non-polar sorbents. Polychlorinated biphenyls 
(PCBs) were selected as model compounds and the method performance was evaluated in 
human serum samples. After extraction, samples were analyzed by gas chromatography 
mass spectrometry (GC-MS).  The factors that affect extraction efficiency of SB-µ-SPE 
were optimized. Under optimum conditions, a good linearity (0.1 – 100 ng mL-1) with 
coefficients of determinations ranging from 0.9868 to 0.9992 were obtained. Limits of 
detections were ranged between 0.003 and 0.047 ng mL -1.  Acceptable values for inter-
day (3.2 – 9.1%) and intra-day (3.1 – 7.2%) relative standard deviations were obtained. 
The optimized method was successfully applied to determine the concentration of PCB 
congeners in human serum samples.  
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5.1. Introduction  
 
Despite of all major advancements in analytical instrumentation, sample preparation is an 
unavoidable step prior to instrumental analysis. It is because original samples are 
sometimes composed of matrix which is not compatible with the components of the 
instrument or too dilute that target compounds cannot be detected directly by the instrument 
or too dirty that matrix components can interfere with analysis. Sample preparation, 
generally involves sample clean-up, removal of interferences and preconcentration of 
target compounds [1]. Solid-phase extraction (SPE) and liquid-liquid extraction (LLE) are 
most commonly used sample preparation methods but they consume large amounts of 
chemicals and hazardous organic solvents. Moreover, they are laborious because of 
extended multistep extraction procedures [2]. The trend has been shifting toward 
miniaturized sample preparation methods. Over the last two decades, number of 
microextraction methods have been introduced including solid phase microextraction [3], 
liquid-phase microextarction [4,5] , dispersive solid phase extraction [6], dispersive liquid-
liquid microextraction [7] and many of their modifications. These methods overcome 
disadvantages of conventional SPE and LLE. In addition, these methods are comparatively 
simple, cost effective, efficient, green, and easy to perform.  
Micro-solid phase extraction (µ-SPE) was introduced by Basheer et al., in 2006 [8]. Since 
then, µ-SPE has been extensively used in environmental [9,10], biological [11,12] and food 
[13] analysis. This approach involves packing of small quantity of sorbent material inside 
a porous membrane, whose ends are heat sealed. This sorbent containing bag is then placed 
inside the sample solution and allowed to tumble freely using magnetic stirrer. After 
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extraction, the analytes are desorbed from the packed sorbent in suitable desorption solvent 
by ultrasonication. Although, in µ-SPE, a stir-bar is placed inside the sample solution to 
agitate the solution by magnetic stirring but it has been frequently observed that µ-SPE 
device sticks to the one wall of the sample vial or floats over the sample solution, which 
allows the µ-SPE device to extract only on the surface of the sample solution. 
Polypropylene (PP) is commonly used membrane for fabrication of μ-SPE devices.  It is 
hydrophobic in nature  [14]. Even after conditioning in organic solvent, µ-SPE device does 
not get enough wettability that it can totally sink inside the sample solutions. This is only 
possible when water penetrates inside the membrane and adsorbed by the sorbent [15]. 
However, the hydrophobic nature of PP membrane and sorbent does not allow that much 
water to be adsorbed, thus it keeps floating near the surface. This can be seen in a figure of 
µ-SPE device given in a published work [16]. Hence, we have proposed a simple 
modification in µ-SPE device to solve this problem by packing a stir-bar inside 
polypropylene envelope along with sorbent. In this way, packed stir-bar does not allow the 
membrane to float over surface or stick to the wall of the glass vial. Moreover, it keeps the 
µ-SPE device in continuous state of motion and rotation, which in turn increases effective 
surface area of the sorbent exposed to the target compounds in the sample solution.   
Although stir-bar sorptive extraction (SBSE), is a well-established micro-extraction 
technique but it has limitation that only few materials can be coated over the stir-bar. 
Thickness and stability of the coating is very critical in order to evaluate reproducibility of 
SBSE. Most commonly used PDMS coated stir-bars can only be employed for extraction 
of non-polar or weekly polar target compounds [17]. However, our proposed stir-bar 
supported micro-solid phase extraction (SB-µ-SPE), has flexibility for selection of sorbent. 
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Sorbent can be selected according to the nature of target compounds and then an accurate 
amount can easily be packed inside the membrane along with stir-bar.  
To evaluate the performance of SB-µ-SPE, determination of PCBs in serum samples were 
investigated. PCBs were widely used in industrial applications before 1970. Although, they 
were  banned in 1970s [18] but still their measurable concentrations have been reported in 
the environment. They are persistent in nature and have ability to accumulate in tissues and 
biological matrix [19]. Their presence in body fluids such as blood has been linked with 
different carcinogenic[20] and non-carcinogenic [21] disorders. Hence, it is highly 
desirable to develop sensitive analytical methods to monitor PCBs in environmental and 
biological matrices. 
5.2. Experimental  
5.2.1. Chemicals and reagents  
 
Accruel polypropylene sheet membrane (pore size of 0.2 µm, 157 µm thickness) was 
purchased from Membrana (Wuppertal, Germany). HPLC-grade solvents (methanol, 
toluene, acetonitrile and n-hexane) were obtained from Fisher (Loughborough, UK). The 
PCB congeners mixture (100 µg mL-1) was purchased from Restek (Bellefonte, US). Stock 
solution of PCBs mixture (10 µg mL-1) was prepared in methanol and stored at -4°C and 
working solutions (0.1 – 100.0 ng mL-1) were freshly prepared before experiments. C18 
column packing material (average particle size: 12 µm; surface area; 180 m2/g) was 
obtained from Sigma-Aldrich. Muti-wall carbon nanotubes (MWCNTs) (outer diameter: 
20 – 30 nm, length 10 – 30 µm and purity > 95%) were purchased from Cheap Tubes Inc. 
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(Cambridgeport, USA). Coconut activated carbon was purchased from Cenapro Chemical 
Corporation (Mandauae City, Philippines).  
5.2.2. Serum samples and standard solutions  
Real pooled human serum was used for method development and it was obtained from 
KFUPM laboratory, Alkhobar. Research ethics regarding use of human biological samples 
were taken into account while collection of the samples. The blood samples were extracted 
from volunteers by venipuncture in sterilized blood tubes. Serum was separated by 
centrifugation at 6000 rpm for 12 min and collected together in 50 mL glass bottles 
equipped with Teflon caps. Collected serum was stored at -20°C prior to use. The serum 
samples used for method optimization were free of PCBs .  Optimization experiments were 
carried out with 10 times diluted serum samples spiked at 25 ng mL-1. Serum samples were 
also collected from individual patients to test the applicability of the method. Standard 
safety protocols were adopted for handling and disposing of biological samples.  
5.2.3. Gas chromatography-mass spectrometric (GC-MS) analysis 
The separation and quantitation of target compounds were performed on a Shimadzu 
(Kyoto, Japan) QP2010 GC-MS. The system was equipped with a Shimadzu AOC-20s 
auto sampler and AOC-20 auto injector. Rxi-5 Sil MS column with thickness of 0.25 µm, 
length of 30.0 m and diameter of 0.25 mm (Restek, Bellefonte, US) was used for separation 
of target compounds. The high purity helium gas was employed as carrier gas at flow rate 
of 1.01 mL min-1. The GC injection port temperature was kept 250°C and all the samples 
were injected in splitless mode.  The opening time of split vent was 1.0 min. The GC-MS 
interface temperature was 220°C and ion source temperature was 200°C.The oven 
temperature was programmed as follows: initial temperature was 40°C and held for 1 min; 
129 
 
then increased to 100°C at 10°C/min and held for 2 min; then increased to 165°C at 
10°C/min and held for 0 min; then increased to 190°C at 6°C/min and held for 3 min; after 
that it was increased to 220°C at 3°C/min and held for 3 min; and finally increased to 240°C  
at 2°C/min and held for 1 min. Total run time was 46.67 min. For qualitative analysis, data 
acquisition was performed in scan mode to confirm the retention times of target 
compounds. For quantitative analysis, selective ion monitoring (SIM) mode was employed. 
Selected target ions are listed in Table 5-1.  
5.2.4. SB-µ-SPE procedure  
SB-µ-SPE device was fabricated by packing a tiny stir-bar (7 mm x 2 mm) and accurately 
weighed amount of sorbent into a porous polypropylene (PP) membrane envelope whose 
edges were heat sealed. Briefly, PP flat membrane sheet was cut into rectangular pieces 
with dimensions of 1.6 cm by 2.0 cm. The shorter length was folded and heat sealed with 
an electrical heat sealer. One of the two remaining open edges was heat sealed to give it a 
shape of an envelope with one open edge. The sorbent and tiny stir bar were added from 
the last open edge that was finally heat sealed to give SB-µ-SPE device. 
Before extraction, SB-µ-SPE device was conditioned in toluene for 1 min.  For extraction, 
SB-µ-SPE device was placed inside a glass vial containing 5 mL of sample or spiked matrix 
solution. This vial was placed on a magnetic stirrer. The SB-µ-SPE device was stirred in 
the sample solution for an optimum extraction time .SB-µ-SPE device was taken out of the 
sample solution, and dried with the help of lint free tissue. The device was then inserted 
into an Eppendorf vial and 250 µL of desorption solvent were added. Analytes were then 
effectively desorbed or eluted by using ultra-sonication for an optimum desorption time. 
After desorption, 1 µL of extract was injected into GC-MS.  
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Table 5- 1: List of target compounds, their CAS numbers, m/z of selected target ions and 
chromatographic retention times 
Compound name Congener CAS number m/z of target 
ions 
Retention 
Time 
2-Chlorobiphenyl PCB-1 2051-60-7 188, 152, 126 16.90 
2,3-Dichlorobiphenyl PCB-5 16605-91-7 222, 152, 186 20.02 
2,2',5-Trichlorobiphenyl PCB-18 37680-65-2 256, 221, 186 21.50 
2,4',5-Trichlorobiphenyl PCB-31 16606-02-3 256, 186, 93 23.62 
2,2',5,5'-
Tetrachlorobiphenyl 
PCB-52 35693-99-3 292, 220, 255 25.31 
2,2',3,5'-
Tetrachlorobiphenyl 
PCB-44 41464-39-5 292, 220, 255 26.27 
2,3',4,4'-
Tetrachlorobiphenyl 
PCB-66 32598-10-0 292, 220, 184 28.63 
2,2',4,5,5'-
Pentachlorobiphenyl 
PCB-101 37680-73-2 326, 324, 256 29.92 
2,2',3,4,5'-
Pentachlorobiphenyl 
PCB-87 38380-02-8 326, 324, 291 31.31 
2,3,3',4',6-
Pentachlorobiphenyl 
PCB-110 38380-03-9 326, 324, 254 31.82 
2,2',3,5,5',6-
Hexachlorobiphenyl 
PCB-151 52663-63-5 360, 325, 290 32.47 
2,2',4,4',5,5'-
Hexachlorobiphenyl 
PCB-153 35065-27-1 360, 290, 218 34.87 
2,2',3,4,5,5'-
Hexachlorobiphenyl 
PCB-141 52712-04-6 360, 325, 327 35.70 
2,2',3,4,4',5'-
Hexachlorobiphenyl 
PCB-138 35065-28-2 360, 290, 325 36.71 
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2,2',3,4',5,5',6-
Heptachlorobiphenyl 
PCB-187 52663-68-0 394, 396, 359 37.84 
2,2',3,4,4',5',6-
Heptachlorobiphenyl 
PCB-183 52663-69-1 394, 396, 359 38.26 
2,2',3,4,4',5,5'-
Heptachlorobiphenyl 
PCB-180 35065-29-3 394, 396, 324 41.94 
2,2',3,3',4,4',5-
Heptachlorobiphenyl 
PCB-170 35065-30-6 394, 396, 359 44.01 
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5.3. Results and discussion  
5.3.1. Optimization of SB-µ-SPE 
The factors that affect the extraction efficiency of SB-µ-SPE were optimized by using real 
human serum samples spiked at 25 ng mL-1.    
An ideal sorbent for μ-SPE should have good solid state flow properties. It should be “non-
sticky” so that it can be accurately weighed and transferred into PP bag. It should also be 
“non-adhesive” to the membrane material so that interference with heat sealing of PP sheet 
during sorbent packing can be avoided [22]. The presence of solid particles in heat sealed 
area of μ-SPE device tend to weaken the seal during sonication for desorption process. In 
addition, sorbent should allow target compounds to be easily desorbed under mild 
desorption conditions. Application of sonication for extensively longer period of time may 
result re-adsorption of target compounds into sorbent and tearing of μ-SPE device. 
Similarly, use of very high temperatures during desorption may result in evaporation of 
target compounds.  
The selection of the suitable sorbent is very critical in all types of solid phase extractions 
and it is mainly dictated by the nature of target compounds to be extracted. Hence, three 
commonly used sorbents; multiwall carbon nanotubes (MWCNTs), C18 and activated 
carbon were investigated.  25 mg of each sorbent were used to fabricate SB-µ-SPE. Figure 
5-1 shows that best extraction results were obtained with C18 and this might be due strong 
hydrophobic interactions of PCBs toward C18 [23]. Although, carbon based materials such 
as MWCNTs and activated carbon show strong interactions toward hydrophobic 
compounds, their low extraction efficiency might be attributed to different factors. When 
the sorbent has strong hydrophobic interactions with target compounds, desorption 
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becomes a more difficult task. Thus low extraction efficiencies of CNTs might be due to 
poor desorption of target compounds by sonication. Increase in sonication time might be 
helpful. Thus sonication time was evaluated between 5 – 45 min. However, no significant 
increase in chromatographic peak areas was observed after 15 min. Desorption times above 
35 min resulted in decrease of peak areas. This is attributed to temperature rise by 
continuous sonication that transfers the target compounds to headspace above the 
desorption solvent in desorption vial and they may escape when vial is opened. Moreover, 
longer sonication time may also result in re-adsorption of target compounds into sorption 
sites by diffusion through pores [10,12,24]. Third factor is related to packing of sorbent 
above than a certain amount into µ-SPE envelope that makes the device too large to fit in 
desorption vial. Such device will not immerse completely in solvent and results in poor 
desorption [12].  Since, 25 mg of C18 occupies very less space compared to 25 mg of CNTs. 
CNTs are light weight and occupy more space. Thus, 25 mg of CNTs will result in a large 
sized µ-SPE device and it will require extra desorption volume to desorb the analytes.  
Hence, C18 was selected as an optimum sorbent for the next optimization experiments as it 
fulfills aforementioned criterion for an ideal sorbent. Moreover, it can be facilely handled 
for µ-SPE procedures compared to CNTs and activated carbon [22,25].   
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Figure 5- 1: Influence of sorbent type on extraction of PCBs. Conditions: PCBs 
concentration: 25 ng mL-1; amount of sorbent: 25mg; extraction time: 15 min; desorption 
solvent: toluene; desorption volume: 250µL; stirring speed: 800 rpm; desorption time: 10 
min. 
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The amount of sorbent and volume of desorption solvent should have a good compromise 
between them. The amount of sorbent should be sufficient enough to reproducibly extract 
target compounds with selected volume of desorption solvent.  The volume of desorption 
solvent should be sufficient enough to completely immerse the SB-µ-SPE device for 
effective desorption.  Thus amount of sorbent was investigated in range of 15 – 75 mg and 
desorption volume was tested in range of 50 – 350 μL. Desorption volume (250 μL) was 
sufficient to completely immerse the device for all range of amount of sorbent.  Under the 
same extraction and desorption conditions, chromatographic peak areas of all the analytes 
were increased up to 45 mg.  Further increase in the amount of sorbent had not resulted in 
increase of peak areas (Figure 5-2). Hence, 45 mg of C18 was used as optimum amount of 
sorbent.  For all the optimization experiments, volume of desorption solvent was fixed as 
250 µL, because it is minimum volume that can effectively desorb or elute the target 
compounds from SB-µ-SPE device. Volumes of desorption solvent lesser than 250 µL gave 
poor reproducibility because of ineffective desorption while volumes higher than 250 µL 
resulted in decrease of chromatographic peak areas because of dilution.  
Desorption solvent is of prime importance for effective desorption or elution of analytes 
from SB-µ-SPE device. Hence, the solvents with varying polarity index were investigated. 
Figure 5-3 shows that best extraction results were obtained with toluene followed by n-
hexane, methanol and acetonitrile. PCBs are non-polar and hydrophobic in nature and it is 
expected that n-hexane will give best desorption. The reason for better desorption with 
toluene, might be attributed to its role in effectively dilating the pores of porous PP 
membrane than n-hexane. Acetonitrile and methanol are polar solvents and thus lesser 
desorption or elution was observed with these solvents.  
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The amount of analytes that is transferred from donor phase (sample solution) to acceptor 
phase (sorbent) is dependent on rate of mass transfer. This mass transfer is expected to 
increase with the time of extraction before reaching to a steady state. Hence, the time of 
extraction is an important parameter to consider. Extraction times were evaluated in range 
of 5 – 25 min. The higher peak areas for all the analytes were obtained at extraction time 
of 20 min (Figure 5-4). After 20 min, almost a steady state was achieved. Hence, a time of 
20 min was selected as an optimum extraction time.  
Salting out effect is another important parameter to consider in microextractions. Addition 
of salt into sample solution decreases the solubility of target compounds in the donor phase. 
In current optimization, a slight increase was observed in peak areas upon addition of 5% 
(w/v) of NaCl. Afterwards, any further increase of salt into sample solution resulted in 
significant decrease in peak areas of all target compounds. This might be attributed to 
increased viscosity of the solution which may hinder mass transfer of target compounds 
from donor to acceptor phase. Such observations are also very common in microextraction 
methods [26,27]. Because there were no significant enhancements in peak areas of target 
analytes, thus for the simplicity of sample preparation, no salt was added into the sample 
solution.   
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Figure 5- 2: Influence of sorbent amount on extraction of PCBs. Conditions: PCBs 
concentration: 25 ng mL-1; sorbent: C18, extraction time: 15 min; desorption solvent: 
toluene; desorption volume: 250µL; stirring speed: 800 rpm; desorption time: 10 min. 
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Figure 5- 3: Influence of desorption solvent on extraction of PCBs. Conditions: PCBs 
concentration: 25 ng mL-1; sorbent: C18, amount of sorbent: 45mg; extraction time: 15 min; 
desorption solvent: toluene; desorption volume: 250µL; stirring speed: 800 rpm; 
desorption time: 10 min. 
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Figure 5- 4: Influence of extraction time on extraction of PCBs. Conditions: PCBs 
concentration: 25 ng mL-1; sorbent: C18, amount of sorbent: 45mg; desorption solvent: 
toluene; desorption volume: 250µL; stirring speed: 800 rpm; desorption time: 10 min. 
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As stir-bar was packed inside the membrane along with sorbent, stirring speed may 
influence the extraction process. Stirring the sample solution permits effective contact 
between the target compounds and SB-µ-SPE device by bringing fresh solution to the 
surface. Hence, the effect of stirring speed on extraction process was examined in the range 
of 200 – 1000 rpm. The highest chromatographic signals for all the analytes were obtained 
at 800 rpm and afterwards, no significant increase was observed. Thus, 800 rpm was 
adopted as optimum stirring speed (Figure 5-5).  SB-µ-SPE gives two unique advantages 
compared to µ-SPE from stirring perspective (i) it does not allow the extraction device to 
stick in any corner of the glass vial (ii) the packed stir bar keeps the extraction device 
positioned inside the solution in addition to normal stirring of sample solution.  
As it was a previously investigated parameter, the effect of desorption time for C18 based 
µ-SPE device was investigated in range of 5 to 20 min. An increase in peak areas was 
recorded up to 15 min. Afterwards, a slight decrease in chromatographic signals was noted. 
This may be due to increase of the temperature of sonication bath with the time. In case of 
higher temperature, analytes may evaporate and distribute into headspace of desorption 
vial leading to decreased concentrations in desorption solvent. Thus, 15 min was selected 
as an optimum desorption time (Figure 5-6).    
The results of µ-SPE and SB-µ-SPE were compared under optimum extraction and 
desorption conditions. Figure 5-7 clearly indicates that the latter is more effective 
extraction approach. The reasons for high extraction efficiency of SB-µ-SPE can be 
explained by (i) enhanced contact between sorbent containing device and the target 
compounds in the sample solution after packing stir-bar inside the device (ii) complete 
immersion of the device inside the sample solution.  
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Figure 5- 5: Influence of stirring speed on extraction of PCBs. Conditions: PCBs 
concentration: 25 ng mL-1; sorbent: C18, amount of sorbent: 45mg; desorption solvent; 
extraction time: 20 min, toluene; desorption volume: 250µL; desorption time: 10 min. 
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Figure 5- 6: Influence of desorption time on extraction of PCBs. Conditions: PCBs 
concentration: 25 ng mL-1; sorbent: C18, amount of sorbent: 45mg; desorption solvent: 
toluene; extraction time: 20 min, desorption volume: 250µL; stirring speed: 800 rpm. 
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Figure 5- 7: Comparison of µ-SPE and SB-µ-SPE under optimum extraction conditions. 
PCBs concentration: 25 ng mL-1; sorbent: C18, amount of sorbent: 45mg; desorption 
solvent: toluene; extraction time: 20 min, desorption volume: 250µL; stirring speed: 800 
rpm; desorption time: 15 min. 
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5.3.2. Method validation, real sample analysis and comparison with reported 
methods   
 
To access the practical applicability of proposed SB-µ-SPE method, most favorable 
extraction conditions were adopted to evaluate method’s linearity, limit of detections 
(LODs) and reproducibility. 6-point calibration lines were plotted for all target compounds 
using real human serum samples spiked with known concentrations of PCBs ranging from 
0.1 to 100 ng mL -1. Good linearity for all tested PCBs was obtained with coefficients of 
determination (r2) between 0.9868 and 0.9992.  LODs were calculated based on signal to 
noise ratio of 3. LODs were ranged in between 0.003 and 0.047 ng mL -1. Method’s 
precision was assessed based on inter-day and intra-day reproducibility by using real 
human serum samples spiked at 25 ng mL -1 (n=7).  RSDs were in range of 3.1 – 7.2 % and 
3.2 – 9.1% for intra-day and inter-day precision respectively, indicating good precision of 
the method. Relative recoveries for all target compounds were calculated by spiking to real 
serum sample at 1.0, 25 and 50 ng mL -1 (n=5). The relative recovery, in this case, will be 
defined as the ratio of the peak areas of the analytes in serum to ultrapure water sample 
extracts, when both samples spiked at the same concentration levels of PCBs. Relative 
recoveries of all target compounds were ranged between 85.2 to 103.6%. Absolute 
recoveries were ranged from 59.0 to 86.7. µ-SPE is not an exhaustive technique like SPE 
rather it is based on equilibrium. Hence low absolute recoveries are justified. Enrichment 
factors were calculated based on ratio of concentration of analytes in sample solution to 
concentration of analytes in final extract. Enrichment factors in range of 11.7– 18.4 were 
obtained. Analytical features of proposed method are given in Table 5-2.   
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The developed SB-µ-SPE method was used to determine PCB concentrations in serum 
samples collected from 6 patients visited the clinic for routine checkup. Some PCB 
congeners were detected in real samples. Real concentrations of PCBs (only for congeners 
which were detected) are given in Table 5-3.  Figure 5-8 compares chromatograms of 
unspiked and spiked (at 25 ng mL-1) real samples.  
Table 5-4 compares the performance of SB-µ-SPE with microextraction methods reported 
in the literature for extraction of PCBs in blood or serum. It can be noted that analytical 
parameters for proposed SB- µ-SPE are either better or comparable with methods reported 
in literature. 
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Table 5- 2: Analytical features of proposed method 
Compound  DLRa 
(ng 
mL-1) 
r2  LODs  
(ng  
mL-1)  
RSDc(%)  
(n=7) 
 
Relative  
Recoveries (%) (n=5) 
Absolute 
recovery 
(%) (n=5) 
  
25 ng mL-
1 
Enrichment factors 
(n=3) 
Intra-
day 
Inter-
day 
1 ng 
mL-1 
25 ng 
mL-1 
50 ng 
mL-1 
PCB-1 0.1 – 
100.0 
0.9969: 0.017 3.1 4.1 96.4 97.3 98.0 
78.4 
15.7 
PCB-5 0.1 – 
100.0 
0.9897 0.030 3.9 4.5 86.1 88.3 88.5 
59.0 
11.8 
PCB-18 0.1 – 
100.0 
0.9992 0.047 2.5 3.2 98.5 99.1 100.0 
75.1 
15.0 
PCB-31 0.1 – 
100.0 
0.9863 0.026 5.3 5.7 99.7 101.2 99.5 
67.3 
13.5 
PCB-52 0.1 – 
100.0 
0.9908 0.013 2.9 3.6 100.0 103.6 102.7 
63.9 
12.8 
PCB-44 0.1 – 
100.0 
0.9972 0.027 3.6 6.2 97.6 99.0 98.5  
62.3 
12.5 
PCB-66 0.1 – 
100.0 
0.9901 0.024 6.1 5.9 94.0 93.8 95.1 
60.5 
12.1 
PCB-101 0.1 – 
100.0 
0.9914 0.043 5.2 6.7 94.2 98.5 99.3 
60.3 
12.1 
PCB-87 0.1 – 
100.0 
0.9889 0.025 3.8 4.3 98.5 102.3 98.4 
59.0 
11.8 
PCB-110 0.1 – 
100.0 
0.9992 0.041 4.6 4.5 97.6 99.4 101.2 
58.5 
11.7 
PCB-151 0.1 – 
100.0 
0.9898 0.028 2.9 3.5 95.0 97.2 97.0 
62.3 
12.5 
PCB-153 0.1 – 
100.0 
0.9976 0.036 6.5 5.8 92.1 95.0 98.2 
62.5 
12.5 
PCB-141 0.1 – 
100.0 
0.9886 0.004 2.3 3.7 88.4 91.8 92.7 
61.4 
12.3 
PCB-138 0.1 – 
100.0 
0.9986 0.003 3.1 5.3 94.0 94.5 95.1 
61.9 
12.4 
PCB-187 0.1 – 
100.0 
0.9893 0.019 4.6 4.2 86.3 89.6 92.6 
65.1 
13.0 
PCB-183 0.1 – 
100.0 
0.9977 0.046 3.5 5.9 96.9 99.1 99.0 
58.8 
11.8 
PCB-180 0.1 – 
100.0 
0.9967 0.042 4.9 5.2 85.2 88.4 88.7 
65.0 
13.0 
PCB-170 0.1 – 
100.0 
0.9979 0.042 7.2 9.1 96.4 100.0 99.4 
86.7 
17.3 
aDynamic linear range; bLimit of detection: calculated as three time of the baseline noise ; creproducibility; 
r2 (coefficient of determination)  
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Table 5- 3: Concentrations of PCBs in real serum samples 
Sample No.   PCBs Detected   Concentration (ng mL-1) 
1 PCB-1 0.24  
PCB-5 0.32 
PCB-18 0.65 
PCB-31 0.34 
2 PCB-31 0.36 
3 PCB-52 0.17 
4 PCB-5 0.19 
PCB-31 0.45 
PCB-101 0.23 
PCB-87 0.43 
5 PCB-31 0.13 
6 PCB-5 0.15 
PCB-18 0.27 
PCB-31 0.24 
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Figure 5- 8: GC-MS trace of a real serum sample (a) and spiked real sample at 25 ng mL-1   
(b) both extracted under most favorable SB-µ-SPE conditions. (1) PCB-1 (2) PCB-5  (3) 
PCB-18 (4) PCB-31 (5) PCB-52 (6) PCB-44 (7) PCB-66 (8) PCB-101 (9) PCB-87 (10) 
PCB-110 (11) PCB-151 (12) PCB-153 (13) PCB-141 (14) PCB-138 (15) PCB-187 (16) 
PCB-183 (17) PCB-180 (18) PCB-170. 
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Table 5- 4: Comparison of SB-µ-SPE with other methods reported in literature 
Method  Number 
of PCB 
congeners 
studied  
Matrix Linear 
Range  
LODs Enrichment 
factors 
RSDs 
(%) 
Ref 
LPME-
GC/MS 
8 Blood 2.5 – 200  0.07 – 
0.93 
67 – 241 2.5 – 
10.8 
[19] 
HS-
SPME-
GC/ECD 
18 Serum  0.051 – 
0.207 
0.001 
– 
0.012 
 3.0 – 
12.0 
[28] 
SPE-
GC/µECD 
15 Serum  Different 
ranges for 
different 
compounds 
0.0012 
– 
0.0051 
 2.5 – 
26.4 
[29] 
SB-µ-SPE 18 Serum  0.1 – 100  0.003 
– 
0.047 
11.7 – 18.4   3.1 – 
9.1 
Present 
work  
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5.4. Conclusion  
In this work, a new mode of membrane protected µ-SPE was described as stir-bar supported 
µ-SPE.  In this mode, a magnetic stir-bar and an accurately weighed amount of sorbent was 
packed inside the porous polypropylene membrane. This mode of extraction improved the 
extraction performance considerably. PCBs were employed as model compounds to access 
the extraction performance of the proposed method in human serum samples. The extracted 
samples were analyzed by GC-MS. The performance of this method in extraction of PCBs 
from serum samples was excellent. This method provided low LODs, good linearity and 
satisfactory intra-day and inter-day reproducibility for all tested PCBs. SB- µ-SPE can be 
extended to analysis of other types of organic and inorganic pollutants in complex sample 
matrices.   
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6. CHAPTER  
 APPLICATION OF ZINC OXIDE INCORPORATED 
CARBON FOAM AS SORBENT IN MICRO-SOLID-
PHASE EXTRACTION OF ORGANOCHLORINE 
PESTICIDES IN MILK SAMPLES 
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Abstract  
Organochlorine pesticides belong to famous persistent organic pollutants and are well 
known for their harmful effects on human health and wildlife. The milk stands among 
highly consumed foods and it can get contaminated with OCPs through agricultural food 
that is provided to animals. This demands development of highly efficient and precise 
analytical methods for determination of OCPs in milk samples. In this work, ZnO 
nanoparticles incorporated porous carbon foam was utilized as sorbent for extraction and 
preconcentration of OCPs in milk samples. This sorbent was prepared by a single step and 
fast reaction between the sucrose and zinc nitrate that was accomplished by heating the 
mixture for 10 minutes. The resulting sorbent was characterized by scanning electron 
microscopy and X-ray diffraction. The sorbent was then packed inside a porous 
polypropylene membrane sheets by heat sealing of membrane to construct µ-SPE devices. 
The factors that affect performance of µ-SPE were optimized. This method provided good 
linearity up to 0.9998 with limit of detections ranging from 0.19 to 1.64 ng/mL. This 
method also provided satisfactory values for intra and inter-day precision with RSDs 
ranged between 2.3 to 10.2%.    
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6.1. Introduction  
 
Organochlorine pesticides (OCPs) are famous class of persistent organic pollutants (POPs).  
OCPs are hazardous and persistent environmental pollutants that are also susceptible to 
long range atmospheric transport because of their volatility.  They can accumulate in the 
tissues of living organism through food web or polluted environment. OCPs have been 
linked with several carcinogenic and non-carcinogenic disorders in the human. Although, 
their industrial production was banned in 1970s but still their measurable concentrations 
have been reported in various matrices.  
Milk has high nutritional and immunological value to infants and aged people and it stands 
among imperious and highly consumed foods. Milk can get contaminated with OCPs 
through different sources including environmental diffusion and direct uptake of 
contaminated agricultural food by the animals. It is therefore highly desired to monitor 
OCPs in the milk samples.  
Milk is highly complex matrix because of presence of variety of biomolecules, salts, 
proteins, fats and vitamins. This high fat and protein content can interfere during analytical 
determination of target compounds. Hence, pretreatment or/ and extraction is unavoidable 
step prior to instrumental analysis.  This process of pretreatment or extraction may involve 
several clean-up steps to remove any extraneous material from the matrix. Thus, routine 
procedures for extraction of OCPs in milk samples such as LLE and SPE  1 are time and 
labor intensive, consume large volumes of organic solvents and produce considerable 
quantity of waste. Over the last two decades, area of sample preparation is moved toward 
development of miniaturization extraction techniques. These techniques are featured by 
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minimum or no consumption of organic solvents, small sample size and shorter extraction 
time.  Various methodologies such as QuEChERS 2, SPME 3,4 and MSPE 5 were used for 
determination of OCPs in milk samples. Although, these methods provide adequate 
efficiency, but when it comes to complex samples like milk, some limitations are associated 
with them. For example, SPME fibers cannot be directly exposed to milk samples because 
fats and other large biomolecules will adsorb on the fiber. Hence, two approaches are 
adopted either sample is diluted by several folds or SPME fiber is exposed only in 
headspace. 
Membrane protected micro-solid-phase extraction (µ-SPE) was introduced by Basheer et 
al., as an alternative to multistep SPE. In this technique, a small amount of solid sorbent is 
secured inside a porous polypropylene (PP) bag through heat-sealing. In this way, sorbent 
does not come directly in contact with sample solution and target compounds are 
transferred to the sorbent through porous PP sheet. After extraction, the sorbent containing 
PP bag is taken out of the sample solution, washed with water and dried with lint free 
tissues. Then analytes are then desorbed into suitable desorption solvent by aid of 
ultrasonication. This technique particularly suits for samples with complex biological 
matrices because PP membrane effectively secures the sorbent from fats, proteins and other 
large biomolecules. Hence, µ-SPE is widely used for extraction of variety of organic 
pollutants from tissues and biological fluids. Thus, it obviates the aforementioned steps 
required for SPME.      
In recent years, novel carbon based materials have shown exciting potential for analytical 
extraction of target compounds in variety of matrices. These novel materials include pure 
and functionalized graphene, carbon nanotubes, graphite fiber, carbon soot and their 
158 
 
modified forms. Extremely high surface area and excellent chemical, thermal and 
mechanical stabilities and ability to form 𝚷-𝚷 interactions with target compounds, make 
carbon based materials as an attractive choice for extraction applications6. Notably, there 
has also been seen a growing trend in use of metal and metal oxide nanoparticles in 
combination with carbon materials as sorbent for analytical extractions 7. Functionalization 
or incorporation of other materials into carbon nanotubes or graphene is accomplished by 
extended synthesis protocols. Recently, carbon foam has shown some exciting applications 
in different areas. ZnO incorporated carbon foam was synthesized through a facile one step 
procedure.  To the best of our knowledge, carbon foam has not been utilized in analytical 
extractions. For the first time, we have explored the potential of ZnO incorporated carbon 
foam as a sorbent for µ-SPE of OCPs in milk samples.  
6.2. Experimental  
6.2.1. Chemicals and materials  
 
A mixture of OCPs standard was purchased from Restek (Bellefonte, US) and 15 
compounds listed in Table 6-1 were considered for analysis. Zn(NO3)2.6H2O was 
purchased from Sigma Aldrich. Crystalline sucrose was purchased from local market. 
Accruel polypropylene sheet membrane (pore size of 0.2 µm, 157 µm thickness) was 
obtained from Membrana (Wuppertal, Germany). HPLC-grade solvents (methanol, 
toluene, acetone, acetonitrile and n-hexane) were purchased from Fisher (Loughborough, 
UK). C18 column packing material (average particle size: 12 µm; surface area; 180 m
2/g) 
was provided by Sigma-Aldrich. Muti-wall carbon nanotubes (MWCNTs) (outer diameter: 
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20 – 30 nm, length 10 – 30 µm and purity > 95%) were obtained from Cheap Tubes Inc. 
(Cambridgeport, USA).  
6.2.2. Synthesis of ZnO incorporated carbon foam and its characterization  
 
ZnO incorporated carbon foam was synthesized with certain modifications in the procedure 
already reported in the literature for synthesis of carbon foam [8]. Briefly, 3 grams of 
sucrose and 1.5 g of Zn(NO3)2.6H2O were taken in a beaker and heated on a hot plate whose 
temperature was programmed to reach at 110°C. As the temperature increased, mixture 
started melting. During melting, mixture was continuously stirred with a glass rod. At 
105°C, a yellow colored,   foam like swelled material, started expanding in size to upward 
and after heating for approximately 10 minutes at 110°C, the color of the foam started to 
change to black and within next few seconds it burned in presence of O2 and changed into 
carbon foam.  
The reaction can be represented by the following chemical equation  
 
C12H22O11 + Zn(NO3)2.6H2O                     C foam+ ZnO + N2 + H2O + NOx + CO2 
 
Zn(NO3)2.6H2O is a strong oxidizing agent, after its thermal decomposition and reaction 
with sucrose, different gases are generated (N2, NOx, CO2, H2O vapours etc.). These gases 
cause melted mixture to blow and swell. This swelling increase the surface area and change 
the material into foam. After, complete emission of all the gases, material (which is now 
110°C 
10 minutes  
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combination of C and ZnO) changes to black color and ultimately burns and splashes into 
ash consisting of very fine particles of carbon and ZnO.  
The synthesized material was characterized by scanning electron microscope and x-ray 
diffraction. 
6.2.3. µ-SPE procedure  
 
µ-SPE device consisted of sorbent enclosed in an envelope made from porous 
polypropylene (PP) membrane sheet whose edges were heat sealed. The dimensions of µ-
SPE device were 2.2 cm × 1.0 cm. Before use, the sorbent inside the device was conditioned 
by putting it in the toluene and sonication for 3 mins.  
A 10 mL aliquot of milk sample was taken in a sample vial (15 mL). A magnetic stir bar 
(15mm × 5mm) was added to sample solution. The µ-SPE device was then added to sample 
solution and stirred at 1000 rpm. The extraction was allowed to take place for 30 min. The 
µ-SPE device was then removed from the sample vial, rinsed with water, dried with lint 
free tissue and transferred into a 600 μL desorption vial. Then toluene (300 μL) was added 
into the desorption vial and analytes were desorbed by ultrasonication for a period of 10 
min. After desorption, extract was injected to GC-MS system for analysis.  
6.2.4. GC-MS 
 
GC-MS (QP2010 Shimadzu (Kyoto, Japan)) was used for separation and quantitation of 
target OCPs. The system was equipped with a Shimadzu AOC-20s auto sampler and AOC-
20 auto injector. Rxi-5 Sil MS column with thickness of 0.25 µm, length of 30.0 m and 
diameter of 0.25 mm (Restek) was used for separation of target compounds. The high 
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purity helium gas was used as carrier gas at flow rate of 1.00 mL min-1. The GC injection 
port temperature was maintained 200°C while GC-MS interface temperature was kept at 
220°C. The ion source temperature was fixed as 200°C.The oven temperature was 
programmed as follows: initial temperature was 50°C that was increased to 180°C at 
10°C/min and held for 4 min; then it was further increased to 210°C at 2°C/min and held 
for another 4 min; and finally it was increased to 231°C at 3°C/min and held for 5 min. 
Total run time was 48 min. For qualitative analysis, data acquisition was performed in scan 
mode to confirm the retention times of target compounds. For quantitative analysis, 
selective ion monitoring (SIM) mode was employed. Selected target ions are listed in Table 
6-1. 
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Table 6- 1: Target compounds, their retention time and selected target ions for SIM mode 
Retention time Target compounds Selected target ions 
16.20 Alpha Lindane  219, 181, 109 
17.68 Lindane  109, 111, 181 
19.35 Delta Lindane  109, 111, 219 
21.36 Heptachlor  100, 65, 272 
26.19 Heptachlor epoxide  81, 353, 355 
27.91 cis-Chlordane  373, 375, 237 
28.85 trans-Chlordane  375, 373, 377 
30.85 4,4'-DDE  246, 318, 248 
32.31 Endrin  81, 67, 79 
33.41 Endosulfan  195, 160, 197 
34.46 4,4'-DDD  235, 237, 165 
37.14 Endosulfan sulfate  272, 274, 229 
38.02 4,4'-DDT  235, 237, 165 
41.12 Endrin ketone  67, 317, 315 
43.24 Methoxychlor  227, 228, 113 
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6.3. Results and discussion  
6.3.1. Characterization of zinc oxide incorporated carbon foam.  
 
The synthesized material was characterized by scanning electron microscope and x-ray 
diffraction. SEM images revealed foam like structure of the sorbent. Figure 6-1 shows 
overall morphology of the material surface at different magnifications.  Figure 6-2 shows 
SEM images indicating uniformly distributed ZnO NPs over the surface of carbon foam. 
Energy dispersive x-ray (EDX) analysis can be used to find out the semi-quantitative 
composition of a specimen in SEM images. EDX spectra of different positions on SEM 
image also supported uniform distribution of ZnO NPs over the surface of the carbon foam 
(Figure 6-3).  
XRD spectrum shows characteristic peaks of ZnO but resolution is indicative to poorly 
crystalline material (Figure 6-4). However, when carbon foam was synthesized under 
controlled nitrogen environment and heated up to 180°C, it does not burn. When this 
material was calcined in tube furnace at 900°C for 2 hours under nitrogen environment, 
material became more crystalline and sharp XRD peaks were obtained (Figure 6-5). 
However, this calcined carbon foam had relatively low extraction efficiency than ZnO 
incorporated carbon foam.  
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Figure 6- 1: SEM images of ZnO incorporated carbon foam showing overall surface morphology at 
different magnification levels 
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Figure 6- 2: SEM images at different magnifications showing distribution of ZnO nanoparticles on 
the surface of carbon foam  
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 Spectrum In stats. C O Zn 
     
Spectrum 1 Yes 60.56 33.71 5.74 
Spectrum 2 Yes 61.47 33.15 5.37 
Figure 6- 3: EDX of ZnO incorporated carbon foam 
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Figure 6- 4: XRD pattern of ZnO incorporated carbon foam   
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Figure 6- 5: XRD pattern of calcined ZnO incorporated carbon foam 
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6.3.2. Optimization of µ-SPE 
 
Optimization experiments were conducted using OCPs free milk samples spiked at 25 ng 
mL-1. Each optimization experiment was conducted in triplicate. The parameters that affect 
the efficiency of µ-SPE  including sorbent type, amount of sorbent, desorption solvent, 
desorption volume, extraction time, stirring speed and desorption time were suitably 
optimized. Extraction efficiency was evaluated based on chromatographic peak areas.   
Like SPE, selection of suitable sorbent material is of prime importance in µ-SPE. The 
affinity toward target compounds is decisive factor in selection of suitable sorbent. The 
materials such as MWCNTs, activated carbon and C18 are known for their excellent affinity 
toward hydrophobic analytes.  In order to evaluate the extraction potential of ZnO-CF, its 
extraction efficiency was compared with MWCNTs, ZnO-CNTs hybrid and C18. For this 
purpose, 20 mg of each sorbent was packed inside the µ-SPE device. The highest extraction 
efficiency was provided by ZnO-CF (Figure 6-6). This high extraction efficiency was 
attributed to 𝚷-𝚷 electrostatic interaction between CF and target analytes. The uniformly 
distributed ZnO NPs were considered to add an extra value to the extraction because there 
are several examples where metal oxide NPs functionalized over different materials 
showed better extraction efficiency [9].   
The amount of sorbent was investigated in range of 5 – 25 mg. The extraction efficiency 
was increased up to 15 mg and then became constant. Hence 15 mg was selected as an 
optimum amount of sorbent (Figure 6-7).  
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Figure 6- 6: Influence of different sorbents on extraction efficiency of µ-SPE.   
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Figure 6- 7: Influence of amount of sorbent on extraction efficiency of µ-SPE.   
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The desorption solvent or eluent should be carefully selected as it has significant 
importance in desorption process. Affinity between desorption solvent and target 
compounds in terms of polarity is an important parameter to consider. In μ-SPE, desorption 
solvent should not only effectively desorb the target compounds from the sorbent but it 
should also properly dilate the pores of PP membrane for effective transfer of target 
compounds from sorbent to desorption solvent. A wide range of organic solvents with 
varying polarity index was employed as desorption solvent. Toluene was found most 
effective desorption solvent compared to methanol, n-hexane and acetonitrile. Toluene was 
observed to effectively dilate the pores of PP membrane compared to other solvents. Hence, 
it was selected as an optimum desorption solvent (Figure 6-8).  
In order to elute the target compounds from µ-SPE device in a reproducible manner, the 
volume of desorption solvent should be sufficient enough to completely immerse the 
device. 300 µL was minimum volume of the desorption solvent to completely immerse µ-
SPE device. Desorption volumes lesser than 300 µL provided low reproducibility because 
of ineffective desorption of target compounds while volumes higher than 300 µL gave low 
chromatographic peak areas because of dilution. Hence, 300 µL of desorption solvent was 
used throughout optimization experiments (Figure 6-9).  
µ-SPE is time dependent equilibrium based procedure. The mass transfer of target 
compounds increases with extraction time until an equilibrium is attained. The extraction 
time was investigated in range of 10 – 50 min. After 30 min, no further increase in peak 
areas of target compounds was observed. Thus, extraction time of 30 min was opted as 
optimum extraction time (Figure 6-10).  
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Figure 6- 8: Influence of desorption solvent on extraction efficiency of µ-SPE   
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Figure 6- 9: Influence of volume of desorption solvent on extraction efficiency of µ-SPE   
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Figure 6- 10: Influence of extraction time on extraction efficiency of µ-SPE   
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It is very common to evaluate the effect of salt addition on extraction efficiency of 
microextraction techniques. Basically, addition of salt into sample solution decreases 
solubility of target compounds in the donor phase by enhancing salt strength (salting out 
effect). However, in this case, addition of salt resulted in decreased extraction efficiency. 
This is probably due to increase of viscosity of the solution which can hinder the diffusion 
of target compounds into the acceptor phase.  
Partitioning of target compounds from donor phase to acceptor phase (µ-SPE device) is 
based on dynamic equilibrium.  Hence, increase in stirring speed can assist in rapid 
attainment of equilibrium. The stirring speed was investigated in the range of 300 – 1250 
rpm. As expected, extraction efficiency was increased with increase in stirring speed up to 
1000 rpm. At higher stirring speeds, formation of bubbles on µ-SPE device was observed. 
These bubbles may slow down the diffusion of target compounds in µ-SPE device. Hence, 
1000 rpm was selected as an optimum stirring speed (Figure 6-11).  
Desorption was carried out immersing the µ-SPE device in organic solvent containing 
Eppendorf vial. Desorption was performed by the aid of sonication. Sonication times were 
evaluated in the range of 5 – 25 min. Peak areas were increased up to 15 min and then a 
slight decrease was observed. This attributed to rise of temperature by longer sonication 
times. This rise in temperature may evaporate target compounds in the headspace over the 
organic solvent in desorption vial. These compounds may escape when vial is opened. The 
second reason for low extraction efficiency at higher sonication periods may be due to re-
adsorption of target compounds (Figure 6-12).  
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Figure 6- 11: Influence of stirring speed on extraction efficiency of µ-SPE.   
 
 
 
 
 
 
 
 
 
0
100000
200000
300000
400000
500000
600000
700000
800000
900000
1000000
400 rpm 600 rpm 800 rpm 1000 rpm 1200 rpm
Stirring speed
Alpha Lindane Lindane Delta Lindane Heptachlor Heptachlor epoxide
cis-Chlordane trans-Chlordane 4,4'-DDE Endrin Endosulfan
4,4'-DDD Endosulfan sulfate 4,4'-DDT Endrin ketone Methoxychlor
178 
 
 
Figure 6- 12: Influence of desorption time on extraction efficiency of µ-SPE.    
 
 
 
 
 
 
 
0
200000
400000
600000
800000
1000000
1200000
5 min 10 min 15 min 20 min 25 min
Desorption time
Alpha Lindane Lindane Delta Lindane Heptachlor Heptachlor epoxide
cis-Chlordane trans-Chlordane 4,4'-DDE Endrin Endosulfan
4,4'-DDD Endosulfan sulfate 4,4'-DDT Endrin ketone Methoxychlor
179 
 
6.3.3. Method validation  
 
Method validation parameters such as linearity, limit of detections (LODs) and 
reproducibility were studied under most optimum extraction conditions. 6-point calibration 
curves were plotted for all target analytes using uncontaminated milk samples spiked with 
known concentrations of OCPs. Good linearity for all target compounds was obtained with 
coefficients of determination (r2) between 0.9926 and 0.9998.  LODs were calculated based 
on signal to noise ratio of 3. LODs were ranged in between 0.19 and 1.64 ng mL -1. 
Method’s precision was evaluated based on inter-day and intra-day reproducibility by using 
uncontaminated milk samples spiked at 25 ng mL -1 (n=7).  RSDs were in range of 2.3 – 
9.7 % and 2.8 – 10.2 % for intra-day and inter-day precision respectively, indicating good 
precision of the method. Relative recoveries  were calculated in order to access the matrix 
effect by spiking milk samples at  1.0, 25 and 50 ng mL -1 (n=5). Relative recoveries of all 
tested OCPs were ranged between 85.1 to 100.7%. Analytical features of proposed method 
are given in Table 6-2.   
The developed µ-SPE method was applied to determine OCP concentrations in different 
brands of milk samples. Figure 6-13 compares chromatograms of unspiked and spiked (at 
25 ng mL-1) samples.  
Table 6-3 compares the performance of SPE with microextraction methods reported in the 
literature for extraction of OCPs in milk samples.  
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Table 6- 2: Analytical features of the method  
Compound  Linear 
range 
(ng/mL) 
Coefficient of 
determination 
(r2)  
LOD 
(ng/mL) 
Matrix effect  
(Mean relative 
recoveries n=3)  
RSDs (%) 
5 
ng/mL 
10 
ng/mL 
25 
ng/mL 
Intra-
day 
Inter-
day 
Alpha lindane  1 – 250  0.9973 
0.27 
95.3 96.8 97.2 4.5 5.2 
lindane  1 – 250 0.9964 0.26 98.2 98.1 99.0 2.3 4.7 
Delta lindane  3 – 250  0.9983 0.80 97.2 96.8 98.5 3.7 3.9 
Heptachlor 1 – 250 0.9978 0.19 89.3 92.1 95.4 5.1 6.9 
Heptachlor 
epoxide 
3 – 250 0.9956 
     0.90 
100.0 101.6 100.7 2.4 3.5 
Cis-chlordane 5 – 250  0.9945 
1.24 
87.5 91.7 92.2  6.2 7.3 
Trans-
chlordane 
5 – 250  0.9966 
1.43 
94.0 93.2 96.1 5.1 7.6 
4,4’-DDE 5 – 250  0.9991 1.64 92.5 92.0 94.1 2.5 2.8 
Endrin 5 – 250  0.9968 1.57 85.1 87.2 88.8 9.2 8.5 
Endosulfan 5 – 250  0.9949 1.07 88.7 90.2 91.0 4.7 6.2 
4,4’-DDD 3 – 250  0.9969 0.69 95.0 97.2 97.0 6.3 8.9 
Endosulfan 
sulfate 
3 – 250  0.9926 
0.47 
95.1 95.0 97.2 3.8 5.3 
4,4’-DDT 1 – 250  0.9943 0.35 85.4 85.8 91.7 9.7 10.2 
Endrin ketone 5 – 250  0.9998 
1.06 
94.0 96.2 98.0 2.8 5.3 
Methoxychlor 3 – 250  0.9965 
0.57 
86.3 89.6 90.6 4.5 5.1 
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Figure 6- 13: GC-MS chromatogram of non-spiked and spiked (25 ng/mL) milk samples 
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Table 6- 3: Comparison with methods reported in literature  
 
 
 
 
 
 
 
 
 
Method  Number 
of OCPs 
studied  
Linear 
Range  
LODs RSDs 
(%) 
Ref 
SPE-GC/ECD 6 -- 
 
 
0.5 – 1.8 
ng/mL 
1.7 – 
5.8 
[10] 
QuEchERS-GC/ECD 12 0.01 – 0.1 
µg/mL 
-- 0.28 – 
7.55  
[11] 
SPE-GC/ECD 9   0.01mg/Kg  [1] 
PLE-GC/MS/MS 4  0.03 – 0.800 
µg/Kg 
7.0 – 
17.0  
[12] 
ZNO-CF-µ-SPE 15 1, 3, 5 – 250 
ng/mL 
0.19 – 1.64 
ng/mL 
2.3 – 
10.2  
Present 
work 
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6.4. Conclusion  
 
In this work, a simple and facile method was adopted for synthesis of zinc oxide 
incorporated carbon foam. For the first time, this synthesized material characterized using 
SEM and XRD analysis. Later, it was utilized as sorbent in µ-SPE of OCPs in milk samples. 
The method provided good linearity and LODs for tested target compounds.  
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7. CHAPTER  
 INVESTIGATION OF RELATIVE ACCUMULATION 
PROFILES OF ENDOCRINE DISRUPTING 
COMPOUNDS IN DIFFERENT TYPES OF HUMAN 
CANCER TISSUES  
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Abstract  
Endocrine disrupting compounds are well known for interfering with normal hormonal 
activity in human and thus triggering different kind of carcinogenic and non-carcinogenic 
disorders. Organochlorine pesticides (OCPs) and polychlorinated biphenyls (PCBs) have 
negative impact on the human health. They are persistent in nature and accumulate in cells 
and tissues and induce different type of cancers as a result of endocrine disruption. We 
have evaluated the burdens of OCPs and PCBs in breast, colorectal, thyroid and kidney 
cancer tissues collected from Saudi Arabia. The compounds were extracted using 
ultrasonic assisted solvent extraction and determined by gas chromatography mass 
spectrometry.   ΣOCPs were highest in colorectal (3951.8 ng/g) and breast (3921.3 ng/g) 
tissues while significant concentrations were also found in thyroid and kidney tissues. 
ΣPCBs were highest in thyroid tissues followed by colorectal, breast and kidney tissues.  
ΣOCPs were several times higher than ΣPCBs in all types of cancer tissues. In order to get 
more deep insight into concentrations and bioaccumulation trends in cancer tissues, OCPs 
were divided into five groups of closely related compounds. Concentrations of ΣBHCs 
were higher than ΣCHLs, ΣDDs, Σdrins and Σendosulfan in all type of tissues except the 
kidney where ΣCHLs were slightly higher than ΣBHCs. These high concentrations of 
OCPs and PCBs in cancer tissues suggest that the environment of Saudi Arabia is heavily 
polluted with these pollutants.  
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7.1. Introduction  
 
Endocrine disrupting compounds (EDCs) are known to interfere with normal hormonal 
activities in humans and wildlife [1]. They affect synthesis, transportation and binding of 
natural hormones which leads to variety of ailments in human body. EDCs represent a wide 
class of chemicals including organochlorine pesticides, polychlorinated biphenyls, 
phthalates, heavy metals, natural and synthetic hormones etc. Exposure to EDCs  is 
associated with  problems in cognitive behavior, disorders in neurological and reproductive 
systems [2] and induction of variety of cancers [3] in humans including breast, prostate and 
thyroid.    
EDCs become functional at very low concentration levels such as part per billion and part 
per trillion [1]. Human exposure to EDCs occurs through inhalation,  dermal penetration 
and digestion of contaminated food [4]. Major concern about EDCs arises from the studies 
where their measurable concentrations have been reported in wastewater, drinking 
water[5,6], food chain[7], indoor and outdoor environment[8]. 
EDCs are persistent in their nature and have potential to accumulate in tissues [9,10]. 
Exposure of cells to EDCs may result in variations in structure and gene expressions, 
leading to initiation of cancers in body [11].Concentrations of EDCs in biological fluids 
have been associated with high risk of breast cancer [12]. Malignancies related to female 
reproductive tract are also reported to have direct link with EDC exposures [13]. Indeed, 
hundreds of studies that report a link between EDCs accumulation and different disorders 
in human, have been published within past few years.  After compiling the reports 
published worldwide, a recent document issued by UNEP and WHO establishes a 
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relationship between exposure of EDCs and occurrence of variety of cancers. Moreover, 
past 40-50 years witnessed unmatchable increase in rates of endocrine related cancers 
mainly because of large scale production and distribution of EDCs in the environment [14].  
Two broad groups of EDCs, organochlorine pesticides (OCPs) and polychlorinated 
biphenyls (PCBs) have been particularly considered in most of the reports because of their 
wide abundance in environment and potential to induce serious health implications. They 
also fall among persistent organic pollutants (POPs). Although their sources are local but 
they disperse around the globe due to relatively moderate vapor pressures and commerce.   
Consistent use of these chemicals in a particular place and long range atmospheric transfer, 
both contribute to their dispersion in environment.  Literature reveals that number of 
studies has been carried out across the globe to find out concentrations of POPs in different 
kind of biological samples [15–17]  and their measureable concentrations were found in 
human[18] and animal tissues [19]. High concentrations of PCBs and OCPs in developing 
countries are due to extensive use of these chemicals in the past and poor regulations to 
control their current use in industry and agrochemical sector [20].    
To access the exposure and sources of EDCs in a particular region, environmental 
pollutants are monitored in biological samples collected from local human and animal 
population. Cancer incidence rates have been dramatically increased in the kingdom of 
Saudi Arabia during last few years. According to a report published by Saudi cancer 
registry for year 2004, endocrine related cancers position among top commonly occurring 
cancers [21]. The objectives of this study were to investigate burdens of OCPs and PCBs 
in human cancer tissues collected from Saudi Arabia. We investigated breast, thyroid, 
colorectal and kidney cancer tissues for screening of OCPs and PCBs to get their relative 
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bioaccumulation patterns. To best of our knowledge, for the first time in Saudi Arabia, 
human cancer tissues were screened out to find out bioaccumulation of EDCs.   
7.2. Materials and Methods 
7.2.1. Sampling site and information about samples 
 
Jeddah is second largest city of Saudi Arabia and it is located on the coast of the Red Sea. 
It represents the largest seaport on Red Sea. According to 2007 estimations, its population 
was 3.4 million. It has fourth largest industrial district of Saudi Arabia. 
Human cancer tissues were collected from King Fahd Center for Medical Research at King 
Abdulaziz University, Jeddah. Samples were packed in sterilized plastic tubes and labelled 
properly. 73 cancer tissue samples were collected in all, which included breast (n=25), 
colorectal (n=11), thyroid (n=26) and kidney (n=11) tissues. All the samples were stored 
at temperature of -20°C prior to analysis.  
7.2.2. Chemicals and materials  
 
A standard containing mixture of PCBs was purchased from the Restek . 11 compounds 
which include 2,2′,4,5,5′-Pentachlorobiphenyl (PCB-101), 2,2′,3,4,5′-Pentachlorobiphenyl 
(PCB-87), 2,3,3′,4′,6-Pentachlorobiphenyl (PCB-110), 2,2′,3,5,5′,6-Hexachlorobiphenyl 
(PCB-151), 2,2′,4,4′,5,5′-Hexachlorobiphenyl (PCB-153), 2,2′,3,4,5,5′-
Hexachlorobiphenyl (PCB-141), 2,2′,3,4,4′,5′-Hexachlorobiphenyl (PCB-138), 
2,2′,3,4′,5,5′,6-Heptachlorobiphenyl (PCB-187), 2,2′,3,4,4′,5′,6-Heptachlorobiphenyl 
(PCB-183), 2,2′,3,4,4′,5,5′-Heptachlorobiphenyl (PCB-180), 2,2′,3,3′,4,4′,5-
Heptachlorobiphenyl (PCB-170) were selected as target compounds.  A standard 
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containing mixture of OCPs was purchased from the Restek  and 16 compounds (alpha-
BHC, gama-BHC, beta-BHC, delta-BHC, Heptachlor, Aldrin, Heptachlor epoxide, cis-
Chlordane, trans-Chlodane, 4,4’-DDE, Endrin, Endosulfan, 4,4’-DDD, Endosulfan sulfate’ 
4,4’-DDT, Methoxychlor) were considered for this study.  All the solvents used were of 
HPLC garde.    
7.2.3. Sample preparation, extraction and analysis  
 
Sample preparation is an important step for analysis of trace levels of organic pollutants in 
any matrix. The quantity of the real cancer tissues we obtained from a local hospital was 
very small (each sample less than a gram). Hence it was needed to develop an efficient 
extraction method for pre-concentration of target analytes without losing any sample. Thus, 
a simple ultra-sonication assisted solvent extraction method was developed for pre-
concentration of target analytes. Initially the method was developed on fish tissues and its 
applicability to real cancer tissues was confirmed by recovery experiments. Good 
recoveries are supportive to apply the method on real tissues.  
The weights of real samples were measured before extraction which were in range of few 
milligrams to several hundred milligrams. 500 µL of toluene was added to each sample 
vial and it was properly closed. Then, sample vials were placed in ultrasonication bath for 
a specified period of time which was operated at certain power.  All the samples were then 
transferred to refrigerator for 1 hour. Purpose of this cooling was to settle and freeze any 
fatty stuff at the bottom. After 1 hour of cooling, upper layer was taken into GC vials and 
1 µL was injected to GC-MS. 
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Different parameters that may affect the extraction efficiency of ultra-sonication assisted 
solvent extraction were optimized. These parameters include extraction solvent, power of 
ultra-sonication and extraction time. As a result of optimization, toluene was selected as 
extraction solvent. The optimum power at which ultra-sonication device was operated was 
75% and the optimum extraction time was found as 25 minutes. 
7.2.4. Gas chromatography-mass spectrometry  
 
All the samples were analyzed using gas chromatograph mass spectrometer (Shimadzu, 
QP2010 ultra equipped with autosampler AOC-20i, column Rxi-5 Sil MS 30.0 m x 0.25 
µm x 0.25 µm). Different temperature programs were developed for both PCBs and OCPs. 
For OCPs injection temperature was 200°C and the oven temperature was programmed as: 
initial temperature was 50 °C and then it was increased to 180°C at rate of 10°C/min and 
held for 4 minutes and then increased to 210°C at rate of 2 °C/min and held for 4 minutes 
and finally increased to 238 at rate of 3°C/min. Total run time was 45.33 minutes.  
For PCBs initial temperature was kept 100°C which was held for 1 minute and then 
increased to 190°C at the rate of 20°C /min and held for 2 minutes and then increased to 
260°C at rate of 3°C /min and held for 3 minutes. Total run time was 30.50 minutes. For 
qualitative measurements, mass spectrometer detector was operated in scan mode from m/z 
of 50 to 500. For quantitative determination, mass spectrometer detector was operated in 
selective ion monitoring mode.   
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7.2.5. Quality assurance (QA) and quality control (QC) 
 
Quality assurance and quality control were given due importance during whole process of 
analysis. Glassware was properly washed and oven dried before using for preparation of 
any solution. No target compounds were found in solvent or procedural blank. Different 
standard concentrations were extracted using the proposed extraction methods and a linear 
calibration graph was obtained for each compound (R2>0.99).  
7.2.6. Statistical Analysis 
 
Results of analyzed samples were categorized based on the type of the tissues i.e. breast 
(n=25), colorectal (n=11), thyroid (n=26) and kidney (n=11) tissues. 11 PCBs and 16 OCPs 
were screened in all categories of cancer tissues.  Mean, standard deviation and range of 
detected concentrations were calculated and results were compared to get useful 
conclusions.  
16 OCPs were further classified into 5 groups of closely related compounds which were: 
BHCs (alpha, beta, gamma and delta BHCs), CHLs (heptachlor, heptachlor epioxide, cis-
chlordane and trans-chlordane), drins (aldrin and endrin), DDs (4.4’-DDT, 4,4’-DDE and 
4,4’-DDD) and endosulfans (endosulfan and endosulfan sulfate). The total concentration 
(as a sum) of each group was determined in all categories of cancer tissues and represented 
by ΣBHCs, ΣCHLs, Σdrins, ΣDDs, Σendosulfans. In order to find overall burden of PCBs 
and OCPs on different type of cancer tissues ΣPCBs and ΣOCPs were also calculated and 
compared.  
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7.3. Results and discussion  
 
Optimized conditions were used for the extraction of OCPs and PCBs to enhance their 
recoveries in biological tissues. The extraction yields were evaluated by peak area analysis 
using GCMS. Optimization was carried out by considering triplicate uncontaminated fish 
tissue sample analysis spiked with known concentrations. The parameters optimized were: 
extraction solvent, extraction time and sonication power. Higher peak areas corresponded 
to higher extraction efficiencies. 
7.3.1. Optimization of extraction parameters  
7.3.1.1. Extraction solvent  
 
Solvents with boiling point higher than 60°C were selected for extraction. This is because 
of heating effect which is produced as a result of ultrasonication and temperature 
sometimes may rise upto 50°C. Hence, the solvents with low boiling point may evaporate.  
The Four organic solvents toluene, acetonitrile, propanol and carbon tetrachloride were 
tested for extraction.  Based upon larger peak areas for all extracted compounds (OCPs and 
PCBs), toluene was found most suitable extraction solvent.  
7.3.1.2. Extraction time  
 
Different extraction times (5 min, 15 min, 25 min, 30 min) were evaluated to find the 
optimum extraction time. Time of 25 min was selected because high peak areas for target 
compounds. There was no significant increase in peak areas after 25 minutes. The reason 
for such long time of ultrasonication assisted extraction can be attributed to strong 
interactions of target compounds within the tissues due to their bio accumulative nature.   
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7.3.1.3. Intensity of ultra-sonication  
 
Percentage of ultrasonication power can affect extraction of organic pollutants in biological 
tissues.  The higher power can accelerate the mass transport of analytes from tissues to 
organic solvent. The maximum peak areas for analytes were obtained at ultra-sonicaion 
power of 75% and then a steady state was reached. Further increase in power of ultra-
sonication did not affect extraction efficiency. Hence 75% power was chosen as optimum.  
7.3.2. Concentrations of OCPs in human cancer tissues 
 
Mean concentration of OCPs in all type of cancer tissues, the range of detected 
concentrations, and percentage of the samples in which a particular target compound was 
detected, are summarized in Table 7-1.  
Concentration of OCPs in the tissues have been widely linked with breast cancer. For this 
purpose, number of studies have been carried out throughout the world. Although, most of 
the reports describe high concentrations of OCPs in cancer patients than the controls 
[22,23] but there are some reports where no significant differences in OCP concentrations 
among cancer patients and controls were observed [24,25]. Without being critical into the 
debate, one fact is understood that bioaccumulation of OCPs in human and animal tissues 
may lead to serious consequences and it indicates the nature of the exposure for a certain 
period of time to contaminated environment. In the current study, Figure 7-1 (a) highlights 
relative mean concentrations of OCPs in breast cancer tissues (n=25). The highest mean 
concentration was recorded for 4,4'-DDE which was 888.0 ng/g. 4,4'-DDE was detected in 
92% of breast cancer tissues. The other compounds with subsequent higher mean 
concentrations were: beta-BHC (769.0 ng/g) and heptachlor (733.8 ng/g).  Heptachlor and 
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4,4'-DDE stand among most frequently detected compounds in breast cancer tissues (92% 
samples). The lowest mean concentration was found 1.8 ng/g for cis-chlordane. The lowest 
concentration of any individual compound in a single tissue was 0.4 ng/g for 4,4'-DDE and 
the highest was 2600 ng/g for heptachlor.  
Thyroid cancer is rare kind of cancers in human and it accounts less than 2 % of all cancers. 
However, it is the most common endocrine related malignancy in the world. During past 
decades, incidence rates of thyroid cancer have been  increased significantly[26]. Although 
some studies linked exposure of OCPs with thyroid cancer [27] but it is difficult to find 
any reports where OCPs were measured directly in thyroid tissues. In this study we 
analyzed OCPs in malignant thyroid tissues (n=26), the highest mean concentration was 
recorded for beta-BHC which was 279.8 ng/g. beta-BHC was detected in 84.6% of thyroid 
cancer tissues. The other compounds with subsequent higher mean concentrations were: 
heptachlor (204.0 ng/g) and 4,4'-DDE (189.1 ng/g). 4,4'-DDE was detected in 92.3% of 
thyroid cancer tissue samples. The lowest mean concentration was found 1.3 ng/g for 
methoxychlor. The lowest concentration of any individual compound in a single tissue was 
18.2 ng/g for cis-chlordane and the highest was 597.4 ng/g for beta-BHC. Overall we 
observed very high concentrations of BHCs, heptachlor, 4,4'-DDE, gamma-BHC and 
aldrin.  Figure 7-1(b) shows relative mean concentration of OCPs in thyroid cancer tissues.  
Colorectal cancer is third most common cancer in the world. Etiology of colorectal cancer 
is not clearly understood, however, diet is thought to play an important role in determining 
the risk. Consumption of polluted diet is major source of exposure to organic pollutants 
and longer contact of these pollutants with colon may lead to development of malignancies. 
Although, EDCs mainly develop hormone dependent cancers and colorectal cannot be 
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placed in this category.  However, still there is some evidence of role of hormones [28]. 
Hence, we screened colorectal malignant tissues for presence of OCPs. The highest mean 
concentration was recorded for 4,4'-DDE which was 1064.8 ng/g. 4,4'-DDE was detected 
in 90.9% of colorectal cancer tissues. The other compounds with subsequent higher mean 
concentrations were: beta-BHC (951.5 ng/g) and alpha-BHC (462.6 ng/g).  Alpha-BHC, 
beta-BHC and 4,4'-DDE were detected in 90.9 of the colorectal cancer tissue samples. The 
lowest mean concentration was found 4.7 ng/g for heptachlor epoxide and it was detected 
in 27.3% of the samples. Such lowest concentrations were recorded in fish tissues in China 
by Nakata et al.[23].  Trans-chlordane was not detected in any colorectal cancer tissue 
samples. The lowest concentration of any individual compound in a single tissue was 0.7 
ng/g for 4,4'-DDD and the highest was 2786.0 ng/g for beta-BHC. Figure 7-1(c) gives an 
overview of relative mean concentrations of OCPs in colorectal malignancies.  
The kidney performs many important functions in body such as balance of fluids, removal 
of waste from blood, formation of urine etc.  There is a significant evidence of 
accumulation of OCPs in kidneys of different animals [29–31], however, literature 
regarding the humans is lacking this aspect. In our study, 11 samples of kidney cancer 
tissues were evaluated for presence of OCPs.  The highest mean concentration was 
recorded for heptachlor which was 533.3 ng/g. Heptachlor was detected in 90.9% of kidney 
cancer tissues. The other compounds with subsequent higher mean concentrations were: 
beta-BHC (314.0 ng/g), 4,4'-DDE  (179.4 ng/g) and endosulfan sulfate (106.7 ng/g). Beta-
BHC detected in all kidney cancer tissues. The lowest mean concentration was found 21.5 
ng/g for endrin. Methoxychlor was not detected in any samples. Figure 7-1(d) shows mean 
concentrations of OCPs in different types of cancer tissues.  
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Beta-BHC was abundantly recorded in all type of cancer tissues standing among the 
frequently detected compounds with high concentrations. This frequent detection of beta-
BHC may be due to its excessive and non-stop use in the past being a relatively cheaper 
and major contributor in group of OCPs. These observations are in agreement with some 
other studies where high concentrations of BHCs were recorded in vegetable and food stuff 
[32,33]. Although all OCPs showed significantly high mean concentrations in tissues 
samples, but compared to other compounds concentrations of 4,4'-DDE  and heptachlor 
were very high in all type of cancer tissues. These results are not very strange from the 
perspective of previously reported literature where very high concentrations of these 
compounds were detected in vegetables and fruits and authors stated that continuous 
consumption of contaminated food may lead to accumulation and serious chronic effects 
[34].  
OCPs were further divided into groups of closely related compounds in order to find impact 
of each kind of compounds on different type of cancer tissues i.e.  ΣBHC (sum of mean 
concentration of alpha, beta, gamma and delta BHCs), ΣCHLs(sum of mean concentration 
of  heptachlor, heptachlor epioxide, cis-chlordane and trans-chlordane), Σdrins (sum of 
mean concentration of aldrin and endrin),  ΣDDs (sum of of mean concentration 4.4’-DDT, 
4,4’-DDE and 4,4’-DDD) and Σendosulfan (sum of e of mean concentration endosulfan 
and endosulfan sulfate).Figure 2 shows relative mean concentrations of  ΣBHCs , ΣCHLs, 
Σdrins,  ΣDDs and Σendosulfan in cancer tissues. ΣBHCs were highest in colorectal tissues 
while lowest in kidney cancer tissues. ΣCHLs were highest in breast tissues while lowest 
in thyroid tissues.   ΣDDs showed highest  concentrations in colorectal cancer tissues 
followed by breast cancer tissues. This agrees with another report, where high 
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concentrations of DDs (DDT and DDD) were observed in breast cancer patients compared 
to the patients with benign breast disease [35]. Concentrations of different groups of OCPs 
in all type of cancer tissues are listed in Table 7-2 and Figure 7-2.    
ΣOCPs which denotes sum of mean concentrations of all analyzed compounds in one type 
of cancer tissues, is an important parameter to analyze the overall burden of OCPs in 
particular type of environmental or biological samples. Σ OCPs were found in following 
order: colorectal (3951.8 ng/g) > breast (3921.3 ng/g) > kidney (1426.5 ng/g) > thyroid 
(1135.3 ng/g). Mean concentration of ΣOCPs were almost same in breast and  colorectal  
tissues. 
The concentration of OCPs in human tissues recorded in different parts of the world are 
listed in Table 7-3. Comparison shows that the concentrations of beta-BHC and aldrin were 
much higher in the current study while the concentrations of 4,4'-DDE  were comparable 
or higher than reported in other parts of the world. The concentartions of 4,4'-DDT were 
lower or comparable with other studies. This comparison suggests that the environment of 
Saudi Arabia is highly polluted with beta-BHC, aldrin and 4,4'-DDE.    
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Table 7- 1: Mean concentrations of OCPs, range of detected concentrations, standard deviation and %age of the samples 
above LOD 
 
 
 
 
 
Compounds Breast tissues (n=25) Thyroid tissues (n=26) Colorectal tissues (n=11) Kidney tissues (n=11) 
Mean Range SD a* Mean Range SD a* Mean Range SD a* Mean Range SD a* 
alpha-BHC 
267.5 3.2 – 
909.4 
 
303.6 84.0 146.8 33.3 – 
459.9 
165.0 65.4 462.6 31.5 – 
1484.0 
466.8 90.9 19.4 34.4 – 
71.5  
28.2 36.4 
beta-BHC 
769.0 52.8 – 
920.0 
851.1 80.0 279.8 28.6 – 
597.4 
213.1 84.6 951.5 51.7 – 
2786.0 
924.5 90.9 314.0 56.0 – 
1012.0 
305.1 100.0 
gamma-BHC 
167.6 0.6 – 
1589.8 
347.3 80.0 116.0 28.9 – 
504.4 
139.2 73.1 183.4 4.2 – 
1244.0 
367.7 100 60.5 28.2 – 
143.0 
52.1 72.7 
delta-BHC 
4.5 45.0 – 
68.5 
16.1 8.0 4.5 22.6 – 
69.2  
14.8 11.5 25.8 1.3 – 
195.0 
62.0 27.3 28.8 26.6 – 
245.3 
73.3 27.3 
Heptachlor 
733.8 2.1 – 
2600.0 
855.7 92.0 204.0 46.7 – 
567.8 
177.6 80.8 195.8 9.2 – 
1065.5 
321.3 72.8 533.3 23.1 – 
981.0 
368.5 90.9 
Aldrin 
286.3 1.6 – 
1909.1 
534.0 88.0 60.1 24.1 – 
449.7 
102.5 53.8 131.5 3.7 – 
662.0 
193.4 81.8 99.9 24.1 – 
864.0 
255.7 45.5 
Heptachlor 
epoxide 
2.5 5.6 – 
34.9 
7.5 16.0 0.0 N.D  0.0 0.0 4.3 7.3 – 
28.9 
9.0 27.3 N.D N.D 0.0 0.0 
trans-
Chlordane 
5.9 3.3 – 
83.5 
18.6 16.0 1.5 38.7 – 
38.7  
7.6 3.8 0.0 0.0 – 0.0 0.0 0 14.1 51.3 – 
102.6  
33.1 27.3 
cis-Chlordane 
1.8 13.3 – 
17.7 
5.0 12.0 3.8 18.2 – 
54.7 
12.0 11.5 14.6 1.8 – 
159.4 
48.0 18.2 N.D N.D 0.0 0.0 
4,4-DDD 
60.1 0.9 – 
621.8 
127.2 84.0 7.7 21.4 – 
72.2 
18.2 19.2 81.4 0.7 – 
650.0 
196.3 72.7 6.6 28.9 – 
44.1 
15.1 18.2 
4,4-DDE 
888.0 0.4 – 291 859.2 92.0 189.1 20.2 – 
536.6 
139.7 92.3 1064.8 32.6 – 
2694.0 
967.4 90.9 179.4 28.3 – 
675.0 
275.2 45.5 
Endrin  
202.3 47.2 – 
2570.1 
540.6 32.0 43.9 47.0 – 
457.6 
111.6 23.1 414.5 109.0 – 
2192 
656.5 54.5 31.1 21.5 – 
228.0 
71.0 27.3 
Endosulfan  
63.1 2.3 – 
598.7 
123.5 80.0 29.8 20.6 – 
275.7 
70.1 26.9 49.8 8.7 – 
143.9 
57.1 81.8 30.6 31.8 – 
182.9 
56.2 36.4 
Endosulfan 
sulfate 
200.8 3.6 – 
1150.0 
338.2 68.0 35.0 26.6 – 
172.9 
53.0 42.3 195.4 24.6 – 
1350.6 
391.6 72.7 106.7 85.9 – 
858.9 
259.3 27.3 
4,4-DDT 
38.9 1.4 – 
223.8 
63.0 56.0 12.1 21.2 – 
126.9 
31.8 19.2 76.6 39.5 – 
645.4 
194.5 27.3 2.1 23.5 – 
23.5  
7.1 9.1 
Methoxychlor 
229.1 6.1 – 
2531.8 
608.0 48.0 1.3 34.1 – 
34.1 
6.7 3.8 99.8 11.4 – 
937.0 
280.4 36.4 N.D N.D 0 0.0 
Σ16OCPs 3921.3    1135.3    3951.8    1426.5    
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Figure 7- 1: Mean concentrations of OCPs in different types of human cancer tissues 
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Table 7- 2: Sum of mean concentrations of OCPs in cancer tissues 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Groups of 
OCPs 
Breast 
tissues 
(n=25) 
Thyroid 
tissues (n=26) 
Colorectal 
tissues (n=11) 
Kidney 
tissues (n=11) 
BHCs 1208.6 547.1 1623.4 422.6 
CHLs 744.0 209.2 214.8 547.5 
drins 488.6 104.0 546.0  131.0 
endosulfans 263.9 64.8 245.2 137.3 
DDs 987.0 208.9 1222.8 188.2 
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Figure 7- 2: Sum of mean concentrations of different groups of OCPs in different types of 
human cancer tissues 
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Table 7- 3: Mean concentrations of some OCPs in tissues samples reported in the literature. 
Country/City  Nature 
and 
number of 
samples 
beta-
BHC 
Aldrin 4,4-
DDE 
4,4-
DDD 
4,4-DDT Ref 
New York  Controls 
(n=5) 
10.1    160   4.1 [22] 
Breast 
cancer 
patients 
(n=5)  
12.5  379  10.7 
Germany  Tissues of 
breast 
cancer 
patients 
(n=45) 
84  838  30 [23] 
Tissues of 
breast of 
controls 
(n=20) 
72  450  24 
Connecticut Adipose 
tissues of 
breast 
cancer 
patients 
(n=304) 
  736.5  51.8 [24] 
Adipose 
tissues of 
controls 
(n=186) 
  784.1  55.6 
Finland Adipose 
breast 
tissues of 
130  960   70  [36] 
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patients 
(n=44) 
Adipose 
breast 
tissues of 
controls 
(n=33) 
80  980  60  
Spain  Adipose 
tissues of 
breast 
cancer 
patients 
(n=198)  
 2.84   326.86  [25] 
Adipose 
tissues of 
controls 
(n=260) 
 2.37   307.34 
Woodland 
Hills, CA 
Adipose 
tissues of 
breast 
cancer 
patients 
(n=73) 
  693.6 9.2 231.4 [37] 
Adipose 
tissues of 
controls 
(n=73) 
  642.1 21.7 197.6 
Canada  Biopsy 
tissues of 
breast of  
cancer 
patients 
(n=217) 
43.1  693  22 [38] 
Biopsy 
tissues of 
breast of  
41.5  596  19.3 
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controls 
(n=217) 
Saudi Arabia 
 
Breast 
cancer  
tissues 
(n=25) 
 
769.0 268.3 888 60.1 38.9 Current 
study 
Thyroid 
cancer 
tissues 
(n=26) 
279.8 60.1 189.1 7.7 12.1 
Colorectal 
cancer 
tissues 
(n=11) 
951.5 131.5 1064.8 81.4 78.6 
Kidney 
cancer 
tissues 
(n=11) 
314.0 99.9 179.4 6.6 2.1 
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7.3.3. Concentrations of PCBs in human cancer tissues 
 
Mean concentration of PCBs in each type of cancer tissues, the range of detected 
concentrations, and percentage of the samples in which a particular target compound was 
detected, are summarized in Table 7-4.  
Exposure to PCBs has been associated with breast cancer risk.  We measured 11 PCB 
congeners in breast cancer tissues.  For breast cancer tissues (n=25), the highest mean 
concentration was recorded for PCB-87 which was 107.6 ng/g. PCB-87 was detected in 
56% of breast cancer tissues. The other compounds with subsequent higher mean 
concentrations were: PCB-138 (84.9 ng/g), PCB-151 (59.8 ng/g) and PCB-183 (51.8 ng/g). 
The lowest mean concentration was found 0.1 ng/g for PCB-180 and it was detected in 
only one sample. The highest concentration in any individual breast cancer tissue was 
2451.0 ng/g for PCB-187. Figure 7-3 (a) shows mean concentrations of PCBs in breast 
cancer tissues. 
Thyroid cancer is endocrine related malignancy. The incidence rates of thyroid cancers 
have been increased in last few decades. In addition to several other factors, thyroid 
malignancies have been linked with exposure to environmental pollutants such as 
polyhalogenated aromatic hydrocarbons[39] and life style changes [40].   Therefore, we 
screened PCBs in thyroid cancer tissues (n=26).  The highest mean concentration thyroid 
tissue was recorded for PCB-138 which was 429.4 ng/g. PCB-138 was detected in 84.6% 
of thyroid cancer tissues. The other compounds with subsequent higher mean 
concentrations were: PCB-110 (305.3 ng/g) and PCB-151 (48.1 ng/g) It was observed that 
the mean concentrations of PCB-110 and PCB-138 were relatively much higher in thyroid 
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tissues than breast tissues. Figure 7-3 (b) shows mean concentrations of PCBs in thyroid 
cancer tissues.  
PCB burdens in the body may initiate several disorders in human body. Exposure to PCBs 
may also contribute in development of colorectal cancer [28]. In this work, we screened 11 
colorectal cancer tissues for presence of PCBs. Our results revealed that PCB-138 had 
maximum mean concentration (295.9 ng/g) in colorectal tissues. PCB-138 was detected in 
63.6% of colorectal cancer tissues. The other compounds with subsequent higher mean 
concentrations were: PCB-110 (170.8 ng/g) and PCB-87 (90.6 ng/g).  PCB-87, PCB-110, 
PCB-141 and PCB-187 were detected in 90.9% of the samples. The lowest mean 
concentration was found 1.4   ng/g for PCB-180 and it was detected in only one sample. 
The mean concentrations of PCBs for most of the compounds in colorectal tissues were 
higher than both breast and thyroid tissues. Figure 7-3(c) shows mean concentrations of 
PCBs in colorectal cancer tissues.  
The relationship between exposure to PCBs and incidence of kidney cancer is not that 
much explored. However, occupational exposure to PCBs was suspected to cause kidney 
cancer in few cases [41]. In our study,   for kidney cancer tissues (n=11), the highest mean 
concentration was recorded as 278.7 ng/g for PCB-87. PCB-87 was detected in 90.9% of 
kidney cancer tissues. The lowest mean concentration was found 1.0 ng/g for PCB-101. 
The lowest concentration of any individual compound in a single tissue was 0.1 ng/g for 
PCB-101 and the highest was 2839.9 ng/g PCB-87. The overall mean concentrations of all 
the PCBs in kidney tissues were lesser than what were observed in breast, thyroid and 
colorectal cancer tissues except the PCB-87 which was higher than all other type of tissues. 
Figure 7-3 (d) shows mean concentrations of PCBs in kidney cancer tissues. Mean 
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concentrations of some PCBs in tissue samples reported in the literature are given in Table 
5 for comparison. 
ΣPCBs which denotes sum of mean concentrations of all analyzed compounds in one type 
of cancer tissues, was also calculated to analyze the overall burden of PCBs in particular 
type cancer tissues.  ΣPCBs were found in following order: thyroid (920.0 ng/g) > 
colorectal (812.4 ng/g) > breast (398.3 ng/g) > kidney (349.6 ng/g). A comparison with 
PCB concentrations recorded in other parts of the world is given in Table 7-5. 
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Table 7- 4: Mean concentrations of PCBs, range of detected concentrations, standard 
deviation and %age of the samples above LOD  
 
 
 
 
 
Compounds Breast tissues (n=25) Thyroid tissues (n=26) Colorectal tissues (n=11) Kidney tissues (n=11) 
Mean Range SD a* Mean Range SD a* Mean Range SD a* Mean Range SD a* 
PCB-101 
4.9 
 0.2 – 
101.8 
20.5 
20.0 6.1 
 2.9 – 
52.3 
14.2 
30.8 73.2 
 2.9 – 
537.4  
166.4 
45.5 1.0 
 0.1 – 
8.3 
2.5 
27.3 
PCB-87 
107.6 
 0.9 – 
2451.0 
489.4 
56.0 20.6 
 0.6 – 
186.5 
43.3 
53.8 97.6 
 0.4 – 
549.4 
164.5 
90.9 278.7 
 0.1 – 
2839.9 
850.8 
90.9 
PCB-110 
42.1 
 0.7 – 
609.6 
121.5 
72.0 305.3 
 0.6 – 
3244.0 
688.6 
92.3 170.8 
 1.8 – 
1202.5 
371.6 
90.9 7.1 
 0.4 – 
31.3 
10.4 
63.6 
PCB-151 
59.8 
 2.9 – 
1481.2  
296.1 
16.0 48.1 
 8.1 – 
1146.9 
224.3 
23.1 77.8 
 1.9 – 
749.5 
223.7 
45.5 3.3 
 0.4 – 
23.5 
7.6 
27.3 
PCB-153 
8.7 
 0.4 – 
134.8 
27.8 
36.0 9.1 
 2.3 – 
59.9 
18.3 
34.6 6.7 
 0.8 – 
44.3 
14.0 
36.4 1.9 
 1.2 – 
5.9 
2.2 
54.5 
PCB-141 
24.7 
 0.2 – 
410.0 
82.0 
76.0 32.6 
 0.5 – 
50.1 
42.1 
76.9 41.5 
 1.7 – 
181.0 
68.5 
90.9 4.0 
 0.4 – 
33.0 
9.8 
54.5 
PCB-138 
84.9 
 2.7 – 
1062.7 
216.2 
52.0 429.4 
 19.7 – 
2268.2 
695.0 
84.6 295.9 
 13.4 – 
1500.0 
495.3 
63.6 26.4 
 10.0 – 
190.2 
57.6 
36.4 
PCB-187 
13.0 
 0.4 – 
144.9 
29.3 
96.0 37.5 
 0.6 – 
224.5 
57.5 
92.3 23.3 
 0.4 – 
106.0 
30.5 
90.9 5.5 
 0.7 – 
35.1  
10.2 
72.7 
PCB-183 
51.8 
 0.3 – 
1114.0 
222.3 
44.0 11.8 
 1.1 – 
120.1 
28.4 
42.3 15.0 
 1.2 – 
79.0 
25.6 
63.6 6.8 
 0.5 – 
45.6 
13.9 
54.5 
PCB-180 
0.1 
2.7 – 
2.7 
0.5 
4.0 1.4 
 17.5 – 
18.8 
4.9 
7.7 1.4 
 15.7 – 
15.7 
4.7 
9.1 1.9 
 2.4 – 
18.1 
5.4 
18.2 
PCB-170 
0.8 
 2.3 – 
12.5  
2.6 
16.0 18.2 
 9.1 – 
253.2  
52.7 
26.9 9.4 
 4.1 – 
93.8 
28.1 
36.4 13.1 
 0.5 – 
93.5 
29.2 
45.5 
 Σ11 PCBs 398.3      920.0      812.4      349.6      
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Figure 7- 3: Mean concentrations of PCBs in different types of human cancer tissues 
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Table 7- 5: Mean concentrations of some PCBs in tissue samples reported in the literature. 
Country/City  Nature 
and 
number of 
samples 
PCB-
153 
PCB-
138 
PCB-
187 
PCB-
183 
PCB-
180 
PCB-
170 
Ref 
New York  Breast 
adipose 
tissues of 
controls 
(n=213) 
98.3  66.8  24.2  9.5 65.7 32 [38] 
Breast 
adipose 
tissues of 
cancer 
patients 
(n=217)  
105.2 73.8 25.7 10.3 71.9 34.3 
Bolivia  Adipose 
tissues of 
general 
population 
(n=112) 
52.7 84.0 --  -- 32.8  [42] 
China Adipose 
tissues of 
general 
population 
of e-waste 
recycling 
sites 
(n=64) 
14.5 12.8 2.0 1.03 5.18 3.30 [43] 
Saudi Arabia 
 
Breast 
cancer  
tissues 
(n=25) 
 
8.7 84.9 13.0 51.8 0.1 0.8 Current 
study 
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Thyroid 
cancer 
tissues 
(n=26) 
9.1 429.4 37.5 11.8 1.4 18.2 
Colorectal 
cancer 
tissues 
(n=11) 
6.7 295.9 23.3 15.0 1.4 9.4 
Kidney 
cancer 
tissues 
(n=11) 
1.9 26.4 5.5 6.8 1.9 13.1 
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7.3.4. Comparison of ΣOCPs and ΣPCBs 
 
Figure 4 gives a comparison of total concentrations of OCPs and PCBs in all types of cancer 
tissues. It can be clearly observed that ΣOCPs were much higher than ΣPCBs in all type of 
cancer tissues. ΣOCPs to ΣPCBs ratios  were  9.83, 6.31, 4.86 and 8.69 in breast, thyroid , 
colorectal and kidney cancer tissues respectively.  This observed scenario supports that the 
sources of OCPs in the environment of Jeddah are widespread. Such high concentrations 
may have routes in the contaminated food such as vegetables and fruits.  
This is the first work carried out in Saudi Arabia to find out the concentrations of EDCs in 
cancer tissue samples and it can be considered as a preliminary step towards the 
investigation of relationship between the environmental pollutants and risk of cancer 
induction. However, this work lacks in two aspects (i) the sample size (n=73) is very small 
and it cannot be subjected to statistical analysis to establish a relationship between the 
causes and effects (ii) we screen the concentrations only in cancer patients and healthy 
people have not been considered. However, these concentrations are in some cases much 
higher than what reported in literature for healthy controls.  
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Figure 7- 4:  Sum of mean concentrations of OCPs and PCBs in different types of human 
cancer tissues 
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7.4. Conclusion  
 
In this work, we have investigated concentrations of OCPs and PCBs in different types of 
human cancer tissues. Samples were extracted using ultrasonication assisted solvent 
extraction. . ΣOCPs were highest in colorectal (3951.8 ng/g) and breast (3921.3 ng/g) 
tissues while significant concentrations were also found in thyroid and kidney tissues. 
ΣPCBs were highest in thyroid tissues followed by colorectal, breast and kidney tissues. 
Notably, ΣOCPs were several times higher than ΣPCBs in all types of cancer tissues. OCPs 
were further classified into five groups of closely related compounds. Concentrations of 
ΣBHCs were higher than ΣCHLs, ΣDDs, Σdrins and Σendosulfan in all type of tissues 
except the kidney where ΣCHLs were slightly higher than ΣBHCs. This study suggests 
sorting out the sources of these compounds in the Saudi Arabian environment for complete 
correlation among the disease and cause.  
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8. CHAPTER  
 SCREENING OF ORGANOCHLORINE PESTICIDES IN 
PLASMA SAMPLES OF CANCER PATIENTS  
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Abstract  
In this study, plasma samples were collected from 73 patients suffering from colorectal or 
breast cancers. Fifteen organochlorine pesticides (OCPs) were determined in all samples. 
The volume of the plasma sample that was used for extraction of target compounds was 
500 µL. The extraction was carried out by adding 1.0 mL of toluene into plasma samples 
in Eppendorf vial and then sonicating for 5 minutes. The vials were placed in refrigerator 
for 1 hour to freeze the plasma and water content inside the vial. Then, 1 µL from the upper 
layer was injected into GC-MS. Out of fifteen OCPs analyzed, only three compounds 
(heptachlor, endrin and endrin ketone) were detected in plasma samples. Data analysis was 
carried out by dividing plasma samples based on malignancy, malignancy type and stage. 
The data analysis indicated that heptachlor and endrin were only present in the plasma 
samples of the patients with malignancies while they were absent in the samples of patient 
with non-malignant tumors. This might be an indication that exposure to heptachlor and 
endrin can be a cause of malignancy. However, this needs to be confirmed by the cell line 
studies. Heptachlor and endrin were only found in the plasma samples of colorectal cancer 
patients while they were not detected in any of the samples collected from breast cancer 
patients. It indicates that these two compounds may have a dominant role in triggering 
colorectal cancer tissues. Endrin ketone was detected in the samples of colorectal as well 
as breast cancer patients with high mean concentrations of 154.57 and 83.84 (ng/mL) 
respectively. Moreover, endrin ketone was found in samples of all stages with high mean 
concentrations in stage I and III.  
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8.1. Introduction  
 
Persistent organic pollutants (POPs) exemplify a toxic class of organic chemicals which 
have budding to travel in lipids, store in tissues and induce variety of health problems.  
Since POPs very long half-lives, they manage to withstand in environment for years and 
that is the cause why some POPs can be found in environment although their use was 
banned in early 1970s.  
More chemicals are being added to the famous “dirty dozen” which were confirmed as 
POPs by Stockholm Convention and now this number is preceded to 23. This is a 
significant increase over a period of one decade but the story actually does not stop here 
because many other chemicals have been reported to possess persistent nature and ability 
to accumulate within biological matrix and have not been regulated yet.  Stockholm 
convention categorizes these 23 POPs under different annexes like A, B and C. POPs in 
annex A are banned for any production, use and applications. Annex B POPs are also 
banned for production and use but there exist certain exemptions while POPs in annex C 
are produced as a consequence of some unintended processes. It is pretty important to note 
that these 23 compounds have been regulated but there are hundreds of other organic 
compounds which show similar characteristics but have not been paid that much attention 
with regard of regulations. For examples some organo-metals such as methylmercury and 
other derivatives are highly persistent and tend to bioaccumulate in food chain and human 
body [2].       
POPs present a global challenge and hundreds of reports are published every year 
describing current status, concentrations in different matrix and health effects. Primary 
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sources of POPs, although, have been banned but they had heavily contributed in 
developing secondary sources which include seawater, sediments, aquatic organisms, other 
water bodies, and vegetation soils. These secondary sources have been expected to release 
POPs for next hundred years or even more. POPs have been extensively reviewed from 
different aspects in past few years. 
Many organic pollutants including POPs are well-known to interfere  with endocrine 
system by imitating, hindering and prompting normal activity of hormones and thus effect 
the health and reproductive system of humans and wildlife [3].  These compounds are 
named as endocrine disrupting compounds (EDCs). Number of these compounds is 
increasing day by day due to continuous consumption and applications in the industrial 
sector. These compounds are basically of xenobiotic and exogenous origins which are 
considered to have adverse effect on the normal action of endocrine system and disturb all 
the functions i.e. synthesis, secretion, transport, and binding of hormones. 
EDCs are broadly classified into four categories (i) naturally occurring androgens and 
estrogens (ii) artificially synthesized androgens and estrogens (iii) phytoestrogens (iv) 
other industrial compounds [4]. Synthesized or industrial EDCs are members of different 
classes of chemical compounds and they have been identified in all industrial products 
including pesticides, alkyl phenols, personal care products, polychlorinated biphenyls, 
heavy metals and so on. Synthesized EDCs were basically designed to perform a certain 
kind of action such as plasticizer, solvent or pesticide but later on it was realized that they 
have functional properties which can result in disruption of endocrine systems. 
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Studies describing adverse effects of such compounds on human health have been 
increased in recent years [5]. Because of rapid industrialization throughout the world, the 
production of such chemicals and their introduction into environment has massively 
increased. Prolonged exposure to trace level concentrations of these compounds can induce 
very serious health complications in human body and wild life [6]. It is matter of fact that 
POPs and EDCs occur at trace levels in various environmental and biological samples and 
thus their detection and removal presents a great challenge to analytical chemists. It 
remained a major focus of researchers to extract and detect extremely low concentrations 
of these toxic pollutants. This has been accomplished by developing microextraction 
procedures for sample preparation in combination with advances in analytical 
instrumentation.  
Although persistent organic compounds like OCPs were banned to use as pesticides but 
still they can be detected in environmental samples. Stockholm convention has declared so 
for 23 POPs and among them 13 belongs to OCPs. These include aldrin, dieldrin, endrin, 
chlordane, heptachlor, DDT, hexachlorobenzene, toxaphene, mirex, lindane, chlordecone, 
α-hexachlorocyclohexane and  β-hexachlorocyclohexane [7]. Generalizing health effects 
of OCPs is a really difficult task because they comprise a diversity of chemicals. Pesticides 
are reported to have very severe neurotoxicity, effects on developing reproductive system, 
ability to induce various forms of cancers. They also damage the normal function of thyroid 
hormones in humans and animals [8]. 
In this part of the work, we have screened OCPs in plasma samples of the cancer patients. 
The samples were first extracted by sonication assisted solvent extraction and then 
analyzed by GC-MS.  
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8.2. Experimental  
8.2.1. Sample information  
 
In total, 73 plasma samples were collected from the patients suffering from colorectal and 
breast malignancies. The samples were further distributed on the nature, type and stage of 
malignancy. Information about samples is listed in detail in Table 8-1.  
8.2.2. Chemicals and reagents  
 
A mixture of OCP standards was obtained from Restek (Bellefonte, USA). Fifteen OCPs 
considered for analysis are listed in Table 2. HPLC grade toluene was obtained from Sigma 
Aldrich.   
8.2.3. Extraction Procedure 
 
The plasma samples (500 µL) were taken in Eppendorf vial and 1.0 mL of toluene was 
added into each sample vial. Eppendorf vial was properly closed and samples were placed 
in a sonication bath for a period of 10 min. All the samples were, then, placed in a 
refrigerator for 1 hour. This resulted in freezing of water and plasma samples while toluene 
layer remained in liquid state. 1 µL of toluene layer was injected into GC-MS for 
determination of OCPs.    
8.2.4. GC-MS 
 
GC-MS (QP2010 Shimadzu (Kyoto, Japan)) was used for separation and quantitation of 
target OCPs. The system was equipped with a Shimadzu AOC-20s auto sampler and AOC-
20 auto injector. Rxi-5 Sil MS column with thickness of 0.25 µm, length of 30.0 m and 
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diameter of 0.25 mm (Restek) was used for separation of target compounds. The high 
purity helium gas was used as carrier gas at flow rate of 1.00 mL min-1. The GC injection 
port temperature was maintained 200°C while GC-MS interface temperature was kept at 
220°C. The ion source temperature was fixed as 200°C.The oven temperature was 
programmed as follows: initial temperature was 50°C that was increased to 180°C at 
10°C/min and held for 4 min; then it was further increased to 210°C at 2°C/min and held 
for another 4 min; and finally it was increased to 231°C at 3°C/min and held for 5 min. 
Total run time was 48 min. For qualitative analysis, data acquisition was performed in scan 
mode to confirm the retention times of target compounds. For quantitative analysis, 
selective ion monitoring (SIM) mode was employed. Selected target ions are listed in Table 
8-2. 
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Table 8- 1: Information about plasma samples 
Total number of plasma samples 73 
Samples based on malignancy 
 
Samples from patients with non-malignant 
tumors 
8 
Samples from patients with malignant 
tumors 
65 
Samples based on type of malignancy 
Samples from the patients with colorectal 
cancer  
22 
Samples from the patients with breast 
cancer 
43 
Samples from the patients with 
Stage I 8 
Stage II 15 
Stage III 20 
Stage IV 12 
Stage not known  10 
 
 
 
 
 
230 
 
Table 8- 2: Target compounds, their retention times and selected and m/z of selected target 
ions 
Retention time Target compounds Selected target ions 
16.20 Alpha Lindane  219, 181, 109 
17.68 Lindane  109, 111, 181 
19.35 Delta Lindane  109, 111, 219 
21.36 Heptachlor  100, 65, 272 
26.19 Heptachlor epoxide  81, 353, 355 
27.91 cis-Chlordane  373, 375, 237 
28.85 trans-Chlordane  375, 373, 377 
30.85 4,4'-DDE  246, 318, 248 
32.31 Endrin  81, 67, 79 
33.41 Endosulfan  195, 160, 197 
34.46 4,4'-DDD  235, 237, 165 
37.14 Endosulfan sulfate  272, 274, 229 
38.02 4,4'-DDT  235, 237, 165 
41.12 Endrin ketone  67, 317, 315 
43.24 Methoxychlor  227, 228, 113 
 
 
 
 
 
231 
 
8.3. Results and discussion  
 
The main objective of this work was to determine the concentrations of OCPs in plasma 
samples of cancer patients. In total, 73 plasma samples were collected from colorectal and 
breast cancer patients. The samples were further divided based on nature, type and stage of 
malignancies.   
The plasma samples were extracted using sonication assisted solvent extraction prior to 
GC-MS analysis. Out of 15 OCPs that were selected as target compounds, only 3 
(heptachlor, endrin and edrin ketone) were detected in plasma samples. In order to get a 
more clear idea about accumulation trends of these 3 OCPs, acquired data was analyzed 
based on nature, type and stage of malignancies.  
8.3.1. OCPs in plasma samples of patients with non-malignant and malignant 
tumors  
 
Out of 73 samples, 8 belonged to category of non-malignant and rest of 65 belonged to 
patients with malignant tumors. Heptachlor and endrin were not detected in any of plasma 
samples of patients with non-malignant tumors while endrin ketone was detected in half of 
the samples. The highest concentration of endrin ketone that was detected in non-malignant 
samples was 3519.4 (ng/mL) while the mean concentration of endrin ketone was 464.05 
(ng/mL). On the other hand, all 3 compounds were detected in the plasma samples of the 
patients with malignant samples. The mean concentrations of heptachlor, endrin and endrin 
ketone were 0.43, 9.68, and 107.78 (ng/mL) respectively. The detection frequency of 
heptachlor was very low compared to endrin and endrin ketone, as it was detected in only 
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one  sample out of 65 (1.54%). Endrin and endrin ketone were detected in 10.77% and 
43.08% of the samples respectively.  
The above data indicates that heptachlor and endrin were only present in the plasma 
samples of the patients with malignancies while they were absent in the samples of patient 
with non-malignant tumors. This might be an indication that exposure to heptachlor and 
endrin can be a cause of malignancy. Endrin ketone was detected in both type of samples. 
However, its mean concentration was much higher in non-malignant type than malignant. 
This can be inferred that concentration of endrin ketone decreases as the stage develops 
from non-malignant to malignant (This data is presented in the Table 8-3 and Figure 8-1).   
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Table 8- 3: Mean concentrations (ng/mL) of OCPs in plasma samples of the patients with 
non-malignant and malignant tumors 
OCPs Non-Malignant samples (n=8) Malignant samples (n=65) 
Mean  Range % above 
LOD 
Mean  Range % above 
LOD 
Heptachlor 0.0 ND – 0.0  0.0 0.43 ND – 
28.22 
1.54 
Endrin 0.0 ND – 0.0  0.0 9.68 ND – 
192.17 
10.77 
Endrin 
Ketone 
464.05 ND – 
3519.4 
50.0 107.78 ND – 
3052.49 
43.08 
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Figure 8- 1: Mean concentrations of OCPs (ng/mL) in plasma samples of the patients with 
non-malignant and malignant tumors 
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8.3.2. OCPs in plasma samples of patients suffering from colorectal and 
breast cancer  
 
The plasma samples were further divided based on the type of malignancy. The samples 
were collected only from the patients suffering from colorectal or breast cancers. Out of 65 
samples collected from the patients with malignancies, 22 belong to colorectal cancer 
patients while 43 belong to breast cancer patients. It was observed that heptachlor and 
endrin were only found in the plasma samples of colorectal cancer patients while they were 
not detected in any of the samples collected from breast cancer patients. It indicates that 
these two compounds may have a dominant role in triggering colorectal cancer tissues. But 
this conclusion cannot be supported strongly in favor of heptachlor because it was detected 
in only one sample of breast cancer patient. Endin was detected in 10.77% of the samples 
of breast cancer patients with mean concentration of 9.68 (ng/mL). 
Endrin ketone was detected in the samples of colorectal as well as breast cancer patients 
with high mean concentrations of 154.57 and 83.84 (ng/mL) respectively. The 
concentrations as high as 1849.65 and 3052.49 (ng/mL) were detected in any individual 
plasma sample collected from colorectal and breast cancer patients respectively  (This data 
is presented in the Table 8-4 and Figure 8-2).  
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Table 8- 4: Mean concentrations (ng/mL) of OCPs in plasma samples of the patients with 
different types of cancer 
OCPs Samples from colorectal cancer 
patients (n=22) 
Samples from breast cancer 
patients (n=43) 
Mean  Range % above 
LOD 
Mean  Range % above 
LOD 
Heptachlor 1.28 ND – 
28.22  
4.54 0.0 ND  0.0 
Endrin 28.59 ND – 
192.17  
36.4 0.0 ND  0.0 
Endrin 
Ketone 
154.57 ND – 
1849.65 
45.5 83.84 ND – 
3052.49 
44.2 
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Figure 8- 2: Mean concentrations of OCPs (ng/mL) in plasma samples of the patients with 
different types of cancer 
 
 
 
 
 
 
 
 
0
20
40
60
80
100
120
140
160
180
Colorectal cancer Breast cancer
Heptachlor Endrin Endrin Ketone
238 
 
8.3.3. OCPs in plasma samples of patients at different stages of cancers 
 
In this study, we had 65 plasma samples belonging to patients with malignancies. Out of 
these 65 plasma samples, only 55 were known for the stage of the malignancy.   
The plasma samples collected from the stage I patients were 8 in number. Heptachlor and 
endrin were not detected in any of the stage I samples. However, endrin ketone was 
detected in 37.5% of the samples with a mean value of 387.71 (ng/mL). The highest 
concentration of endrin ketone that was detected in any individual sample was 3052.49 
(ng/mL).  
The plasma samples that belonged to stage II category were fifteen in number. All 3 
compounds heptachlor, endrin and endrin ketone were detected in this category of samples. 
Both heptachlor and endrin were detected in 6.7% of the samples while endrin ketone was 
detected in 46.7% of samples. The mean concentrations of heptachlor, endrin and endrin 
ketone were 1.88, 3.76 and 35.99 ng/mL respectively. In terms of number of samples, 
heptachlor and endrin were detected only in one sample.  
The samples that belonged to stage III were 20 in number. Heptachlor was not detected in 
any of these samples. Endin was detected in 5% of the samples while endrin ketone was 
detected in 50% of the samples. The mean concentrations of endrin and endin ketone were 
2.68 and 150.96 ng/mL respectively. The highest concentration of endrin ketone in an 
individual sample was 1849.65 ng/mL.  
The samples collected from the patients with stage IV of malignancies were 12 in number. 
Results of analysis revealed that heptachlor was not detected in these samples. However, 
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endrin and endrin ketone were detected in 33.4 and 25% of the samples with mean 
concentrations of 38.72 and 17.36 ng/mL respectively (This data is presented in the Table 
8-5 and Figure 8-3).  
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Table 8- 5: Mean concentrations (ng/mL) of OCPs in plasma samples of the patients at 
different stages of cancer 
OCPs Stage I (n=8) Stage II (n=15) Stage III (n=20) Stage IV (n=12) 
Mean Range % 
above 
LOD 
Mean Range % 
above 
LOD 
Mean Range % 
above 
LOD 
Mean Range % 
above 
LOD 
Heptachlor 0.0 ND 0.0 1.88 ND – 
28.22 
6.7 0.0 ND 0.0 0.0 ND 0.0 
Endrin  0.0 ND 0.0 3.76 ND – 
56.42 
6.7 2.68 ND – 
53.56 
5.0 38.72 ND – 
192.17  
33.4 
Endrin 
Ketone 
387.71 21.45 – 
3052.49 
37.5 35.99 ND – 
253.58 
46.7 150.96 ND – 
1849.65 
50.0 17.36 ND – 
98.30 
25.0 
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Figure 8- 3: Mean concentrations of OCPs (ng/mL) in plasma samples of the patients with 
different stages of disease 
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8.4. Conclusion  
In this work, plasma samples belonging to cancer patients were screened for presence of 
OCPs. Out of 15 OCPs studied, only 3 were detected in plasma samples. Data analysis was 
carried out by dividing the samples into different categories such as nature, type and stage 
of cancer. The data analysis indicated that heptachlor and endrin were only present in the 
plasma samples of the patients with malignancies while they were absent in the samples of 
patient with non-malignant tumors. This might be an indication that exposure to heptachlor 
and endrin can be a cause of malignancy. However, this needs to be confirmed by the cell 
line studies. Heptachlor and endrin were only found in the plasma samples of colorectal 
cancer patients while they were not detected in any of the samples collected from breast 
cancer patients. It indicates that these two compounds may have a dominant role in 
triggering colorectal cancer tissues. Endrin ketone was detected in the samples of colorectal 
as well as breast cancer patients with high mean concentrations of 154.57 and 83.84 
(ng/mL) respectively. Moreover, endrin ketone was found in samples of all stages with 
high mean concentrations in stage I and III. 
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9. CHAPTER  
  CONCLUSIONS  
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In this work, different micro-extraction methods were developed for quantification of 
EDCs in biological samples. A MASE-μ-SPE technique used in tandem with HPLC/ UV 
as a novel and efficient method in identifying and quantifying parabens present in 
biological tissues. The porous polypropylene membrane used for construction of μ-SPE 
device, eliminates the entrance of fatty contents and interferences and removes the 
necessity of conducting additional sample-cleanup. Reduced solvent consumption and time 
period are major advantages of μ-SPE compared to SPE. Furthermore, μ-SPE device is 
inexpensive and can be prepared easily. Our research suggests that human ovarian cancer 
tissues contains significant mass fractions of parabens, although a direct causative effect 
cannot yet be attributed to these compounds.   
In the second method, a natural sorbent based µ-SPE was utilized for the extraction of PEs 
in the milk samples. Efficient extraction of PEs was originated from the unique properties 
of the natural sorbent such as porous and fibrous structure and natural enrichment with 
functional moieties. M. oleifera as sorbent is easy to use, reuse and dispose of.  It is green, 
low cost and readily available sorbent.  The proposed natural sorbent based µ-SPE method 
gave reasonable reproducibility and good linearity with LODs lower or comparable to the 
methods reported in the literature. 
In third method, a new mode of membrane protected µ-SPE was described as stir-bar 
supported µ-SPE.  In this mode, a magnetic stir-bar and an accurately weighed amount of 
sorbent was packed inside the porous polypropylene membrane. This mode of extraction 
improved the extraction performance considerably. PCBs were employed as model 
compounds to access the extraction performance of the proposed method in human serum 
samples. The extracted samples were analyzed by GC-MS. The performance of this method 
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in extraction of PCBs from serum samples was excellent. This method provided low LODs, 
good linearity and satisfactory intra-day and inter-day reproducibility for all tested PCBs. 
SB- µ-SPE can be extended to analysis of other types of organic and inorganic pollutants 
in complex sample matrices.   
In another work of method development, a simple and facile procedure was adopted for 
synthesis of zinc oxide incorporated carbon foam. For the first time, this synthesized 
material characterized using SEM and XRD analysis. Later, it was utilized as sorbent in µ-
SPE of OCPs in milk samples. The method provided good linearity and LODs for tested 
target compounds.  
At the end, concentrations of OCPs and PCBs were screened  in different types of human 
cancer tissues. Cancer tissue amples were extracted using ultrasonication assisted solvent 
extraction. . ΣOCPs were highest in colorectal (3951.8 ng/g) and breast (3921.3 ng/g) 
tissues while significant concentrations were also found in thyroid and kidney tissues. 
ΣPCBs were highest in thyroid tissues followed by colorectal, breast and kidney tissues. 
Notably, ΣOCPs were several times higher than ΣPCBs in all types of cancer tissues. OCPs 
were further classified into five groups of closely related compounds. Concentrations of 
ΣBHCs were higher than ΣCHLs, ΣDDs, Σdrins and Σendosulfan in all type of tissues 
except the kidney where ΣCHLs were slightly higher than ΣBHCs. This study suggests 
sorting out the sources of these compounds in the Saudi Arabian environment for complete 
correlation among the disease and cause.  
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In addition to tissue samples, plasma samples belonging to cancer patients were also 
screened for presence of OCPs. Out of 15 OCPs studied, only 3 were detected in plasma 
samples. Data analysis was carried out by dividing the samples into different categories 
such as nature, type and stage of cancer. The data analysis indicated that heptachlor and 
endrin were only present in the plasma samples of the patients with malignancies while 
they were absent in the samples of patient with non-malignant tumors. This might be an 
indication that exposure to heptachlor and endrin can be a cause of malignancy. However, 
this needs to be confirmed by the cell line studies. Heptachlor and endrin were only found 
in the plasma samples of colorectal cancer patients while they were not detected in any of 
the samples collected from breast cancer patients. It indicates that these two compounds 
may have a dominant role in triggering colorectal cancer tissues. Endrin ketone was 
detected in the samples of colorectal as well as breast cancer patients with high mean 
concentrations of 154.57 and 83.84 (ng/mL) respectively. Moreover, endrin ketone was 
found in samples of all stages with high mean concentrations in stage I and III. 
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